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Summary 
Spinal cord injury (SCI) leads to severe functional deficits and currently there 
are no effective treatments. In addition to the initial mechanical damage to 
axons, neurons and glia, traumatic injury also triggers a complex array of 
cellular and molecular events. Some of these processes are thought to 
contribute to mechanisms of progressive damage (secondary mechanisms) whilst 
others concurrently promote limited repair. Functional outcome depends on the 
interaction of these two processes. However, the interacting dynamics and time 
course with which they impact the functional outcome is not fully understood. 
Secondary processes are studied with molecular and anatomical approaches and 
loss of axons or neurons are used to infer reduced function. Similarly, recovery 
of functional outcome is mostly assessed using behavioural approaches. 
However, these are unable to differentiate recovery due to compensatory plastic 
changes in the brain which might contribute to recovery. Therefore, the first 
aim of the thesis was to develop an electrophysiological approach to directly 
assess functional changes in spinal cord circuits following a contusion SCI. The 
second aim was to use this protocol combined with behavioural testing in order 
to investigate the use of human embryonic stem cell derived mesenchymal stem 
cells (hESC-MSCs) as a potential therapy for spinal cord injury. 
An electrophysiological approach was used to assess spinal cord function after 
contusion injuries at the cervical (C6) level of the rat spinal cord. Contusion 
injuries due to high velocity impact were made using an Infinite Horizon 
Impactor device. Cord dorsum potentials (CDPs) evoked by supramaximal 
electrical stimulation of a radial nerve (to activate sensory fibres) or within the 
pyramids (to activate corticospinal fibres) were used to measure changes in the 
function of these fibre systems in the vicinity of the injury. Animals were 
investigated at different time points from acute up to 6 months post injury to 
characterise the temporal progression of changes in spinal cord function. 
Contusion injury produced an immediate substantial reduction in sensory circuit 
function which was highly localized to the site of the impact. However, CDPs 
continued to be evoked both above and below the injury site. This suggests that 
the main sensory axons in the dorsal column which carry impulses past the level 
of the injury are not substantially affected and deterioration of function at the 
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injury centre is a result of damage to the neurons and axon collaterals located at 
the site of impact. Further worsening occurred over the following 3 days but was 
more marked above the level of the injury possibly because it is due to 
demyelination of the main sensory axons. However, CDP mapping at 2 weeks 
showed almost complete recovery of the potentials above this compared to 3 
days reflecting a repair mechanism which is possibly remyelination. The fact 
that CDP amplitudes at 2 weeks are very close to those recorded immediately 
after injury suggests that most of the loss of function produced by the contusion 
is due to primary mechanical trauma and that secondary mechanisms contribute 
relatively little to the loss of function. CDP amplitudes recorded 4 weeks, 7 
weeks and 3 months after injury remained closely similar to 2 weeks suggesting a 
prolonged period of stability in the sensory system. However, a later phase of 
deterioration is observed at 6 months below the injury possibly due to extension 
of the injury cavity causing further neuronal loss. Histology also revealed 
significantly larger cavities in 6 month survival animals.   
CDPs evoked by stimulation of the corticospinal tract below the injury level were 
profoundly depressed immediately following a contusion reflecting extensive 
damage to the main component of the CST in the dorsal columns while 
potentials above the injury were not acutely affected. There was a further 
reduction in CDP amplitudes rostral to the injury at 3 days due to demyelination 
or die back of CST fibres in the dorsal columns. Substantially this improved at 2 
weeks and then remained stable up to 6 months. Below the injury there was a 
gradual increase in the strength of corticospinal connections evident by an 
increase in CDP amplitudes at 7 weeks which was maximal by 3 months. This 
reflects plasticity in the spared corticospinal projection probably those in the 
lateral component. 
Mesenchymal stem cells (MSCs) from bone marrow (BM) have been reported to 
promote repair and some functional improvement in animal models. However, 
autologous transplantation of BM-MSCs has several disadvantages such as the 
need for invasive harvesting, variable cell quality and slow proliferation. We 
have successfully derived MSC-like cells from human embryonic stem cells 
(hESCs) and have found that these cells show anatomical evidence of repair after 
transplantation in an animal model of SCI (Mohamad, 2014). Delayed transplants 
of hESC derived MSCs (hESC-MSCs) were performed in a cervical (C6) contusion 
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(175 kdyn) injury model. These cells were transplanted 3 weeks after injury and 
immunosuppression was begun two days prior to this and continued for the 
remainder of the study. Functional outcomes were evaluated behaviourally using 
grip strength and horizontal ladder walking to assess improvement in forelimb 
function. In electrophysiology experiments cord dorsum potentials (CDPs) evoked 
by supra-maximal electrical stimulation of a radial nerve or within the pyramids  
were used to measure changes in the function of these fibre systems in the 
vicinity of a spinal cord injury at 7 weeks post-transplant.  
There was a substantial reduction in the gripping ability immediately after the 
contusion injury followed by a modest spontaneous recovery. Weekly assessment 
of the grip strength score before and after transplantation revealed no 
differences in hESC-MSC transplanted and control groups of animals. Similarly, 
ladder walk analysis revealed loss of co-ordinated forelimb-hindlimb stepping 
and increased errors of forepaw placement on the ladder rungs after injury. 
There was no difference in the recovery of co-ordination or improvement of 
forelimb function after hESC-MSC transplants compared to control animals. 
Similarly, terminal electrophysiological experiments showed that the amplitudes 
of CDPs evoked by radial nerve stimulation were closely similar at all recording 
locations in both groups of animals. However, corticospinal evoked CDPs showed 
deterioration of function in the transplanted animals compared to the control 
group of animals. Histology indicated that hESC-MSCs survived in considerable 
numbers and were present in all transplanted animals at 7 weeks leading to solid 
infilling of the injury site and a reduction in injury site extent compared to the 
medium injected control group of animals. 
In conclusion, the results in the first part of the thesis suggest that maximum 
damage after contusion injury occurs at the time of injury and spontaneous 
recovery of function largely mitigates the small amount of the secondary 
damage. Therefore, injury due to high velocity impact might not be amenable to 
neuroprotective therapies. Furthermore, evidence of modest spontaneous 
plasticity in the spared corticospinal system suggests some compensatory 
plasticity after the injuries.   
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1.1 Spinal cord injury  
Spinal cord injury (SCI) is a complex and devastating condition that impacts on 
every aspect of an individual’s life, ranging from the patient’s ability to carry 
out everyday responsibilities to skilled tasks. It has a significant impact on the 
quality of life, life expectancy, and economic burden. The majority of spinal 
cord injuries lead to a permanent disability and there is a lifelong dependency 
(Thuret et al., 2006). This lifetime debility is due to the limited capacity of the 
spinal cord for repair and the lack of an effective treatment to overcome these 
detrimental consequences after injury or to reverse the damage (Di Giovanni, 
2006).  
The spinal cord is a caudal extension of the brain stem down into the vertebral 
column. It receives and processes sensory information from the muscles, joints, 
skin and viscera and sends motor signals to the body muscles. It also receives 
autonomic responses from different parts of the body. Traumatic injury to the 
spinal cord leads to disruption of these ascending and descending pathways 
leading to loss of sensory, motor and autonomic function.  This has a number of 
consequences depending on the injury level and severity; paralysis being the 
most common along with other associated conditions due to immobility such as 
deep vein thrombosis, pressure ulcers and osteoporosis; autonomic dysreflexia 
and neuropathic pain are also common complications associated with SCI (Vawda 
et al., 2012). Moreover, patients and relatives experience social and emotional 
stress due to permanent immobility, along with financial burdens (Baptiste and 
Fehlings, 2007).  
1.2 Epidemiology  
It has been estimated that approximately 130,000 new cases of SCI occur 
worldwide each year (Illes et al., 2011). The incidence and aetiology differs 
demographically with a range of 10-83 per million population each year 
(Wyndaele and Wyndaele, 2006) and its prevalence is estimated to be around 235-
1800 sufferers per million in different parts of the world (Hagen et al., 2012). 
Even in the UK and Ireland every year around 1000 individuals are paralyzed due 
to SCI, adding to the overall burden of 50,000 already affected. In the USA, 
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there are about 12,000 new cases annually, excluding those who die immediately 
after injury (National Spinal Cord Injury Stastitical Centre, 2014).  
SCI most commonly affects young people involved in high risk activities (Couris 
et al., 2010, Varma et al., 2010) and especially in their 3rd decade of life 
(Baptiste and Fehlings, 2007). In the USA road traffic collisions (RTCs) contribute 
about 36.5%, 28.5% are a result of falls and 9.2% is due to sporting injuries 
(National Spinal Cord Injury Stastitical Centre, 2014). In the UK about 38.5% are 
due to RTCs and 41.7% falls (Apparelyzed, 2013). Sport related injuries are more 
common in developed countries whereas work related injuries are more common 
in developing countries and more recently injuries related to firearms are on the 
increase in some parts of the world.   
1.3 Anatomy of the Spinal cord 
1.3.1 General anatomy of spinal cord 
The spinal cord is a caudal extension of the brain and it lies inside the vertebral 
column which supports and protects the cord from physical damage. It is covered 
by three membranes called meninges. The dura mater is the outer layer, 
arachnoid mater is the middle layer and innermost is called the pia mater. In 
addition, cerebrospinal fluid (CSF) which gives further cushioning to the cord 
runs in the subarachnoid space (space between arachnoid and pia mater) (Figure 
1-1). CSF also maintains the metabolic environment and relative immunological 
protection to the CNS (Irani and Prow, 2007).  
The spinal cord contains millions of neurons involved in the transmission of 
sensory, motor and autonomic information from trunk, limbs, viscera and other 
parts of the body to CNS and vice versa. Sensory information enters the cord 
through the dorsal nerve roots, which enter the dorsal aspect of the spinal cord. 
Motor nerve roots exit the ventral aspect of the cord and combine with sensory 
roots to form a spinal nerve.  
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Figure 1-1. Organization of the spinal cord.  
Diagram showing arrangement of the 3 layers of meninges (pia mater, arachnoid mater and dura 
mater) and the surrounding vertebral column, providing protection to the delicate spinal cord. The 
transverse section of the spinal cord shows the centrally located butterfly shaped grey matter 
surrounded by white matter. Grey matter is mainly composed of the neuronal and glial cell bodies, 
whereas white matter primarily contains axonal fibres. Each segment of the spinal cord consists of 
two anterior (ventral) and posterior (dorsal) roots which carry motor and sensory impulses 
respectively (Adapted from (Molson Medical Informatics, 2008). 
1.3.1.1 Grey and white matter  
The spinal cord is divided into a butterfly-shaped column called the grey matter 
which consists of neuronal cell bodies and is surrounded by white matter which 
contains nerve fibres (Afifi and Bergman, 2005). The grey matter is further 
divided into the dorsal horn, the intermediate grey, the central grey and the 
ventral horn.  It can also be divided into 10 laminae from dorsal to ventral 
aspect each with different morphological and functional classes of neurons 
(Rexed, 1952). Grey matter is surrounded by the white matter containing 
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ascending and descending pathways and is further divided into dorsal, 
dorsolateral, ventrolateral and ventral funiculi (Molander and Grant, 1995). 
Different ascending and descending tracts run through different parts of the 
white matter. There are some anatomical differences between different species 
with respect to where the tracts are placed in the white matter. Comparison of 
different tracts running in the rat and human spinal cord are shown in the Figure 
1-2. 
 
Figure 1-2. Comparison of rat and human spinal cord. 
Comparison of size of the spinal cord and approximate location of different ascending and 
descending tracts are compared in rat and human spinal cord. Main component of CST in rats lies 
in the ventral part of the dorsal white column. Minor components are located in the lateral and 
ventral white matter. In humans main component is located in the lateral white matter and minor 
component in ventral white matter. Dorsal column pathway lies in the dorsal white matter in both 
rats and humans (Adapted from (Silva et al., 2014). 
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1.3.1.2 Segmental organisation  
The length of the spinal cord is shorter than the vertebral column and thus 
spinal segments do not correspond to the overlying corresponding vertebral 
bones. The spinal cord diameter varies rostrocaudally and contains two 
enlargements at the mid cervical and lumbosacral regions, which extend from 
spinal segments C3 to T2 and L1 to S3 respectively. These enlargements 
represent the location of neurons that innervate the upper and lower limbs (Afifi 
and Bergman, 2005).  
Human spinal cord: The human spinal cord occupies the upper two-thirds of the 
vertebral column and is divided into 31 segments comprising 8 cervical, 12 
thoracic, 5 lumbar, 5 sacral and 1 coccygeal (Figure 1-3).  
Rat spinal cord: The rat spinal cord consists of 34 segments and is divided into 8 
cervical, 13 thoracic, 6 lumbar, 4 sacral and 3 coccygeal.    
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Figure 1-3. Schematic diagram of human spinal cord segments, vertebrae and respective 
roots. 
There are 8 cervical, 12 thoracic, 5 lumbar, 5 sacral and 1 coccygeal nerve arising from the each 
side of the spinal cord. The spinal segments at birth correspond to the vertebral levels. However, 
the vertebral column grows much faster as compared to the spinal cord and thus the adult spinal 
cord occupies the upper two-third of the vertebral column. The terminal portion of the cord tapers to 
form the conus medullaris and is located at L1-2 vertebral regions. The spinal segments continue 
to exit from the corresponding vertebral foramina. The lumbar, sacral and coccygeal roots gets 
longer during the process of development within the vertebral column and the roots collectively with 
conus medullaris are known as the cauda equine. (Adapted from (Silva et al., 2014). 
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1.3.2 Ascending pathways in the dorsal column  
Ascending pathways in the spinal cord carry information from the trunk and 
limbs to the brain. The ascending fibres in the dorsal column are divided into 
two main groups. 1) direct dorsal column pathway (DC pathway) 2) postsynaptic 
dorsal column pathway (PSDC pathway). Ascending pathways in the dorsal 
column have similar organisation both in human and rats (Figure 1-2). 
1.3.2.1 Ascending pathways in the dorsal column of the rat spinal cord 
The direct dorsal column pathway or dorsal column-medial leminiscus pathway is 
the main ascending pathway in the mammalian CNS. In addition, the DC pathway 
contains 25% propriospinal fibres. Cell bodies of the primary afferents of the DC 
pathway lie in the dorsal root ganglion. They send branches peripherally to 
innervate sensory receptors in the skin, muscle and viscera, and also centrally to 
the spinal cord via dorsal roots. In the spinal cord primary afferents bifurcate 
into ascending and descending fibres. Descending fibres generally do not 
maintain a well-organized topographical distribution and usually terminate 
within two segments from their site of entry. However, a small fraction of the 
ascending projecting afferents terminate in the dorsal column nuclei (Figure 
1-4), while most of the other fibres terminate in various regions of the grey 
matter.   
About 15% of the ascending fibres originating in the lumbar region reach the 
nucleus gracilis and up to 63% from the cervical region ascend all the way up to 
the nucleus cuneatus in the medulla. The ascending fibres have a topographical 
arrangement in the dorsal column of the spinal cord as seen in the 
somatosensory cortex. Fibres from the tail and hindlimb project close to the 
midline through the fusciculus gracilis, accumulating laterally as they travel 
rostrally, while fibres from the trunk and forelimb ascend laterally in the 
fasiculus cuneatus as they join the dorsal columns (Smith and Bennett, 1987). 
Axons travelling in the dorsal column send collaterals in the grey matter mainly 
in the dorsal horn, intermediate region and to a certain extent in the ventral 
horn (Willis and Coggeshall, 2004). 
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It is estimated that about 25% of the primary afferents in the dorsal column are 
comprised of unmyelinated fibres in the rat (Chung et al., 1987). These 
unmyelinated afferents carry information from nociceptors or receptors in 
viscera to the dorsal column nuclei (McNeill et al., 1988, Tamatani et al., 1989, 
Patterson et al., 1990). 
The post synaptic dorsal column pathway is a polysynaptic pathway, relayed by 
neurons located in the nucleus proprius located ventral to the substantia 
gelatinosa in lamina III and IV. This pathway consists of axons arising from the 
neurons in the spinal cord which project to the dorsal column nuclei (Giesler et 
al., 1984). The axons from postsynaptic dorsal column neurons terminate at all 
levels of the gracile and cuneate nuclei and also in the external cuneate nucleus 
(de Pommery et al., 1984). All PSDC cells from the lumbar region project via 
dorsal columns but some of the PSDC from the cervical region go through the 
dorsal column and dorsolateral column. 
 
Figure 1-4. Schematic representation of primary afferent fibre organization in the spinal 
cord.  
The somas of the primary sensory neurons are located in the dorsal root ganglia. The ganglion 
gives rise to peripheral and central axonal projections. The central axons from large myelinated 
sensory afferents enter the dorsal column via dorsal roots where these bifurcate into ascending 
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and descending branches. Primary afferents give off collaterals at regular interval which arborize in 
the dorsal horn. The descending branches terminate within one to two segments, while a 
proportion of the ascending fibres travel to the brain to terminate in the dorsal column nuclei. 
(Adapted from (Brown et al., 1981). 
1.3.3 Corticospinal tract 
The Corticospinal (CST) tract is one of the main descending pathways and found 
only in the mammalian CNS. It is an important descending pathway associated 
with fine motor control of hands in humans and other primates and is therefore 
one of the most investigated pathways in animal studies of SCI and repair. The 
distribution of corticospinal neurons in the cerebral cortex is similar in the 
human and rat, however, the organisation of corticospinal pathway in the spinal 
cord is different. In humans the main component of the CST is located in the 
lateral white matter and a minor component lies near the midline in the ventral 
column. Whereas, in the rat the main component of CST (dorsal CST), is located 
in the ventral aspect of the dorsal white matter below the dorsal column 
pathway and minor components lie in the ventral and lateral white matter 
(Figure 1-2).  
1.3.3.1 Origin and course of CST in the rat 
Corticospinal neurons, also called pyramidal neurons are located in layer V of 
the sensorimotor cortex. There is a considerable overlap between the 
somatosensory and motor cortex in the rat cerebral cortex. Pyramidal fibres 
have been shown to send collaterals to various brainstem nuclei including the 
dorsal column nuclei, the red nucleus, inferior olivary nuclei and pontine nuclei 
(O'Leary and Terashima, 1988).  
The CST is divided into a crossed and uncrossed component. The majority of the 
fibres cross to the contralateral side in the medulla oblongata at the pyramidal 
decussation. The main crossed fibres then descend through the ventromedial 
aspect of the dorsal column of the spinal cord and comprise 90% of fibres. 
However, minor components are found in the ipsilateral dorsal, ipsilateral 
ventral and contralateral dorsolateral funiculi (Brosamle and Schwab, 1997). 
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The CST fibres terminate mainly within a region corresponding approximately to 
laminae III-V in the contralateral grey matter of the spinal cord. However, 
terminations are also found in lamina VI at cervical and lumbar enlargements. 
On the other hand, terminations have also been found within other laminae 
including ipsilateral laminae III-X, with an emphasis in laminae VII, VIII and X, 
contralateral laminae VI-X, and sparse projections to the more superficial 
laminae I and II (Casale et al., 1988, Brosamle and Schwab, 1997, 2000) (Figure 
1-5). 
Function: The CST is an important descending motor tract and it is involved in 
fine voluntary movements of the body; for example, forelimb movements as in 
the reaching task (Anderson et al., 2005). In rats, damage to either the main 
dorsal component (McKenna and Whishaw, 1999) of the CST or the motor cortex 
(Schrimsher and Reier, 1993) results in errors involving fine digital movements of 
the limbs.  
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Figure 1-5. Schematic representation of Corticospinal Tract (CST) organization. Schematic 
cross section at mid thoracic level of the adult rat spinal cord.  
Diagram illustrates Biotin Dextran Amine (BDA) tracing from the right hemicortex showing several 
components of the CST. Camera lucida reconstruction of different components of the CST 
photographed from A-D. A: The main contralateral component of CST in the ventral part of dorsal 
white matter (darker area) and ipsilateral dorsomedial funiculus (arrowheads). B: The contralateral 
minor component of CST running in the lateral white matter. C: Ipsilateral ventromedial funiculus 
running in the ventral white matter. D: Ipsilateral lateral white matter. The dash line demarcates the 
white and grey matter (taken from (Brosamle and Schwab, 1997).  
1.4 Injury level and type  
The overall outcome after SCI depends on the level and type of the injury. 
Depending on the preserved neurological function below the level of the injury, 
SCI can be characterized into complete and incomplete injuries. However, post 
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mortem studies reveal that the spinal cord is rarely completely severed after 
trauma (Norenberg et al., 2004). In a complete injury there is no sensation or 
voluntary motor output below the level of the injury. Incomplete injuries have 
some preservation of function below the level of the injury, which could be 
sensory or motor or both. This classification is defined by the lowest level that 
has normal neurological function.  
Clinically, the American Spinal injury Association (ASIA) Impairment Scale (AIS) is 
the most widely accepted scheme for classifying patients according to the injury 
severity and deficits in neurological function (Kirshblum et al., 2011a).  
The AIS is divided into 5 categories from A-E depending on injury level and testing of 
key muscle functions corresponding to 10 myotomes. The sensory level is 
determined as the most caudal level at which there is a normal response to both 
light touch and pinprick. The motor level is determined by normal strength in key 
muscles on both side of the body. Motor strength and spinal level of normal motor 
output are determined by performance of the following voluntary movements; 1) 
elbow flexion “C5” 2) wrist extension “C6” 3) elbow extension “C7” 4) finger flexion 
“C8” 5) finger abduction “T1” 6) hip flexion “L2” 7) knee extension “L3” 8) ankle 
dorsiflexion “L4” 9) toe extension “L5” and 10) ankle plantar flexion “S1”.  
The classification of AIS used in grading the degree of impairment is as follows: 
ASIA A: Also called “complete” SCI where there is complete loss of function. There 
are no motor or sensory outputs observed in the lowest sacral segment i.e. S4-S5. 
ASIA B: categorised as sensory incomplete and sensory but not motor function is 
preserved below the neurological level and also includes sacral segments S4-S5. 
ASIA C: is considered motor incomplete and motor function only is partially 
conserved below the level of the injury and more than half of the key muscles 
below the level of the injury have muscle power of less than grade 3. 
ASIA D: also known as motor incomplete and here motor function is preserved and 
more than half of the key muscles have power of grade 3 or more. 
ASIA E: indicates motor and sensory functions are normal. 
Chapter 1  33 
 
 
The level of the injury in the spinal cord determines the deficits in parts of the body 
where function may be lost and impaired. Cervical level injuries mostly lead to 
quadriplegia in which all the four limbs are affected. Paraplegia occurs in injuries 
usually below the first thoracic level.  
 Cervical level SCI is the most common in Europe and is estimated to account for 
about 45% of all cord injuries; followed by thoracic injuries, approximately 29% and 
23% for lumbar (Hasler et al., 2012).   
Functional deficits with injuries at different levels: Functional deficits depend on 
the level and extent of the injury. There are more severe consequences as the level 
of the injury is higher up the spinal cord. Lumbar and sacral injuries result only in 
loss or decreased control of the lower limbs and pelvic region. Lower thoracic 
injuries between T9-T12 result in partial paralysis of lower body and legs, while 
injuries higher in the thoracic region (T1-T8) leads to poor control of trunk and 
abdominal muscles. People with C7-T1 injuries tend to have deficits in their digits 
and hand function whilst control of the remaining arm musculature is intact. Injury 
at the C6 level leads to loss of finger and hand function whilst wrist function 
remains intact. Patients with C5 injuries have loss of wrist function and are only 
able to control upper arm and shoulder, whereas C4 level pathology might include 
slight control over the shoulder and upper arm but this will be weaker compared to 
C5 level injury. Injury at C3 and above usually leads to loss of control of the 
diaphragm and ventilator support for breathing is needed in this case (Figure 1-6) 
(Thuret et al., 2006). 
In addition to the above complications, regardless of the level of the pathology 
patients might suffer from secondary consequences of spinal injuries such as 
spasticity (Levi et al., 1995), neuropathic pain (Ehde et al., 2003), autonomic 
dysreflexia (Rabchevsky, 2006) and pressure ulcers (Liem et al., 2004).  
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Figure 1-6. Diagram showing levels of SCI and functional deficits caused at each level.  
The symptoms and deficits after SCI depend on the level and severity of the injury. Injury at 
cervical levels lead to quadriplegia e.g. injury at C4 spinal level results in quadriplegia and 
incomplete paralysis below the neck. Injury below the first thoracic level result in paraplegia e.g. T6 
SCI cause paralysis in lower half of the body while maintaining function in upper extremities. Injury 
at L1 leads to paralysis below the waist line. (adapted from (Thuret et al., 2006). 
1.5 Animal models of SCI 
SCI has a complex pathology which is still not fully understood. In order to 
investigate the mechanisms and potential treatments different animal models of 
SCI have been developed. Although it is impossible to address all the features of 
human SCI in animals, different injury models have been utilised to assess 
different aspects of traumatic human SCI. However, it is known that there are 
differences in anatomical, functional and behavioural outcome in different 
animal strains and variations should be kept in mind while assessing the results 
in different injury models (Mills et al., 2001).  
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Both rodents and higher animals including dogs, cats and pigs, have been used to 
develop animal SCI models (Blight and Young, 1989, Jeffery et al., 2005, Navarro 
et al., 2012). However, rodents, including rats and mice, have been the most 
commonly used due to the relative ease of breeding, cost effectiveness, 
relatively low susceptibility to infections, consistency between studies and well 
established functional assessment methods. 
1.5.1 Contusion   
The contusion injury model in animals mimics incomplete SCI as seen in clinical 
cases of human SCI. Initial mechanical trauma is followed by a cascade of 
secondary responses which are considered to continue for months to years. 
Furthermore, contusion also leads to motor and sensory dysfunction below the 
injury, such as paralysis of the hindlimbs and bladder dysfunction in thoracic 
level contusion injuries and both conditions show some degree of functional 
recovery with time.  Histological examination has revealed that grey matter is 
easily disrupted compared to white matter (Gensel et al., 2006, Ek et al., 2010, 
James et al., 2011) and leads to the formation of fluid filled cystic cavities which 
correspond with the findings observed in clinical settings (Edgar and Quail, 1994, 
Squier and Lehr, 1994). The contusion models are potentially useful for 
evaluating neuroprotective strategies, plasticity and demyelination, because of 
partial preservation of tissue. However, due to the incomplete nature of the 
injury and the complexity of spinal tracts it is not an ideal SCI model for 
investigation of regeneration. 
The first well documented contusion injury model using a weight drop method 
was produced by Allen in 1911. Different severities of injuries were produced 
using the New York University (NYU) impactor by dropping a 10-g rod 
perpendicularly onto the dorsal surface of the exposed spinal cord. Different 
severity injuries can be generated by dropping the impactor from different 
heights (Gruner, 1992). However, this method has some limitations such as the 
bouncing of the rod causing multiple impacts and the length of time it stays in 
contact with the cord (dwell time) and the inability to control the final velocity 
of the impactor (reviewed in (Kwon et al., 2002).  
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A more advanced model, using a computer controlled device, is the Ohio State 
University (OSU) impactor (Bresnahan et al., 1987, Noyes, 1987, Stokes, 1992). 
This impactor controls the displacement of the rod and is actively withdrawn 
following the impact (usually ranging from 0.8 to 1.1 mm) and hence avoids 
bouncing. However, the impactor tip has to be placed in contact with the 
surface of the spinal cord (30 μm pre-set displacement) before operation.   
Another device, the Infinite Horizon (IH) impactor is a force-feedback controlled 
device with a sensor attached to the impactor which measures the actual force 
applied to the spinal cord (Scheff et al., 2003). As a result, the IH device can 
optimize the consistency and precision of the mechanical forces applied during 
injury. It can also generate different degrees of injury severity and dwell times 
can be adjusted. The device also gives an instant graphical and numerical output 
of actual force and displacement for immediate evaluation of individual injury.  
Contusion injuries lead to impairment of sensory and motor function, however, 
modest recovery is observed with time depending on the severity of the injury. 
Complete loss of locomotor ability in the hindlimbs is initially observed after 
severe thoracic contusion injury made with IH impactor. The BBB score drops to 
zero 1 day after injury followed by a gradual improvement in locomotor ability 
plateauing at 3 weeks at a score of 10 (Totoiu and Keirstead, 2005). Similarly, 
locomotor function is initially severely impaired with mean BBB score of 3.4 at 1 
day after a mild contusion injury (150 kdyn) at T10. This is followed by 
spontaneous recovery with the BBB score reaching 13 at 3 weeks and remaining 
at this level into chronic post-injury stages (i.e. 6 months post-injury) (James et 
al., 2011). Similar findings are observed in cervical contusion models, where loss 
of gripping ability is seen immediately after the injury followed by a modest 
spontaneous recovery. Maximal improvement in the grip strength is reached at 2 
weeks after the injury (Anderson et al., 2009b). 
1.5.2 Compression 
This injury model was developed in 1978 by Rivilin and Tator to produce static 
compression to the cord (Rivlin and Tator, 1978). It is used to simulate the 
ongoing compression secondary to the residual spinal column displacement. 
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Compression injuries can be produced using clips (Fehlings and Tator, 1995) or 
forceps to pinch the cord (Blight, 1991), applying sub dural inflatable balloons 
(Martin et al., 1992, Vanicky et al., 2001) or placing a certain amount of weight 
on the surface of the cord (Black et al., 1986, Nystrom et al., 1988, Huang et 
al., 2007). As for contusion models, different severity of injury can be produced 
by altering the duration and extent of displacement (Joshi and Fehlings, 2002). 
This model is valuable in understanding acute pathophysiology and studying 
neuroprotective therapies after SCI. 
1.5.3 Transection  
Partial or complete transections of spinal cord using microdissecting instruments 
have also been used frequently to model SCI. These can be performed with 
relative ease and consistency. Transection models are most useful for assessing 
axonal regeneration across the injury (Schrimsher and Reier, 1993, Webb and 
Muir, 2002, Steward et al., 2006) in long white matter tracts. In comparison, 
partial transection is less severe and offers several advantages such as fast 
postoperative recovery. Also a particular tract can be severed to gain specific 
information. Similarly unilateral transection can be done for comparison with 
the contralateral, unaffected side.     
1.5.4 Chemically-mediated SCI 
Different chemically- mediated SCI models also exist and these models are used 
to evaluate specific pathology involved in SCI. For example, excitotoxicity is 
produced by intraspinal injection of quisqualic acid causes release of excitatory 
amino acids and mimics glutamate excitotoxicity as seen after spinal trauma 
(Yezierski et al., 1993, Yezierski et al., 1998). Demyelination is another feature 
seen in SCI and this type of pathology can be triggered by injection of ethidium 
bromide into the spinal cord (Gilson and Blakemore, 2002). Similarly, vascular 
occlusion of spinal vessels by intravenous injection of Erythrosin B 
(photosensitizing agent) followed by irradiation with argon laser leads to 
ischemic necrosis of spinal tissue (Watson et al., 1986, Hao et al., 1991). 
Specific pathologies can be produced in chemically mediated SCI and hence 
specific feature can be studied in detail and therapeutic intervention targeting 
each pathological feature can individually be targeted.     
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1.6 Pathology following SCI  
Most of the pathological information regarding SCI is obtained from animal 
studies, due to the paucity of information from clinical injuries. Traumatic SCI 
results in a cascade of events, starting immediately after the impact, which can 
continue for years (Schwab and Bartholdi, 1996). Events after SCI can be divided 
into an acute stage starting immediately after impact, followed by a secondary 
phase of tissue loss lasting for days and weeks and a chronic phase which can 
continue for months to years (Tator, 1995, Hulsebosch, 2002). Different 
pathological events following SCI are summarized in the Figure 1-7. 
 
Figure 1-7. Summary of pathophysiological events after SCI. 
SCI involves two stages of injury processes. Primary injury is due to the mechanical impact which 
results in local effects causing damage. This initial damage is followed by cascade of secondary 
processes starting minutes after injury and progresses for weeks and months (taken from (Bareyre 
and Schwab, 2003)). 
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1.6.1 Blood flow alterations  
SCI disrupts blood vessels causing haemorrhage in the vicinity of the injury site. 
This is observed in both human and experimental animal models. These blood 
flow alterations are vital in the evolution of the secondary process. Disruption of 
blood flow leads to hypoxia causing a substantial ischemic necrosis (Dumont et 
al., 2001) and oedema develops due to intracellular calcium accumulation and 
an increase in extracellular potassium ion concentration (Schwab and Bartholdi, 
1996). Vasospasm (Anthes et al., 1996) and thrombosis (Koyanagi et al., 1993) 
further aggravate the ischemia. Due to inadequate oxygen this translates into a 
general failure of neural function leading to a stage of spinal shock (Bach-y-Rita 
and Illis, 1993, Dumont et al., 2001), which last for a few days in animal models 
to several weeks in humans (Bareyre and Schwab, 2003). 
Traumatic SCI has shown to lead to up-regulation of the expression of 
proteinases, in particular matrix metalloproteinases which leads to disruption of 
the blood-brain barrier (BBB). This breakdown of the BBB facilitates the influx of 
inflammatory cells into the CNS enhancing the inflammatory response. 
Haemorrhage usually starts centrally in the grey matter and later extends into 
the white matter (Mautes et al., 2000). 
1.6.2 Oedema  
Haemorrhage and leakage of fluid from the damaged capillaries into the normal 
fluid filled spaces contributes to local oedema. This occurs within minutes after 
trauma and is maximal in the first few hours (Griffiths and Miller, 1974). Oedema 
starts in the central portion of the cord and is seen to spread outwards into the 
white matter and is also seen to extend a considerable distance rostrally and 
caudally (Noble and Wrathall, 1989, Wang et al., 1993). The extent depends on 
the severity of injury. It is also suggested that it exerts its harmful effects by 
compressing the local tissue and vasculature, thus contributing to further 
necrosis (Griffiths and Miller, 1974).   
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1.6.3 Necrosis, apoptosis and excitotoxicity  
Immediately after SCI, cellular necrosis starts at the injury epicentre, mainly as 
a result of local mechanical damage. This is associated with the initiation of 
inflammation due to the release of inflammatory cytokines from activated 
macrophages, microglia and astrocytes at the injury site (Dumont et al., 2001), 
along with severe depletion of energy stores. 
The process of programme cell death (apoptosis) also ensues and is 
characterised by activation of proteases especially caspases and calpains, which 
leads to condensation and rupture of cells into their constituent parts (reviewed 
by (Beattie et al., 2000). Enzymatic action on the ionic channels leads to ionic 
imbalance which causes accumulation of intracellular Ca²+ (Iwata et al., 2004). 
This ionic imbalance alters the cellular signalling pathways leading to cellular 
death (Yezierski, 2005). Apoptosis was first observed in rodent models (Shuman 
et al., 1997) and later on was also confirmed in primates SCI (Crowe et al., 
1997). 
It has been shown that excitatory amino acids (EAAs) such as aspartate, 
glutamate, glutamine and aspargine reach toxic levels after SCI, and are 
responsible for causing excitotoxic cell death (Liu et al., 1991). Accumulation of 
these EAAs in the injured cord also increases the intracellular Ca+2, with 
subsequent induction of cyclooxygenase-2 (COX-2) and nitric oxide synthase 
(NOS), leading to formation of reactive oxygen species (ROS), further 
potentiating the cellular death (Kontos and Povlishock, 1986, Bao and Liu, 2002, 
Liu et al., 2004).  
Cellular death due to necrosis, apoptosis and excitotoxicity affects almost all 
cell types including neurons, astrocytes, microglia and oligodendrocytes.    
1.6.4 Inflammatory response 
SCI triggers a strong inflammatory response leading to the activation of glial 
cells (Crown et al., 2006, Gwak et al., 2008) and recruitment of leukocytes. 
Inflammation is known to have both destructive and constructive effects during 
the post-injury inflammatory episode (Bethea, 2000). This complex process 
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involves release of chemical mediators, epithelial damage, changes to vascular 
permeability, activation of microglia and recruitment of peripheral inflammatory 
cells.  
Microglia are the first cells to be activated in the immune response after injury. 
They are stimulated within minutes after injury and start secreting pro-
inflammatory cytokines and chemokines. Blood borne macrophages arrive at the 
injured spinal cord within 2-3 days and remain for weeks and contribute to the 
inflammatory process (Fleming et al., 2006). Activated microglia and infiltrating 
macrophages both produce other mediators of cellular death like ROS, nitric 
oxide and proteases. Activated glia release abundant amounts of chemo-
attractants such as tumor necrosis factor-alpha (TNF-𝛼), interleukin 1-beta (1L-
1𝛽) and interleukin 6 (1L-6), and attract more inflammatory immune cells (Rice 
et al., 2007, David and Kroner, 2011). These mediators are upregulated within 
an hour following injury and down regulated within 6-24 hours with a second 
peak occurring at 2 weeks after injury (Fleming et al., 2006).  
At early stages microglia and astrocytes are also responsible for some beneficial 
effects like removal of myelin and axon debris along with uptake of excess 
extracellular glutamate and K+ (Fleming et al., 2006). In addition, releases of 
anti-inflammatory mediators like IL-10 and TGF-Beta have direct or indirect 
neuroprotective effects (David and Kroner, 2011). Reducing the inflammatory 
response has been shown to improve functional recovery (Stirling et al., 2004). 
However, the endogenous anti-inflammatory mediators are not sufficient to 
overcome the pro-inflammatory effects of macrophages.  Similarly, neurotrophic 
factors likes BDNF are also released from the activated microglia/macrophages 
at the injury site which also helps in producing a limited healing response 
(Dougherty et al., 2000).  
1.6.5 Demyelination & Axonal degeneration 
Along with the neuronal loss after initial trauma, acute and chronic death of 
oligodendrocytes is also reported with subsequent disintegration and breakdown 
of myelin (Norenberg et al., 2004). The first phase of demyelination called 
primary demyelination is initiated by a primary injury response which involves 
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partial or complete destruction of the myelin sheaths at the injury epicentre 
while axons remain relatively intact (Griffiths and McCulloch, 1983). A secondary 
phase of demyelination is observed at 3 weeks which causes further damage to 
myelin sheaths surrounding the affected axons (Griffiths and McCulloch, 1983). 
This process of secondary demyelination is progressive and is reported at 450 
days after SCI (Totoiu and Keirstead, 2005). Human studies suggest that this 
process can continue for more than a decade after SCI (Guest et al., 2005). 
Apart from demyelination at the injury site patches of demyelinating axons are 
also observed at areas away from injury epicentre in later stages of injury 
progression (Totoiu and Keirstead, 2005).  
Axons may be disrupted due to initial trauma but some may still remain intact in 
the early stages and later on undergo anterograde degeneration. This process of 
anterograde degeneration is due to demyelination following oligodendrocyte 
death and this process is called Wallerian degeneration (Becerra et al., 1995). 
Wallerian degeneration is associated with disruption of spinal vasculature 
(Sinescu et al., 2010) and ionic imbalance resulting in calcium influx which 
induces apoptosis (Mattson and Chan, 2003).  
1.6.6 Scar  
Formation of the glial scar is a complex process and various cell types such as 
activated astrocytes, microglial cells, oligodendrocytes, meningeal fibroblasts 
and inflammatory cells are involved. Activated astrocytes undergo prolonged 
mitosis to form a dense network in conjunction with oligodendrocyte precursors 
and meningeal cells to form the glial scar (Faulkner et al., 2004). The glial scar 
is not only a mechanical barrier but also releases inhibitory factors that inhibit 
axonal regeneration and contribute to the inflammatory response. The main 
contributors to this hostile milieu are myelin associated growth inhibitors such as 
Nogo-A (Goldberg and Barres, 2000, GrandPre et al., 2000)  myelin associated 
glycoprotein (MAG), tenascin R (Fawcett and Asher, 1999) and oligodendrocyte 
myelin glycoprotein (OMgp) (Wang et al., 2002b). These are found in white 
matter of the spinal cord and they inhibit axonal growth by stimulating growth 
cone collapse (Wang et al., 2002a). Other growth inhibitory factors such as 
chondroitin sulphate proteoglycans (CSPGs) which are markedly increased after 
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SCI, expressed in membranes of reactive astrocytes found in the glial scar and 
extracellular matrix, are also inhibitory to axonal growth (Silver and Miller, 
2004). 
Besides its detrimental effects, the glial scar helps to support the fragile 
parenchyma and acts as a scaffold for repairing the blood brain barrier (Stichel 
and Muller, 1998). It also helps restrict the degeneration and inflammation from 
spreading to the surrounding normal tissue (Faulkner et al., 2004). 
1.6.7 The lesion cavity  
Cavitation is observed after SCI and cavity formation tends to be initiated in the 
centre of the injury site (Dusart and Schwab, 1994, Fawcett and Asher, 1999). 
Cavities can extend rostro-caudally for several millimetres from the injury (Ek et 
al., 2010, James et al., 2011), with degradation of tissue due to apoptosis and 
inflammation (Sandvig et al., 2004). These lesion cavities are filled with 
extracellular fluid which contain residual macrophages, blood vessels and 
connective tissue (Norenberg et al., 2004). This extracellular fluid-filled space 
acts as another physical barrier to axonal regeneration. However, filled cavities 
with ECM provide a comparatively good substrate for regeneration of axons 
(Norenberg et al., 2004).  
Lesion cavities are mostly seen as single cavities though multiple cavities are 
also observed. In approximately 4% of cases these cavities coalesce and give rise 
to the condition called syringomyelia (Schurch et al., 1996).  
SCIs are relative stable after a period of weeks and months. The injury site is 
characterised by a fluid filled cavity surrounded by a glial scar and a rim of 
preserved tissue surrounding the lesion. The intact tissue surrounding the cavity 
may harbour spared fibres that might be responsible for the preservation of 
some function and spontaneous recovery after SCI. 
1.7 Spontaneous recovery of function 
It has been observed that a variable amount of spontaneous recovery can occur 
after SCI without any intervention in experimental animal models and humans 
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(Fouad and Pearson, 2004, Hagg and Oudega, 2006, Gulino et al., 2007). Though 
spontaneous regeneration and remyelination of injured fibres is very limited 
especially in adult CNS, a limited amount of functional improvement is 
nevertheless seen (Fawcett et al., 2007). The amount of recovery depends 
greatly on the severity and extent of injury.  
1.7.1 Spontaneous recovery in humans  
Spontaneous recovery of motor function in patients with motor-complete SCI 
(i.e. AIS A and AIS B) is limited and predictable (Brown et al., 1991, Fisher et al., 
2005). However, the outcome and extent of recovery in cases with incomplete 
injuries as in AIS C and AIS D are highly variable (Fawcett et al., 2007). In the 
majority of cases with incomplete SCI, recovery is rapid in the first few months 
after trauma. Motor recovery usually reaches a plateau within 12-18 months 
when it is mostly considered stable. However, rarely it can continue for several 
years. Similarly, sensory recovery is considered to follow the same time course 
(McDonald and Sadowsky, 2002, Fawcett et al., 2007). 
Steeves et al. (2011) carried out a retrospective analysis of spontaneous 
recovery of individuals with sensorimotor complete SCI at cervical level (C4-C7) 
who were registered in a European multicentre study about SCI clinical trial. 
They assessed change in the AIS grade and upper extremity motor score (UEMS) 
or motor level over the first year after SCI. Results showed about 70% of the 
individuals had spontaneously recovered at least one motor level and 30% 
recovered to 2 or more motor levels (Steeves et al., 2011). The motor level was 
determined by the lowest key muscle function in the myotome corresponding to the 
sensory level as described in the AIS (Kirshblum et al., 2011b). The average UEMS 
improved 10-11 motor points by the end of 1 year. However, the improvement in 
UEMS was not influenced by change in the AIS grade. Fawcett et al. (2007) reported 
that the majority of ASIA category A patients tend to remain as category A with 
approximately 10% down regulated to category B and 10% to ASIA C over the first 
year after SCI. Similarly, about 15-40% of ASIA B individuals were converted to 
ASIA C and up to 40% to ASIA D category. Conversion of ASIA C to D was between 
60-80% with very few patients fully recovering to normal from ASIA D to ASIA E 
(Fawcett et al., 2007).  
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These finding suggests that almost all of the patients with SCI show some degree 
of spontaneous recovery below the ASIA injury level, however, recovery is highly 
dependent on the injury severity, as patients with less severe injury tend to 
show more robust recovery.  
1.7.2 Spontaneous recovery in animals  
A variable amount of functional recovery can be observed in animal models of 
SCI and there is also evidence of anatomical repair (McKenna and Whishaw, 
1999, Weidner et al., 2001, Bareyre et al., 2004, Courtine et al., 2005, 
Ballermann and Fouad, 2006). A limited amount of spontaneous recovery is seen 
irrespective of the injury model and level of the injury, however, the extent of 
functional recovery depends on the severity of the injury (Noble and Wrathall, 
1989). 
Functional recovery in animal models is mostly assessed by behavioural outcome 
and electrophysiological methods. Different tests are carried out to evaluate 
different functions in SCI models. The Basso, Beattie, and Bresnahan open-field 
locomotor rating scale (BBB scale) is one of the most widely used for the 
assessment of locomotion in rat SCI models (Basso et al., 1995). Improvements in 
behavioural functional outcome using the BBB score are seen in different injury 
models including contusion, transection and hemisection models (Ballermann 
and Fouad, 2006, Collazos-Castro et al., 2006, Gwak et al., 2008). Similarly, 
recovery in cervical injury models with improvements in different forelimb 
function tests (e.g. grip strength, pellet retrieval, FLAS) are also observed 
regardless of the injury model (Gensel et al., 2006, Anderson et al., 2009a, 
Khaing et al., 2012).  
Spontaneous recovery in behavioural assessments is also confirmed by 
electrophysiology, showing enhancements in motor evoked potentials (MEPs) and 
somatosensory evoked potentials (SSEPs) over time (Bazley et al., 2012). These 
findings were correlated with anatomical evidence of repair, tissue preservation 
and sprouting in different pathways including corticospinal (Rosenzweig et al., 
2010), reticulospinal (Ballermann and Fouad, 2006) and propriospinal (Bareyre et 
al., 2004) systems.  
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Overall, it is observed that spontaneous recovery of function in most animal 
models is greater compared to humans suffering with comparable injuries. This 
enhanced recovery in animals may be partly because of the compensatory 
mechanisms, for example, recovery of gait in quadruped animals is due to 
adaptation of trunk, forelimb and hindlimb movements to compensate for the 
deficit caused by SCI (Rossignol et al., 2004, Ballermann and Fouad, 2006).      
1.7.3 Processes underlying spontaneous recovery of function   
Mechanisms which lead to spontaneous functional recovery are complex and not 
fully understood. As previously described axons have intrinsic ability to regrow 
but the hostile environment of the injured spinal cord inhibits this recovery. 
Although local neurotrophin expression is increased after SCI, it is not sufficient 
to overcome the influence of inhibitory molecules released at the injury site and 
sustain the regenerating ability of injured axons (Satake et al., 2000). Plasticity 
and remyelination are thought to be the main contributors to spontaneous 
recovery, and axonal regeneration can be excluded from the mechanisms 
involved in spontaneous functional recovery. 
1.7.3.1 Plasticity 
Plasticity is a generic term which indicates the ability of the nervous system to 
change. Neuronal plasticity was initially described as a change in the neuronal 
circuitry of brain in response to memory and learning (DeFelipe, 2006). It is now 
believed that a degree of spontaneous plasticity is present in most parts of the 
CNS and that it is enhanced after injury (Thuret et al., 2006). It can involve two 
mechanisms: ‘synaptic plasticity’ where there is modification of the synaptic 
connectivity (Gulino et al., 2007) and ‘anatomical plasticity’ which refers to 
formation of new circuits through axonal sprouting (Bareyre et al., 2004).  
Spontaneous plasticity has been investigated in different animal models of SCI, 
including contusion (Hill et al., 2001), partial transection (Fouad et al., 2001) 
and ischemic injury (von Euler et al., 2002). Plasticity observed after SCI 
involves formation of new connections amid axonal sprouting from undamaged 
neurons and those left unaffected (Bareyre et al., 2004), along with 
modifications and changes in synaptic connections (Raineteau and Schwab, 2001, 
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Gulino et al., 2007). Apart from neuronal organization of the spinal cord rostral 
and caudal to the injury site, changes have also been observed in the 
somatosensory cortex (Raineteau and Schwab, 2001, Kaas et al., 2008, Fouad et 
al., 2011) and brainstem (McKenna and Whishaw, 1999) in humans and animals 
(Raineteau and Schwab, 2001, Fouad et al., 2011).  
In addition to having beneficial effects, increased sprouting may lead to 
abnormal connections after SCI. It is thought it may be responsible for some 
adverse effects such as development of pain, autonomic dysreflexia and 
spasticity (Bradbury and McMahon, 2006). 
1.7.3.1.1 Plasticity in the spinal cord after SCI 
Injury-induced plasticity at the spinal cord level has been reported in 
experimental models of SCI. In a primate model spontaneous plasticity has been 
observed as the formation of new synaptic connections after hemisection injury 
(Aoki et al., 1986, Rosenzweig et al., 2010). This includes sprouting of axons 
across the midline from the non-injured contralateral side to the affected side. 
Almost 60% of the pre-lesion density of axons is observed below the injury and 
this is accompanied by improved behavioural outcomes (Rosenzweig et al., 
2010). In rodents plasticity is seen in the form of extensive sprouting of axons 
from the ventral CST following interruption of the main dorsal component 
(Weidner et al., 2001). Descending propriospinal neurons have also been shown 
to be involved in the formation of new circuits which are reorganized after SCI 
(Bareyre et al., 2004, Cote et al., 2012). These new connections act as a relay 
between the cortex and their spinal target of origin. These anatomical 
observations are paralleled by observation of functional recovery (Bareyre et al., 
2004).  
Extensive rerouting and sprouting is also observed in ventrolateral bulbospinal 
pathways after injury of the upper cervical cord and this is correlated with 
respiratory improvements (Darlot et al., 2012). Reticulospinal fibres have also 
shown sprouting and formation of new connections caudal to a thoracic lateral 
hemisection (Ballermann and Fouad, 2006).  
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1.7.3.1.2 Plasticity at a cortical level after SCI 
SCI can produce extensive long term functional and anatomical cortical 
reorganization (Jain et al., 1997, Ghosh et al., 2009), which is observed to begin 
immediately after injury (Aguilar et al., 2010). Cortical reorganization is seen in 
areas with intact peripheral connections which enlarge and invade the regions 
that have lost their connections as a result of injury. Extensive changes in the 
activation of cortical and subcortical areas of the brain are observed during hand 
movements in patients with SCI, irrespective of whether hand function is normal 
or impaired, suggesting reorganization of neuronal activity in these areas 
(Bruehlmeier et al., 1998). Readjustments in different areas of human motor 
cortex are reported such as adaptation of the hand area to a different body 
reference scheme (Bruehlmeier et al., 1998, Raineteau and Schwab, 2001). 
Similarly, massive cortical reorganization after dorsal column lesions in monkeys 
is observed (Jain et al., 1997). Similar observations have also been made in 
different rat models of SCI (Fouad et al., 2001, Bareyre et al., 2004).  
1.7.3.2 Remyelination 
 A certain amount of spontaneous remyelination is observed within the spinal 
cord after injury which contributes to spontaneous functional recovery. 
Oligodendrocyte precursor cells (OPCs) (Gensert and Goldman, 1997, Keirstead 
and Blakemore, 1999) and Schwann cells (Salgado-Ceballos et al., 1998) are the 
main contributors in the process. OPCs are recruited to the site of SCI and 
differentiate into mature oligodendrocytes to form myelin (Gensert and 
Goldman, 1997, Yang et al., 2006). Schwann cells which normally myelinate the 
peripheral nervous system are also capable of migrating to the injury site after 
SCI and start myelinating the denuded axons (Takami et al., 2002a). This process 
of remyelination of demylinated axons in spinal cord is also correlated with 
improvements in behavioural assessment (foot print analysis and rotarod test) 
(Murray et al., 2001). 
There are arguments regarding how long spontaneous remyelination takes place 
and how complete the process of remyelination is.  Some authors have observed 
long term and robust remyelination after injury (Salgado-Ceballos et al., 1998, 
Lasiene et al., 2008, Powers et al., 2012). The most compelling evidence on the 
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amount of spontaneous remyelination comes from the study done by Powers et 
al. 2012. They calculated the number of remyelinated axons by measuring the 
internodal length that traversed the injury site (Powers et al., 2012). Axons with 
shorter internodal length are indicative of remyelination (Lasiene et al., 2008). 
Using the internodal length approach to calculate remyelination Powers and 
colleagues found that the majority of the spared descending fibres are 
remyelinated by 3 months. These remyelinated fibres were concentrated around 
the injury epicentre and axonal diameters were approximately 23% smaller 
compared to rostral and caudal zones. In addition it was also predicted that the 
conduction velocity at the injury epicentre would be reduced by 25% (Powers et 
al., 2012). Similarly, using electron microscopy, comparison of demyelinated 
axons around the injury perimeter one month after injury were 64%, in contrast 
to 30% demyelinated fibres observed 12 months post-injury, suggesting 
remyelination is a slow ongoing process (Salgado-Ceballos et al., 1998).  
However, in another study remyelination was reported to increase in chronic 
progressive fashion beginning 7 days after injury up till 120 days and then 
declined at 450 days after injury (Totoiu and Keirstead, 2005), suggesting that 
the process of spontaneous remyelination may be incomplete and abortive 
(Blight, 1989, Totoiu and Keirstead, 2005).  
Apart from these positive results obtained through spontaneous plasticity it 
should also be kept in mind that recovery can be enhanced by providing 
locomotor training or other forms of rehabilitative therapy (Rossignol, 2000, 
Krajacic et al., 2010).  
Much of the work done in the field of spontaneous plasticity and recovery after 
SCI has focussed on thoracic spinal cord injury models and assessment of 
functional outcome has focussed on the hindlimb. Reports using cervical injury 
models particularly contusion injuries are less common. This is despite cervical 
injuries being clinically more common and the prime importance of restoring 
hand function in quadriplegic patients (Anderson, 2004). Though considerable 
interest in cervical injury has developed over last the few years, there is still a 
need to evaluate functional changes in the spinal cord after contusion injury at 
the cervical level to assess the contributions of primary trauma and secondary 
transformations on the injury outcome over time.  
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1.8 Assessments of Function 
Reliable evaluation of functional recovery is necessary in order to study 
spontaneous functional improvements over time after SCI. Assessment of 
function is also useful in evaluating the beneficial effects of a therapy used in 
SCI models. Therefore, proper selection of appropriate functional assessment 
methods in animal studies is crucial to properly interpret the results. The 
recovery of function is mainly assessed with behavioural testing and more rarely 
by electrophysiology.  
1.8.1 Behavioural testing   
Final functional outcome following SCI depends on the extent of neuronal 
damage, loss of white matter and reorganization of the remaining neural tissue.  
Behavioural assessments help to determine the lesion severity, location and 
extent of spontaneous recovery and also document improvements in response to 
therapeutic intervention. However, it is important to choose a suitable 
behavioural technique to match the relevant hypothesis of the experiment 
(Basso, 2004). Ideally the behavioural responses in animal models of SCI should 
be relevant to those seen in human patients with SCI (Sedy et al., 2008).  
Some of these tests are simple and require little specialist training, while others 
need specialist training and sophisticated equipment. Muir and Webb divided 
behavioural tests according to the type of data collected. These are end point 
measures, kinematic measurements and kinetic measurements (for review see 
(Muir and Webb, 2000).  
1) End point: these are measures in which animals are required to accomplish a 
particular goal and are scored on their ability to achieve it.  
2) Kinematic: these describe qualitative measures where movements of the 
whole body and body segments relative to each other and/or an external frame 
of reference are measured and compared.  
3) Kinetic: these tests help to quantify or describe the force produce by a limb 
or limbs, for example during weight support or force generated during pulling a 
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force transducer such as a grip strength meter (for review see (Muir and Webb, 
2000).  
Behavioural tests can also be divided into motor, sensory, sensory-motor, 
autonomic and reflex based test, according to the predominant sensorimotor 
systems involved in a particular behaviour. However, it is very difficult to 
differentiate one system involvement in a particular behavioural outcome since 
multiple systems normally contribute to all functions. 
1.8.1.1 Motor tests  
These tests primarily assess skeletal muscle functions that are not involved in 
locomotion. There are many tests that look at specific aspects like the inclined 
plane test which evaluates the animal’s ability to maintain body position on a 
board that is continually raised by increasing the angle (Pearse et al., 2005). 
Similarly, the limb hanging test utilizes the grasping function of the paws 
(Pearse et al., 2005) and forelimb asymmetry tests assess asymmetries produced 
by a variety of spinal cord injuries (Gensel et al., 2006). Food pellet reaching 
tests evaluate the ability to use the forelimbs to reach, grasp and retrieve a 
food pellet after cervical injuries (Whishaw, 2000). Grip strength tests assess 
neuromuscular function by sensing the peak amount of force generated by 
animals grasping a bar (Pearse et al., 2005, Anderson et al., 2009a) and will be 
discussed in more detail in the third chapter of this thesis.  
1.8.1.2 Sensory tests  
Purely sensory function in animal models of SCI is difficult to evaluate. However, 
changes in sensory function indicative of pain after SCI can be evaluated by 
observing exaggerated responses in animal behaviour to normally innocuous 
stimuli. For example, von Frey’s filament test is used to evaluate the degree of 
mechanical allodynia (Gris et al., 2004). In the von Frey test calibrated filaments 
of increasing force are applied to the plantar surface of the forelimb or hindpaw 
and a positive response is seen if the paw is briskly withdrawn (Gris et al., 2004). 
Increased sensitivity is indicated by withdrawal from less stiff filament than 
normal. In addition, use of a pre-heated plate for hot plate-based tests and 
noting the time of response in the form of a withdrawal can detect enhanced 
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sensitivity to thermal stimuli (Gale et al., 1985). Altered responses can be 
accompanied by licking, vocalization, overgrooming and aggression (Sedy et al., 
2008). 
1.8.1.3 Sensory-motor tests  
These tests assess coordination and functional integration in sensory and motor 
systems. In the rope walking test animals are trained to run over the horizontal 
oriented rope (Kim et al., 2001) and in the beam walking test rats are trained to 
run over different diameter beams (Hicks and D'Amato, 1975, Metz et al., 2000). 
Animals are videotaped and the number of errors (slips and falls) made by the 
animal while crossing are counted. Similarly the horizontal ladder walking (grid 
walking) test is very sensitive in evaluating sensory-motor coordination 
(Behrmann et al., 1992, Metz et al., 2000). In the horizontal ladder walking test 
animals walk along a horizontal ladder with variable rung spacing (Metz and 
Whishaw, 2002, Chan et al., 2005). Runs are video recorded as for rope and 
beam walking and then the animals limb placement on the rungs evaluated. This 
will also be discussed in further detail later in the thesis.  
1.8.1.4 Locomotor tests  
Locomotor test are those in which the locomotor apparatus, the forelimbs and 
hindlimbs are tested after SCI. These tests are mostly in the form of an ordinal 
rating scale. The Basso, Beattie and Bresnahan locomotor rating scale (BBB 
scale) is the most commonly used test for assessing locomotion in spinal cord 
injured rats. It scores animals’ hindlimb kinematic ability on a scale of 0 to 21, 
where 0 indicates no hindlimb motor function while 21 represents function in an 
uninjured rat (Basso et al., 1995). This scoring system does not require animal 
training, scoring can be learned quickly and reliably, and results can be 
compared with other labs (Basso et al., 1995). Similarly for forelimb locomotor 
assessment a forelimb assessment scale (FLAS) has been devised. The FLAS is a 
modification of the BBB score and it has a scoring from 0 showing no forelimb 
motor function to 17 for uninjured animal (Anderson et al., 2009a).  
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1.8.2 Electrophysiological testing   
Electrophysiology is the study of the electrical properties of cells and tissues. In 
vivo electrophysiology represents a way of directly quantifying function and 
changes in motor and sensory pathways after SCI reliably. Also the 
electrophysiology can be focussed on a particular tract and fibres, and therefore 
changes in a single pathway can be examined. In addition, training of animals is 
not required as in behavioural assessment methods. In addition, 
electrophysiological methods are also used in evaluation of therapies used in SCI 
(Bradbury et al., 2002, Toft et al., 2007). However, these techniques require 
expensive instruments and extensive personnel training and an ability to 
interpret recordings at the time they are recorded to deal with any technical 
issues (Blight, 1992).  
1.8.2.1 Cord dorsum potential 
Cord dorsum potential (CDP) recording is a technique used to measure the 
postsynaptic electrical activity evoked in the spinal cord. CPDs reflect the 
depolarization of interneurons or primary afferents fibres in the dorsal horn 
(Willis and Coggeshall, 2004). The characteristics and amplitude of CDPs reflect 
the level of activation and strength in the local circuits due to stimulation of 
ascending pathways (if stimulation from a peripheral nerve) or due to 
descending pathways (for example stimulation of corticospinal system).These 
potentials can be recorded directly from the surface of the cord, from the skin 
overlying the vertebral column (Sedgwick et al., 1980) and also from the 
epidural space (Shimoji et al., 1977).  
CDPs can be used to assess the functional abilities of spinal pathways after SCI 
(Sedgwick et al., 1980) and monitor the function perioperatively (Ahn and 
Fehlings, 2008). It provides a sensitive and reliable method for observing the 
outcomes of experimental SCIs and also for assessing the effects of potential 
therapies and is therefore useful in SCI research (Bradbury et al., 2002, Riddell 
et al., 2004, Toft et al., 2007). Using a crush injury model of the cervical cord of 
rats, application of chondroitinase ABC was shown to improve CDP potentials 
evoked by CST axons below the injury. This finding correlated with anatomical 
and behavioural evidence (Bradbury et al., 2002). Similarly after a dorsal column 
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lesion with application of OECs, improvements in CDPs evoked by stimulation of 
fibres in dorsal roots were recorded. This was attributed to a neuroprotective 
action (Toft et al., 2007). Hence, assessing CDPs in different SCI models can be 
very useful to evaluate changes in the circuitry in the vicinity of the lesion and 
can also help in evaluating the therapeutic effects of different interventions on 
the spinal circuits.   
1.8.2.2 Somatosensory evoked potentials 
Somatosensory evoked potentials (SEPs) are a series of waves that can be 
recorded from the surface of the somatosensory cortex. SEPs reflect the 
sequential activation of neural structures along the somatosensory pathway in 
response to electrical stimulation of peripheral nerve (Sedgwick et al., 1980). 
SEPs provide direct quantitative measurements of the functional ability of the 
ascending somatosensory pathways. They are used for the diagnosis and 
characterisation of neurological abnormalities in humans (Small et al., 1978, 
Dietz and Curt, 2006). SEPs are also used for monitoring the condition of the 
spinal cord intraoperatively (Grundy, 1983). This sort of direct feedback on the 
state of neural networks and pathways allows surgeons to safely perform 
complicated surgeries, such as resection of tumours and reconstructive 
procedures (Malhotra and Shaffrey, 2010). SEPs have been also used to assess 
the integrity of the spinal cord in animal models of SCI. Changes in the 
amplitudes and latencies of SEPs are correlated with injury severity and 
behavioural outcomes (Fehlings et al., 1989, Nashmi et al., 1997). Thus it can be 
another way of quantitatively analysing the effects of therapeutic interventions 
in SCI models.  
1.9 Repair strategies   
Historically, it was considered that adult neural tissue has no ability to 
regenerate after injury. However, Richardson and Aguayo, in the early 1980’s 
showed that nerve fibres can regenerate through transplants of peripheral nerve 
placed into the injured spinal cord (Richardson et al., 1982). These findings were 
a massive breakthrough in the field of neuroscience and have been followed by 
numerous strategies which have been developed to induce an environment that 
promotes neuronal survival and axonal regeneration in an injured CNS. 
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Although as described previously, there is to some extent spontaneous recovery 
of function after SCI, it is not sufficient to recover normal function. As discussed 
above there are many factors that hinder recovery and might be targeted to 
promote recovery of function. For example, reducing oedema, reducing free 
radicals, controlling inflammation and preventing neural tissue dying off due to 
continued apoptosis. Similarly we need to promote repair of the injured 
demyelinated axons and also provide an environment suitable for neurite 
outgrowth to promote regeneration and plasticity. 
To address the above mentioned aspects, therapies are broadly divided into 4 
main categories 1) therapies that help promote neuroprotection, which can 
minimize secondary damage and preserve residual function, 2) therapies that 
provide an environment permissive for promoting axonal regeneration of the 
axotomized pathways, 3) therapies that help to enhance remyelination and 
reduce the conduction deficits of the demyelinated and damaged axons and 4) 
therapies that augment plasticity by forming new connections and promoting 
axonal sprouting.  
1.10 Therapeutic approaches  
Research into possible treatments for SCI is rapidly progressing but up till now 
there is no efficient and reliable clinical treatment available for SCI patients. 
Although, numerous therapeutic interventions are currently in phase I and II 
clinical trials so far none have offered substantial beneficial effects or reached 
phase III clinical trial. The only strategy used in clinical settings is the 
stabilization and decompression of the spinal cord in combination with the early 
use of high dose methylprednisolone. Although, surgical decompression in animal 
models has shown improved functional recovery and minimizes secondary injury, 
human trials show controversial results especially in the case of early 
intervention and critically ill patients; as is the case with therapeutic 
intervention of methylprednisolone providing neuroprotection. The only other 
option for SCI patients is rehabilitative therapy, in order to optimize residual 
function and help prevent complications like infections, pressure sores, muscle 
wastage, poor ventilation and spasticity.  
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1.10.1 Neuroprotection 
Neuroprotection refers to the action of different therapies which protect the 
spinal cord from harmful effects due to the secondary response after injury and 
therefore help preserve neural pathways and maintain residual function after 
SCI.  
Methylprednisolone is one of the earliest neuroprotective agents to be used. It is 
considered to exert its neuroprotective effects by inhibiting free radical 
production and down regulating the expression of pro-inflammatory genes (Hall, 
1992, Almon et al., 2002). Although it is widely used in clinical settings its 
therapeutic effects in SCI are debatable (Suberviola et al., 2008).  
Erythropoietin is a hematopoietic growth factor which has been shown to exert a 
neuroprotective and trophic effect in the CNS. Administration of erythropoietin 
after SCI has been shown to have a neuroprotective effect by reducing 
inflammation, decreasing apoptosis and so increasing sparing of white and grey 
matter (Arishima et al., 2006, Brines and Cerami, 2008).  
Similarly, an anti-inflammatory cytokine interleukin-10 is reported to be capable 
of reducing the inflammatory response of monocytes and macrophages and 
inhibiting the production of TNF-α by activated astrocytes. Systemic 
administration has been shown to reduce the cavity size by 50% and also to 
enhance functional recovery in animal models (Bethea, 2000). However, Takami 
and co-workers reported that IL-10 administration led to sparing of grey matter 
without functional improvement (Takami et al., 2002a). Therefore further 
preclinical trials are needed to confirm the efficacy of this approach. 
Application of the broad spectrum antibiotic minocycline has been shown to 
lessen the degree of apoptosis observed in oligodendrocytes, inhibit microglial 
activation and inhibit the release of pro-inflammatory mediators. Minocycline 
treatment has also been reported to increase axonal sparing, reduce lesion size 
and improve functional outcome measured using the BBB scale and inclined 
plane test (Wells et al., 2003). Minocycline appears to exert its anti-
inflammatory effects by modulating microglial activation with subsequent 
reduction in the release of cytokines, matrix metalloproteinases (especially 
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MMP-12), nitric oxide and lipid mediators of inflammations (Stirling et al., 2005). 
Minocycline treatment has been shown to reduce TNF-α mRNA levels after SCI 
and prevent the lipopolysaccharide –induced production of TNF-α in glial cells. It 
also reduces in caspase-1-mediated liberation of IL-1β and IL-6 production. 
Minocycline also exerts its neuroprotective effects by increasing the release of 
anti-inflammatory cytokine IL-10 when administered immediately after SCI (Lee 
et al., 2003b). Furthermore, minocycline reduces inflammation by diminishing 
cell infiltration and migration through reduction of chemokine production and/or 
chemokine receptor expression (Stirling et al., 2005). Decreased levels of nitric 
oxide, prostaglandins (PGE-2) and caspase-1 and 3 are also observed after 
treatment with minocycline (Stirling et al., 2004).  
The lipid lowering drug atorvastatin and the non-steroidal anti-inflammatory 
drugs (NSAIDs) like indomethacin and ibuprofen have also been tested in animal 
models with some neuroprotection and improvement in function after SCI 
(Pantovic et al., 2005, Wang et al., 2009).    
1.10.2 Promoting/stimulating axonal growth/regeneration 
Axonal regeneration and sprouting is necessary to re-establish connectivity 
across the lesion site and this is regarded as the ultimate way to restore lost 
function and the most desirable long term goal (Tuszynski and Steward, 2012). 
Axonal regeneration refers to the regrowth of transected nerve fibres and their 
re-connection with target neurons while axonal sprouting refers to formation of 
new fibre branches from spared non-injured fibres (Tuszynski and Steward, 
2012).  
1.10.2.1.1 Neurotrophic Factors 
Trophic factors are associated with cellular growth, neurite guidance and 
survival of neuronal cells. Levels of neurotrophic factors decrease as 
development continues, though these factors persist throughout adult life in 
regions associated with functional plasticity like cortex and olfactory bulb 
(Maisonpierre et al., 1990). However, in the spinal cord there is a huge reduction 
of these neurotrophins from embryonic stages to adulthood (Maisonpierre et al., 
1990).  
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Neurotrophins are a group of molecules which can stimulate axonal sprouting 
and regeneration in sensorimotor pathways after SCI. Nerve growth factor (NGF), 
neurotrophin-3 (NT-3) and glia cell line derived neurotrophic factor (GDNF) can 
promote regrowth of damaged axons across the dorsal root entry zone and 
formation of functional connections in the dorsal horn (Ramer et al., 2000). 
Similarly, brain-derived neurotrophin factor (BDNF) and NT-3 are reported to 
promote regeneration in reticulospinal, rubrospinal, raphespinal and 
proprioceptive sensory axons (Bregman et al., 1997, Bradbury et al., 1999, Liu et 
al., 1999, Kwon et al., 2002, Tuszynski et al., 2003). VEGF, fibroblast growth 
factor (FGF), leukaemia inhibitory factor (LIF) and neurotrophin-4, 5(NT-4/NT-5) 
have also been demonstrated to have beneficial effects in SCI models (Silva et 
al., 2014). Kwon and colleagues suggested that neurotrophic factors are less 
effective in chronic SCI due to loss of receptors in injured neurons (Kwon et al., 
2004).  
1.10.3 Overcoming inhibition/promoting plasticity 
Plasticity, as discussed previously, could be desirable for the recovery of 
function and it is enhanced after injury. However, plasticity in terms of 
sprouting and synaptic remodelling is limited by a number of features in the 
hostile milieu of the injured CNS.  
1.10.3.1.1 Myelin Inhibitors  
Myelin, for instance, produces a number of inhibitory molecules that restrict 
axonal growth. The most commonly known myelin associated inhibitors are 
Nogo-A, myelin associated glycoprotein (MAG) and oligodendrocyte myelin 
glycoprotein (OMgp) (McKerracher et al., 1994, GrandPre et al., 2000, Wang et 
al., 2002a).   
The administration of an antibody against Nogo-A (Anti-Nogo) has been shown to 
improve behavioural outcomes and lead to axonal sprouting and corticospinal 
regeneration (Caroni and Schwab, 1988). Furthermore, Nogo-A, MAG and OMgp 
have all been shown to exert their inhibitory effects by binding to a common 
receptor (Nogo-66 receptor) (Wang et al., 2002b). NEP 1-40 a Nogo receptor 
antagonist which binds with the Nogo-66 region of the Nogo receptor complex 
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inhibits these myelin inhibitors. The administration of NEP1-40 is also 
demonstrated to be effective in axonal regeneration and functional recovery 
(GrandPre et al., 2002).  
1.10.3.1.2 Glial scar inhibitors  
Another important feature in the natural response to injury is the formation of a 
glial scar. The lesion scar acts as a physical barrier to axonal regeneration. The 
glial scar is composed of reactive astrocytes and microglia/macrophages, which 
release various chondroitin sulphate proteoglycans (CSPGs) into the extracellular 
space. These CSPGs in the ECM act as potent inhibitors of endogenous 
regeneration (Morgenstern et al., 2002). CSPG expression has also been shown to 
increase following SCI, to peak within 2 weeks and persist for several months 
(Tang et al., 2003). Chondroitinase ABC (ChABC) is an enzyme that degrades the 
inhibitory chondroitin sulphate proteoglycan (CSPG) molecules present in the 
glial scar. ChABC produces a more permissive environment for axonal 
regeneration and helps restore post-synaptic activity below the injury site and so 
promotes functional recovery (Bradbury et al., 2002).  
1.10.3.1.3 Growth cone collapse inhibitors 
Rho pathway antagonists: The Rho pathway plays an important role in 
transducing extracellular signals that lead to changes in cytoskeletal proteins 
and depolymerisation of actin filaments causing growth cone collapse (Dickson, 
2001). It is reported that inhibition of either Rho or Rho-associated kinase can 
have a beneficial effect on axonal regeneration and recovery of function. C3 
transferase is an enzyme that inhibits the Rho pathway and thereby promotes 
neurite outgrowth (Jalink et al., 1994). A Phase 1 clinical trial in SCI patients 
was carried out using the Rho antagonist BA-210 and showed slight improvement 
in motor recovery without serious side effects (Fehlings and Vawda, 2011).   
It is reported that neurotrophin binding to neuronal membranes via distinct 
tyrosine kinase receptors can lead to elevation of intracellular cAMP. In addition, 
cAMP elevation has also been shown to promote regeneration by inhibiting the 
growth cone collapse in the neurites. Therefore, it might be beneficial to 
increase the intracellular levels of cAMP. Molecules like Rolipram prevent cAMP 
hydrolysis and hence can be used to enhance axonal growth (Whitaker et al., 
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2008). However, rolipram is shown to be more effective when used in 
combination with other cellular strategies like OECs or Schwann cells (Bretzner 
et al., 2010). 
1.10.4 Promoting remyelination  
Damage to the myelin sheath is a common pathological feature of traumatic SCI 
and it is reported that demyelination continues for months to years after SCI 
(Totoiu and Keirstead, 2005). Axonal demyelination leads to loss of normal 
neuronal functioning and it is a potential therapeutic target in SCI. Ongoing 
remyelination after SCI has been reported but the process is not sufficient to 
restore full function and does not always appear to be complete (James et al., 
2011). Therefore, any therapy preventing loss of myelin or helping remyelination 
is likely to promote recovery. Rolipram has been shown to decrease 
oligodendrocyte death after injury and therefore indirectly may promote 
remyelination in injured tissue (Whitaker et al., 2008). Cell transplants are 
among the potential treatments which have been shown to promote 
remyelination in SCI. OPCs and Schwann cells have shown remyelination of 
demyelinated axons after being transplanted into SCI models (Xu and Onifer, 
2009). OPCs were shown to differentiate into mature oligodendrocytes when 
transplanted into injured cord and promote remyelination of demyelinted axons 
(Rossi and Keirstead, 2009). In addition, NPCs and MSCs have also been reported 
to promote some degree of remyelination and improved functional outcome 
after SCI (Chopp et al., 2000, Hawryluk et al., 2014).   
1.11 Cell transplantation 
As discussed previously, it is well known that in many cases of SCI there is 
formation of a fluid filled cavity surrounded by a glial scar. Hence, treatments 
that fill this gap and replace damaged cells with functional cells that support the 
remaining parenchyma and also provide a scaffold for regenerating axonal tracts 
would be ideal. In addition there is a need to provide a milieu favourable for 
regeneration, enhanced plasticity and induce remyelination. Transplantation 
may be an appropriate approach to address many of these properties required of 
an effective therapy. Various cell types have been investigated in SCI models 
including Schwann cells (Duncan et al., 1981, Biernaskie et al., 2007), neural 
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stem/progenitor cells (Akiyama et al., 2001), macrophages (Rapalino et al., 
1998), mesenchymal stem cells (Akiyama et al., 2002), olfactory glial cells 
(Riddell et al., 2004, Toft et al., 2007) and oligodendrocyte precursor cells 
(Bambakidis and Miller, 2004, Keirstead et al., 2005). For an extensive review on 
cellular transplants see Tetzlaff et al. (2011) (Tetzlaff et al., 2011).  
1.11.1 Stem cells  
Stem cells are cells with the capacity of self-renewal and for producing a 
progeny that can differentiate into different mature cell types. Stem cells have 
been identified in the embryo and in several organ systems in the adult. Stem 
cells have the ability to differentiate into cells from any germ cell line and have 
the capability to expand in quantities required for cell transplantation. These 
properties make stem cells potential candidates for transplant mediated repair 
in SCI (Rossi and Keirstead, 2009).  
The benefits of stem cells have been well documented in pre-clinical scenarios 
and they offer several potential therapeutic benefits. The rationale for using 
stem cells in SCI includes replacement of lost neural tissue, secretion of trophic 
factors, prevention of cyst formation and regulation of the glial scar (Sahni and 
Kessler, 2010). However, the effects of stem cells are multifactorial and it is 
difficult to ascertain which mechanism contributes to the beneficial effects 
shown by different types of stem cells. Transplantation of different types of 
stem cells has been shown to promote recovery in rodent models of SCI as 
discussed below. Several types of stem cells have also been tested in safety 
studies in human SCI with modest improvement in function (Sahni and Kessler, 
2010). 
1.11.1.1 Embryonic stem cells 
Embryonic stem cells (ESCs) are pluripotent cells derived from the inner cell 
mass of the blastocyst and have the ability to self-renew. Also ESCs have the 
ability to differentiate into cells derived from all three germ layers. ESCs were 
first derived from pre-implantation mouse embryos (Evans and Kaufman, 1981) 
and later also isolation from human embryos (Thomson et al., 1998). These cells 
are known to grow indefinitely in culture without undergoing senescence. ESCs 
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can be banked stably and also maintain a normal karyotype and differentiation 
potential for years. Currently hESCs show great potential for replacement 
therapies as these are commercially viable (Coutts and Keirstead, 2008).  
ESCs are not normally directly transplanted into injury models due to ethical 
concerns surrounding the use of human embryos in order to isolate ESCs and 
secondly, due to safety concerns for their potential to form teratomas (Silva et 
al., 2014). These cells are usually pre differentiated into a desirable cell 
population in vitro before being transplanted. OPCs differentiated from ESCs 
have been transplanted into contusion SCI and demonstrated to improve 
locomotion and remyelination (Keirstead et al., 2005, Nistor et al., 2005). 
McDonald et al. (1999) used neurally differentiated mouse ESCs in rat spinal cord 
9 days after injury and demonstrated cell survival and differentiation into 
astrocytes, oligodendrocytes and neurons along with functional improvement 
(McDonald et al., 1999).  
1.11.1.2 Induced pluripotent stem cells  
Induced pluripotent stem cells (iPSCs) have been obtained from mouse and 
human fibroblasts by introduction of four genes (Sox2, Klf4, Oct3/4 and c-Myc) 
into the cells (Takahashi and Yamanaka, 2006, Takahashi et al., 2007). These 
cells have been shown to have properties characteristic of ESCs such as 
differentiation potential, cell surface antigens, gene expression and telomerase 
activity (Takahashi et al., 2007). These cells offer advantages over hESCs, firstly, 
they circumvent ethical issues by allowing auto-transplantation and secondly 
they could reduce the risk of immunological rejection when used for autologous 
transplantation (Takahashi and Yamanaka, 2006, Takahashi et al., 2007).  
Miura and colleagues (2009) demonstrated that these cells can be differentiated 
into functional neurons, astrocytes and oligodendrocytes (Miura et al., 2009). 
However they also reported they have the same potential for forming teratomas 
as ESCs (Takahashi and Yamanaka, 2006, Takahashi et al., 2007). In SCI, NSCs 
derived from iPSCs have been used in immunodeficient mouse contusion models 
showing differentiation into neurons, astrocytes and oligodendrocytes. They also 
lead to improvements in behavioural and electrophysiological recovery with no 
malignant transformation (Tsuji et al., 2010, Nori et al., 2011). Furthermore, it 
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is reported that transplantation of iPSCs which have been pre-differentiated into 
neuroepithelial like stem cells are able to support regeneration of CST pathways 
and promote functional recovery of hindlimbs in mice (Fujimoto et al., 2012). 
1.11.1.3 Neural stem cells 
Neural stem cells (NSCs) also called neural progenitor cells (NPCs) are 
multipotent cells which have the ability to differentiate into neurons, 
oligodendrocytes and astrocytes. These are endogenous cells found in the adult 
and developing CNS. These can be isolated from different regions and expanded 
in vitro as neurospheres (Gage, 2000). The rationale for using NPC is that their 
neural origin means they more readily differentiate into neural phenotypes and 
are less likely to become neoplastic compared to ESCs (Coutts and Keirstead, 
2008). There is also evidence that they secrete neurotrophic factors like NGF, 
GDNF and BDNF (Lu et al., 2003). NSCs have also shown to protect against 
excitotoxic injury (Lu et al., 2003, Llado et al., 2004). However, in most 
instances transplanted NSCs in normal or injured spinal cord either remained 
undifferentiated or differentiate along a glial lineage limiting the efficacy of 
direct NSC transplantation (Shihabuddin et al., 2000, Cao et al., 2001). 
Nevertheless, several studies have reported functional improvements and 
evidence of axonal regeneration (Hofstetter et al., 2002, Tarasenko et al., 2007, 
Parr et al., 2008b). However, pre-differentiation into more committed lineages 
especially oligodendrocyte differentiation shows more promising outcomes 
(Hwang et al., 2009, Alexanian et al., 2011b).  
Human NSCs are usually obtained from human cadavers and foetuses; this limits 
the potential supply (Coutts and Keirstead, 2008) and moreover makes it 
difficult from ethical aspects. Similarly, NSCs derived from adult sources are 
more difficult to expand into large quantities to be used in clinical settings 
(Morshead et al., 1998, Doetsch et al., 1999) and cells lose their differentiation 
potential with time in culture (Wright et al., 2006).  
1.11.1.4 Mesenchymal Stem Cells  
Mesenchymal stem cells (MSCs) are one of the most promising stem cell types for 
SCI. There is evidence that they promote functional recovery by providing a 
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neuroprotective and neuroregenerative environment after injection into injured 
spinal cord (Phinney and Prockop, 2007, Rossi and Keirstead, 2009). MSCs are 
multipotent cells with the capability of developing into many cell types including 
bone, muscle, cartilage and neural tissue (Minguell et al., 2001). They were first 
discovered by Alexander Friedenstein as spindle shaped cells in cultures derived 
from bone marrow (Friedenstein et al., 1974). In addition to their derivation 
from adult bone marrow, MSCs have been identified in several other tissues and 
organs of both fetal and adult origin (Campagnoli et al., 2001, Meirelles et al., 
2006, Sessarego et al., 2008) and can easily be harvested from a variety of 
tissues including adipose tissue (Zuk et al., 2001), olfactory mucosa (Tome et 
al., 2009), umbilical cord blood (Erices et al., 2000) and embryonic tissue 
(Thomson et al., 1998, Lee et al., 2010). However, MSCs derived from mature 
differentiated tissue have more restricted potential for differentiation as 
compared to embryonic tissue. MSCs are particularly appealing because they are 
relatively easy to isolate and expand in culture with only subtle loss of potency 
(Jiao et al., 2011). They can be used for both autologus (Fehlings and Vawda, 
2011) and allogenic transplants without having adverse immune reactions (Jiao 
et al., 2011). Moreover, they do not undergo neoplastic transformation (Lee et 
al., 2010) and have demonstrated safety in early clinical trials (Lazarus et al., 
1995).  
1.11.1.4.1 Therapeutic effects of MSCs 
The beneficial effects of MSCs are believed to be due to their ability to 
modulate the detrimental effects of the SCI milieu (Uccelli et al., 2011). These 
cells have been shown to provide neuroprotection against glutamate 
excitotoxicity (Lu et al., 2011) and also secrete neurotrophic factors (Neuhuber 
et al., 2005, Crigler et al., 2006). In addition, there is evidence these cells can 
promote remyelination (Chopp et al., 2000, Liu et al., 2011) and regeneration 
(Sasaki et al., 2006, Sheth et al., 2008) and also function as axon guiding strands 
across the lesion cavity (Hofstetter et al., 2002). Furthermore, MSCs have been 
shown to reduce levels of pro-inflammatory molecules by modulating the 
immune system (Chidgey and Boyd, 2008). It is also reported that MSC may 
transdifferentiate into glial and neuron like cells at least in vitro (Chen et al., 
2006), however, transdifferentiation in vivo is debatable.  
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1.11.1.4.2 MSCs survival in SCI models  
Survival and proliferation of MSCs after transplantation into SCI models is quite 
variable. There are reports showing low survival of transplanted MSCs after SCI 
(Neuhuber et al., 2005, Himes et al., 2006, Sheth et al., 2008, Boido et al., 
2014). In one study survival was as low as 1% after 4 weeks (Boido et al., 2014), 
while in another study gradual decline in the number of cells was observed over 
time with only 15% of cells surviving by 3 weeks (Wu et al., 2003). However, 
better survival with up to 50% of cells surviving at 11 weeks is also reported 
(Himes et al., 2006). Survival of MSCs in the studies were attributed to timing of 
transplant as improved survival of cells was observed in 1 week delayed 
transplant as compared to transplants done immediately after injury (Himes et 
al., 2006). This poorer survival after acute transplants is attributed to the 
hostile environment of the injured spinal cord immediately after injury.  
1.11.1.4.3 Differentiation of MSCs 
There are mixed reports on the differentiation ability of MSCs after 
transplantation into SCI models. Although, neural differentiation into 
oligodendrocytes, astrocytes and neurons reported, convincing evidence is 
lacking. In the majority of studies MSCs remained undifferentiated when 
transplanted into SCI models (Ankeny et al., 2004, Ohta et al., 2004, Yoshihara 
et al., 2006). However, there are reports of MSCs expressing neuronal and glial 
markers (Jendelova et al., 2004, Dasari et al., 2007). Dasari 2007 reported 
marked differentiation of BM-MSCs into neurons, oligodendrocytes and astrocytes 
(Dasari et al., 2007). In contrast, Lee et al. (2003) claimed possible astrocytic 
differentiation of the transplanted BM-MSCs, however, there was no evidence of 
neuronal differentiation using MAP2 or NeuN immunostaining (Lee et al., 2003a). 
In one study MSCs were shown to express neuronal markers in vitro but these 
cells did not show signs of impulse conduction with whole cell recordings 
(Hofstetter et al., 2002). In addition, MSCs expressing neuronal markers in vitro 
did not show any signs of differentiation in vivo (Lu et al., 2005). Regardless of 
whether or not MSCs differentiate into neural cells, MSC transplants in SCI have 
been reported to promote repair and improve functional outcome as discussed 
below.  
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1.11.1.4.4 Regeneration and remyelination after MSC transplantation 
One of the beneficial effects attributed to MSCs is their ability to promote 
remyelination in the injured spinal cord. Extensive remyelination is reported in 
many studies (Chopp et al., 2000, Lu et al., 2007, Liu et al., 2011). Increased 
remyelination is noted by increased expression of MBP in one study (Liu et al., 
2011). Furthermore, some investigations revealed Schwan cell myelination after 
MSC transplants (Lu et al., 2007) while myelination by MSCs themselves is 
reported by others (Akiyama et al., 2002). In contrast, no remyelination was 
observed in demyelinated axons after intralesional MSC transplantation (Hunt et 
al., 2008).  
The axonal regeneration is also reported to be facilitated by MSCs and this is 
attributed to secretion of neurotrophic factors like BDNF by transplanted MSCs 
(Lu et al., 2005, Sheth et al., 2008, Sasaki et al., 2009). Extensive axonal 
regeneration has been claimed in some studies (Chiba et al., 2009). Chiba et al. 
used anterograde tract tracing with Fluoro-ruby and reported a high density of 
regenerating dorsal CST fibres in animals transplanted with MSCs. In addition 
they also claimed co-localization of neuronal markers like NeuN and MAP2 in the 
transplanted MSCs (Chiba et al., 2009). However, in the majority of the studies 
axonal regeneration beyond the transplant could not be demonstrated (Lu et al., 
2005, Cao et al., 2007, Lu et al., 2007). In one of the study significant number of 
neurofilament positive and Ctb traced sensory axons were found at the lesion 
site penetrating through the glial scar in animals transplanted with MSCs as 
compared to control animals (Lu et al., 2007).  
1.11.1.4.5 Anti-inflammatory effects after MSC transplantation 
Anti-inflammatory effects of MSCs are also reported by many studies. MSCs are 
shown to reduce inflammation by decreasing microglia and macrophage 
reactivity (Neuhuber et al., 2005, Himes et al., 2006). It is thought that up-
regulation of anti-inflammatory factors like TGF-β1 by MSCs reduces the 
inflammatory response (Hawryluk et al., 2014). Secondly, these cells have also 
been shown to modify the macrophage phenotype from M1 (considered pro-
inflammatory) to M2 (anti-inflammatory). This shift of macrophage activation 
favours axon and myelin sparing (Nakajima et al., 2012). This 
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immunomodulatory effect of MSCs further makes the conditions favourable for 
axonal regeneration and promotes tissue repair. 
1.11.1.4.6 Tissue repair/cavity reduction 
There are reports that MSC helps in the reduction of the lesion size and help 
preserve the surrounding normal tissue (Wu et al., 2003, Ankeny et al., 2004, 
Bakshi et al., 2006, Boido et al., 2014). This reduction is due to neuroprotective 
effects of transplanted MSCs via reduction of glial cavity and increased sparing 
of white matter. It is assumed that MSCs penetrate the glial cavity and reduce 
its volume by degrading the inhibitory molecules leading to reduction of the 
cavity (Boido et al., 2014). There is also evidence of secretion of laminin which 
contributes to reduced cavitation and supports nerve regeneration (Wu et al., 
2003, Ankeny et al., 2004). 
1.11.1.4.7 Functional outcomes after MSC transplantation 
There are several studies which demonstrate functional improvements after 
MSCs transplantations in different animal models of SCI (Lee et al., 2007, Abrams 
et al., 2009, Osaka et al., 2010, Pal et al., 2010, Alexanian et al., 2011a, Kang 
et al., 2012, Boido et al., 2014). The improvement of function is observed in 
different injury models including contusion (Hofstetter et al., 2002), 
compression (Urdzikova et al., 2006) and transection (Kamada et al., 2005). 
Transplantation of adult rat bone marrow derived MSCs seven days after thoracic 
contusion injury is reported to lead to a significant improvement in BBB score 
(Chopp et al., 2000, Hofstetter et al., 2002, Pal et al., 2010). Similar results 
have been reported when adult human MSCs have been delivered intravenously 
(Cizkova et al., 2006a, Osaka et al., 2010) or injected directly into injury site 
(Himes et al., 2006). In contrast, there have been reports that MSCs have failed 
to show functional improvement after transplantation into SCI (Ankeny et al., 
2004, Lu et al., 2005, Sheth et al., 2008, Sasaki et al., 2009). However, recently 
a meta-analysis showed a trend towards functional improvement in contusion 
and compression injury models. This analysis showed that significantly higher 
BBB scores were reported in transplanted animals compared to non-transplanted 
controls with none of the studies reporting any detrimental effects after MSC 
transplants (Oliveri et al., 2014). Improvements in electrophysiological 
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recordings of MEP and BBB scores have ever been reported in a completely 
transected injury model with axonal regeneration across the lesion site being 
claimed (Kang et al., 2012).  
1.11.1.4.8 Effect of dose on functional outcome 
In one study improvements in function even been reported to be dose-dependent 
suggesting enhanced recovery of function in animals transplanted with large 
amount of cells compared to smaller doses (Pal et al., 2010), however, there are 
findings that increasing the dose of MSCs does not have significant effect on 
functional improvements (Kang et al., 2012) or any effect on the tissue sparing 
and cavity reduction (Bakshi et al., 2006).  
1.11.1.4.9 Effect of timing of transplantation on functional outcome 
Similarly, there are also different reports on the effect of timing of 
transplantation on the functional outcome and tissue improvement in SCI model. 
Transplants performed sub-acutely have revealed more encouraging results 
(Chopp et al., 2000, Hofstetter et al., 2002, Cizkova et al., 2006a) as compared 
to transplants carried out immediately after SCI (Ankeny et al., 2004). Bakshi 
and colleagues performed MSCs transplants at different time points after 
contusion SCI to optimize a suitable time for MSC transplants. They found that 
cell survival was significantly better if transplants were performed before 2 
weeks, however, they also observed MSCs survival in a 4 week delayed 
transplantation (Bakshi et al., 2006). Partially filled cavities and improvements 
in BBB score are also reported after MSC transplantation at 3 months post injury 
(Zurita and Vaquero, 2006). 
Delaying the transplants after injury increases the chances of graft survival as 
the inflammatory responses after SCI tend to subside with time. Furthermore, 
improved graft survival can lead to robust secretion of growth factors and 
neurotrophins which can further enhance the regenerative capabilities of 
transplanted MSCs and hence improve functional outcome.  
Although MSCs derived from bone marrow are the most widely studied in SCI 
models, promising results are also observed with the transplantation of human 
umbilical cord blood (Cao and Feng, 2009) and adipose tissue derived (Ra et al., 
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2011) MSCs in experimental SCI models. These have been shown to reduce glial 
scar formation (Veeravalli et al., 2009), decrease cavity size and increased 
tissue sparing (Park et al., 2011, Shang et al., 2011) along with promotion of 
significant functional improvements (Lim et al., 2007, Lee et al., 2011). 
1.11.1.4.10 MSCs transplant in SCI patients 
Pre-clinical animal studies suggest that MSC transplants have translational 
potential in SCI. MSC transplantation has been attempted in clinical settings for 
human spinal cord injury but results obtained have not been promising. Slight 
improvement in motor score and electrophysiological recordings were observed 
in 3 out of 10 patients with ASIA A injury after transplantation of autologous 
MSCs from bone marrow in 6 months follow up (Park et al., 2012). In another 
study only one patient out of 13 transplanted with autologous bone marrow 
derived MSCs showed improvement from ASIA A to B (Bhanot et al., 2011). 
However, results from clinical trials have shown that MSC transplantation in SCI 
patients is safe with no major transplant related complications (Sykova et al., 
2006, Bhanot et al., 2011, Park et al., 2012).    
1.11.2 Other cell types 
1.11.2.1 Olfactory ensheathing cells  
Olfactory ensheathing cells (OECs) are a glial cell type present only in the 
olfactory mucosa. These cells have the ability of lifelong regeneration and act as 
support cells surrounding the olfactory axons. OECs can be obtained from nasal 
biopsies and although difficult to isolate and cultured to obtain sufficient cell 
numbers (Feron et al., 2005, Lima et al., 2006) can also be used for autologous 
transplantation. OECs have been used in experimental models of SCI focussing on 
regeneration, remyelination and functional recovery with variable results.  
Some studies have reported long distance axonal regeneration (Li et al., 1997, 
Ramon-Cueto et al., 2000, Keyvan-Fouladi et al., 2003), while others have failed 
to observe this (Andrews and Stelzner, 2004, Ramer et al., 2004, Lu et al., 
2007). There is evidence of functional improvement after transplantation of 
OECs in animal models of SCI both in acute and chronic injuries (Nash et al., 
2002, Guest et al., 2008, Takeoka et al., 2011, Ziegler et al., 2011). However, a 
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large number of experiments failed to demonstrate any therapeutic 
improvements after transplantations in SCI models (Ramer et al., 2004, Riddell 
et al., 2004, Steward et al., 2006, Deumens et al., 2013). Tetzlaff et al. 
reviewed preclinical studies using OECs and concluded that about two-thirds of 
the experimental studies reported showed improvements in behaviour outcome 
(Tetzlaff et al., 2011). In addition to regeneration, OECs have also been shown 
to improve functional outcome by neuroprotective mechanisms (Takami et al., 
2002b, Sasaki et al., 2006) and local plasticity (Chuah et al., 2004). It is 
suggested that the methods of obtaining and purifying cells along with their 
source could affect the ability of OECs to support neuronal survival and 
regeneration after SCI (Novikova et al., 2011).  
1.11.2.2 Schwann cells 
Schwann cells (SCs) are one of the most studied cell types in SCI transplantation. 
These cells produce the myelin sheath that surrounds PNS axons and play a key 
role in endogenous repair of peripheral nerve. Therapeutic effects of SCs are 
thought to be mainly due to their ability to produce a variety of growth factors, 
by expression of surface adhesive molecules and production of extracellular 
matrix molecules, which support axon growth (Mirsky et al., 2002, Oudega and 
Xu, 2006, Park et al., 2010a). Endogenous SCs also have the ability to 
proliferate, de-differentiate and infiltrate the site of a SCI (Xu et al., 1997, 
Weidner et al., 1999, Hill et al., 2006).  
SCs are relatively easy to isolate (from peripheral nerves), purify and expand in 
culture to generate a considerable number of cells. These cells can potentially 
also be derived from different categories of stem cells (Park et al., 2010a). SCs 
transplanted into SCI models have demonstrated reduced cavity formation and 
sensory and spinal axon extension into grafts. Moreover, these regenerated 
fibres were myelinated and also led to improved locomotor function (Takami et 
al., 2002b). Axonal regeneration along with remyelination and improvement in 
electrophysiological function has also been reported in many studies with SC 
transplants (Li and Raisman, 1994, Tuszynski et al., 1998, Kohama et al., 2001). 
However, it has been shown that SCs aggravate the astrocytic reaction which 
limits less effective integration into the host spinal cord (Lakatos et al., 2000, 
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Shields et al., 2000). In addition, CST axons show poor and delayed regeneration 
after SC transplants (Keyvan-Fouladi et al., 2005) and the axons do not grow 
through the grafts (Pinzon et al., 2001). However, when used in combination 
with other neurotrophic factors and blockers of inhibitory factors improved 
therapeutic outcomes are reported (Chen et al., 1996, Chau et al., 2004).  
1.11.2.3 Oligodendrocytes progenitor cells 
Oligodendrocyte precursor cells (OPCs) are precursors to oligodendrocytes and 
when differentiated form the myelin sheath which supports and insulates central 
axons. The myelin sheath is essential for normal propagation of impulses in 
axons. As discussed previously, demyelination is a common feature in SCI and 
leads to loss of function of the affected axons. OPCs are therefore a potential 
candidate in SCI repair.  OPCs can be derived from stem cells including human 
and animal embryonic stem cells.  
OPCs injected into demyelinated spinal cord differentiate into oligodendrocytes 
and show myelination of affected axons (Rossi and Keirstead, 2009). OPCs are 
also shown to provide trophic support and repair the environment by up 
regulation of neurotrophic factors such as TGF-B2 and BDNF (Zhang et al., 2006). 
Limited axonal sprouting is also observed but this is often abortive due to 
insufficient trophic factors to overcome the inhibitory environment and 
therefore, a combinatory therapy might be a more appropriate for therapeutic 
outcome (reviewed in (Watson and Yeung, 2011). OPCs transplanted into 
thoracic contusion SCI seven days post-injury (Keirstead et al., 2005) or 
immediately after complete spinal cord transection (Erceg et al., 2010) led to 
remyelination and improvement in locomotor function (Keirstead et al., 2005, 
Erceg et al., 2010). Similarly, OPCs transplanted 7 days after cervical SCI in rats 
showed improvements in forelimb function, reduction in cavity formation, 
increased sparing of white and grey matter and altered gene expression (Sharp 
and Keirstead, 2009). 
1.11.2.4 Activated macrophages 
The immune system is known to contribute to healing of damaged tissue. 
However, in damaged CNS it is believed to have some harmful effects and 
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suppression of the immune response might be helpful in prevention of ongoing 
damage. Macrophages especially monocytes are capable of expressing different 
functional programs in response to environmental signals (Nagorsen et al., 2005). 
It is known that “classical” activation of macrophages turns them into potent 
effector cells that destroy microorganisms and tumour cells. On the other hand, 
“alternatively” activated macrophages are capable of producing growth factors, 
promoting angiogenesis and scavenging neurotoxins such as glutamate (Butovsky 
et al., 2006).     
It is observed in animal models of SCI that activation of intrinsic macrophages by 
pro-inflammatory agents has negative effects on functional outcome (Popovich 
et al., 2002). However, depletion of macrophages led to significant improvement 
in overground locomotion, sparing of white matter and a decrease in tissue 
cavitation (Popovich et al., 1999). Schwartz and Yoles (2006) have reported that 
adequately activated macrophages can positively contribute to homeostasis in 
the CNS. However, the timing of treatment was found to be important for 
successful functional recovery. The optimal time for transplantation was found 
to be 1-2 weeks post-injury (Schwartz and Yoles, 2006).  
  
Chapter 1  73 
 
 
1.12 Summary of study aims 
The aims of this thesis were as follows: 
1. The aim of work described in chapter 2 was to use a direct 
electrophysiological approach to investigate and characterise the effects on 
spinal cord function of a moderate contusion SCI at the cervical level. Local 
circuit function was assessed by recording CDPs immediately after injury and at 
different time points for up to 6 months after SCI in order to characterise the 
time course of damage contributed by primary and secondary processes and to 
determine any spontaneous recovery of function in the vicinity of the impact. It 
is hypothesized that high velocity injury would produce both primary and 
secondary damage that would be revealed by assessing function at different 
time points after injury. 
2. The aim of work described in chapter 3 was to combine the injury model and 
electrophysiology used in chapter 2 with assessments of function in order to 
determine whether delayed transplantation of human embryonic stem cell 
derived mesenchymal stem cells (hESC-MSCs) promote improved recovery of 
function.
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2 Responses of the local somatosensory 
pathways to cervical contusion injury 
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2.1 Introduction  
Traumatic injury to the spinal cord leads to disruption of ascending and 
descending pathways leading to motor, sensory and autonomic dysfunction. 
Initial trauma causes primary injury and loss of function but this is followed by a 
cascade of secondary molecular and cellular events. These events include both 
degenerative and reparative mechanisms. Some of these processes are thought 
to contribute to mechanisms of progressive damage leading to further 
deterioration and loss of function. Concurrently, other mechanisms promote 
limited repair and spontaneous recovery of function over time.  
As reviewed in chapter 1 (Introduction) several processes are postulated to 
contribute to the progression of the secondary damage. Briefly, there are 
vascular changes (haemorrhage, thrombosis, vasospasm) and disruption of blood 
brain barrier which causes oedema and ischemic necrosis of the surrounding 
tissue. In addition, formation of free radicals causes disruption of membranes 
leading to ionic imbalance and loss of functional integrity. Apoptosis, necrosis 
and excitoxicity is observed in all neural tissue. The inflammatory response from 
resident microglia and infiltrating macrophages further aid cellular death and 
also help phagocytose cellular debris leading to cavity formation. Astrocytes 
along with oligodendrocyte precursors and meningeal cells lead to glial scar 
formation, which surrounds the cavity. Demyelination and axonal degeneration 
can continue for months to years along with extension of the injury cavity.      
The mechanisms behind spontaneous recovery of function are also not fully 
understood and it is suggested that injury induced plasticity or rearrangements 
in the nervous system may play a role in functional recovery after SCI (Raineteau 
and Schwab, 2001). Anatomical and synaptic plasticity in the injured and 
remaining un-injured axons have been observed in animal models of SCI. 
Merzenich et al. 1984 illustrated that non-functioning synapses and pathways 
become functional after injury (Merzenich et al., 1984). Sprouting is also 
observed in the spared axons and these may form new functional synapses 
(Weidner et al., 2001, Bareyre et al., 2004). Remyelination of the injured axons 
by the endogenous oligodendrocyte precursors and infiltrating Schwann cells has 
also been shown to improve functional outcome (James et al., 2011). Although it 
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is shown that adult neurons have the intrinsic ability to regrow over long 
distances (David and Aguayo, 1981), anatomical evidence suggests that this 
regrowth is inhibited by the hostile milieu after SCI. Therefore regeneration is 
unlikely to contribute to the spontaneous functional recovery.  
Although it is known that both secondary injury processes and reparative 
processes are triggered by the initial injury, the interacting dynamics and net 
effects of these two processes are poorly understood and the time course with 
which they impact on spinal cord function is not clear. In fact, we do not know 
to what extent function in white matter tracts and local circuits in the grey 
matter are affected by the initial impact of a contusion injury. Similarly, it is 
unclear how much secondary injury mechanisms add to the initial loss of 
function which occurs in the first few hours after injury, and how long these 
processes continue to cause deterioration of function. Furthermore, we are not 
sure when the secondary processes resolve, and/or the endogenous repair 
processes outweigh the continuing deterioration leading to functional 
improvement. In addition the time over which functional improvements continue 
to occur, and the time point at which an injury can be considered chronic in a 
rodent contusion injury model, is also undetermined. 
Most of our understanding of secondary processes comes from cellular, 
molecular and anatomical studies and loss of axons or neurons are used as 
indicators of functional loss. There has been so far no direct measurement of the 
effects of secondary mechanisms on spinal cord function. Similarly, recovery of 
function is regularly assessed by behavioural testing in animals, but these 
measure overall function and do not directly measure function in the spinal 
cord. Compensatory changes in the brain are likely to contribute to recovery of 
function (Jain et al., 1997, Ghosh et al., 2009) and it is therefore difficult to 
distinguish recovery due to compensatory plastic changes within the brain and 
restorative and reparative mechanisms in the spinal cord. Therefore, a method 
is required which can directly measure function in the local circuits and specific 
long tracts within the spinal cord.  
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2.2 Aims 
The aim of the study described in this chapter was to use an electrophysiological 
approach to directly assess the functional changes in local spinal circuits in the 
vicinity of a spinal cord contusion injury. 
The aim was to use this approach to investigate the following: 
1) To assess how much damage is caused acutely by the contusion injury. 
2) To determine the contribution made by secondary processes to loss of 
function. 
3) To determine how long function in local spinal circuits and pathways 
continues after injury. 
4) To establish the time point at which repair/functional improvements at 
the spinal level begin. 
5) To determine if there is any plasticity in the spinal circuits/pathways. 
6) To determine how long functional improvement in local circuits and 
pathways continues after injury and when the SCI has functionally 
stabilised.  
To assess the functional changes in the ascending and descending pathways of 
the spinal cord, cord dorsum potentials (CDPs) evoked by stimulation of the 
radial nerve and CST stimulation at the level of the pyramids were recorded in 
the vicinity of the contusion injury from the surface of the cord. Comparison of 
these potentials were made in normal animals and in contusion injured animals 
at time points range from acute injury to 6 months following injury.   
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2.3 Materials and methods   
2.3.1 Animals  
All the experiments in this project were approved by the Ethical Review Process 
Application Panel of University of Glasgow and performed in accordance with the 
UK Animals (Scientific Procedure) Act, 1986. 
A total of 158 male adult Lister Hooded rats (Harlan, Loughborough, UK) were 
used in this study. The Lister Hooded strain was used as these animals are good 
at performing reaching tasks which we had originally planned to carry out along 
with the electrophysiology. Among these, twenty-four (24) rats were used as 
non-injured controls for comparison with injured animals. One of the control 
animals died during the preparatory surgery for electrophysiology. All other 
animals (134) were subjected to bilateral contusion injuries of 175 kilo-dyne 
(Kdyn) severity. Injuries were intended to be performed at the 6th cervical level 
of the spinal cord. Among the injured rats, 7 animals died during the post-
operative recovery period and 2 animals developed scratching at the surgical 
wound and were euthanized. 13 animals died during the preparatory surgery for 
electrophysiology experiments. In addition, injuries were found to be 
erroneously located rostral or caudal to the C6 segment in 12 animals and these 
were excluded from the final analysis. Furthermore, in 10 of the non-injured and 
7 injured animals pyramidal evoked CDPs could not be included either due to 
difficulty in obtaining correct placement of the stimulating electrode within the 
pyramids. Therefore, the findings in this chapter are based on a total of 124 
animals for the radial nerve evoked CDPs and 107 for the pyramidal evoked 
CDPs. The number of animals for radial nerve and pyramidal evoked CDPs for 
each group of animals are shown in Table 2-1. All the animals were housed pair-
wise in cages with a 12 hour light/dark cycle and bedding was changed every 
week.  
2.3.2 Contusion injury  
Contusion injuries in this project were performed by Dr. John Riddell and Mr 
Andrew Toft with assistance from myself and the animal house technical staff. It 
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would take me a long time to reach a level of consistency; all surgeries were 
performed by Dr Riddell and Mr. Toft. 
2.3.2.1 Drugs 
All the animals undergoing contusion injury routinely received pre-operative 
medications as required. 
Buprenorphine (Vetergesic): 0.05 mg/kg was administered subcutaneously at 
the time of induction of anaesthesia for analgesia. A second dose was given the 
following morning. 
Carprofen (Rimadyl): This non-steroidal anti-inflammatory drug was given at a 
dose of 5 mg/kg body weight subcutaneously at the time of surgery.  
Saline: 0.2-0.4 ml/100 gm of body weight was administered subcutaneously two 
or three times daily for three days and as required afterwards. 
Enrofloxacin (Baytril): This antibiotic was administered at a dose of 5 mg/kg 
subcutaneously twice daily for 7 days starting on the day of surgery. 
Ampicillin (Amfipen): This antibiotic was administered at a dose of 22.5 mg/kg 
subcutaneously once pre operatively. 
An ophthalmic ointment was applied to the animals eyes at the time of surgery 
to prevent drying. 
2.3.2.2 Anaesthesia 
Animals were anaesthetized with 5 % isoflurane in oxygen at the time of 
induction. Anaesthesia was maintained using 1-3 % isoflurane in oxygen for the 
rest of the surgery. 
2.3.2.3  Contusion injury procedure 
After induction of anaesthesia, the animal was placed in a stereotactic frame 
with a head holder. The T2 vertebra was identified and fixed with the help of a 
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clamp to straighten and position the cord horizontally. The vertebral column was 
exposed at the cervical level by a midline incision. The cervical spinal cord at C6 
was exposed by performing a laminectomy to remove the C5-C6 laminae. The 
vertebral bodies of C4 and C7 were clamped with lockable Adson’s forceps to 
stabilize the spine.  
The Infinite Horizon ImpactorTM (Precision Systems and Instrumentation, LLC, 
Lexington, KY, USA; Figure 2-1), a commercially available instrument was used 
to perform the contusion injury. The impactor tip was aligned with the midline 
of the exposed spinal cord, using the left and right-side C6 dorsal roots as a 
visual guide. The edge of the impactor tip was then aligned with the border 
between C5 and C6 dorsal roots (Figure 2-2). A force of 175 kdyn was set and a 
computer controlled stepper motor was activated. The impactor tip was lowered 
at approximately 120 m/s to contuse the exposed spinal cord until the user-
defined force was reached, triggering automatic retraction of the tip. Graphs of 
force and displacement vs. time were generated by the IHI software and saved 
and stored for further analysis offline (Figure 2-3). 
Graphs generated by the software provided an instant indication of whether the 
impactor tip was hitting the cord accurately with a desired force. Any graph with 
a blunted or a second peak on the ascending phase of force vs. time graph was 
suggestive of the impactor hitting the surrounding bone, along with reduced 
displacement of the cord. However, this rarely happened in this study.  
For animals which were allowed to recover post injury, the muscle layers were 
closed using a 3-0 vicryl suture and the skin was closed with wound clips. Post-
operative medications as described previously were administered routinely. 
Animals were allowed to recover and placed in a warm incubator (27-30 ºC) for 
24 hours with easy access to food and water. Afterwards the animals were 
transferred to the normal housing conditions for a period of up to 6 months 
depending on the time course group allocated. The animals which were intended 
for acute CDPs recordings underwent electrophysiological recordings 
immediately after contusion injury. 
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2.3.2.3.1 Post-operative care 
Animals were checked post operatively for recovery from anaesthesia and during 
the night for any signs of distress and dehydration. Bladder was manually 
palpated 2 times daily for 3-4 days until the normal voiding reflex has returned. 
Post-operative care was provided by the animal house technical staff in the 
morning and at night by myself or Andrew Toft.    
2.3.3 Electrophysiological experiments  
2.3.3.1 Anaesthesia  
Anaesthesia was induced with 5 % isoflurane in oxygen and maintained 
afterwards with 1-3 % isoflurane in oxygen during the initial surgery. 
Subsequently, the anaesthesia was maintained with frequent intravenous doses 
of sodium pentobarbital (10 mg/kg) when required, after jugular venous 
cannulation (described in 2.3.3.4). The depth of anaesthesia was monitored by 
assessing pedal withdrawal reflexes, corneal reflexes, electrocardiogram and 
arterial blood pressure. Further doses of anaesthetic were administered if there 
was a withdrawal reflex due to pinching of the limb or blood pressure increased 
due to pinching or if the resting blood pressure was abnormally high. 
Throughout the recording phase, animals were paralysed and artificially 
ventilated (explained below) and hence withdrawal reflexes were eliminated. 
During this time, anaesthetic was routinely given at regular intervals, consistent 
with the rate required before paralysing. The adequacy of this regime was 
checked by continuous monitoring of arterial blood pressure and its response to 
noxious stimuli and additional anaesthetic top ups could be given if required. 
2.3.3.2 Pre-operative drugs 
Before commencement of the surgery atropine sulphate (Martindale 
Pharmaceutical, UK) 0.05 mg/kg was administered subcutaneously to reduce 
bronchial constriction and salivary secretions.  
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 Dexamethasone sodium phosphate (Faulding Pharmaceutical Plc, UK) was 
injected intramuscularly at a dose of 2-3 mg/kg to prevent swelling of brain and 
spinal cord. 
2.3.3.3 Preparatory surgery 
After induction of anaesthesia the animal was placed in a supine position on the 
operating table. Core body temperature was monitored with a rectal 
thermometer and maintained at 37°C using a heating blanket. The animal was 
secured with adhesive tapes attached to each limb and needle electrodes were 
placed in the skin of both forelimbs and right hind limb to continuously monitor 
the heart rate and electrocardiogram. Fur was removed from the relevant areas 
with the help of an animal fur clipper before making any skin incision. A 
dissecting microscope (Zeiss S5, Germany) with foot controller was used to aid 
fine surgery including cannulations, radial nerve dissection and laminectomy. To 
stop bleeding, an electrocautery (Eschmann Equipment, TD50, UK) was used. 
2.3.3.4 Cannulations 
The carotid artery, jugular vein and trachea were cannulated in order to monitor 
arterial blood pressure, administer intravenous drugs and artificially ventilate 
the animal after paralysing, respectively. A midline skin incision was performed 
overlying the trachea. The skin and muscles are retracted and with careful blunt 
dissection through the muscles and connective tissue about a 2 cm length of 
carotid artery was exposed and separated from the vagus nerve. The artery was 
ligated distally with 5-0 silk thread and clamped proximally. A small incision was 
made near the distal ligature and a cannula inserted in the direction of the heart 
and tied in place before removal of the clamp. The cannula was filled with 
heparinised saline (50 units/ml heparin in saline) to prevent blood clotting and 
maintain patency of the vessel for continuous monitoring of arterial blood 
pressure. The arterial cannula was attached to a force transducer to allow 
measurement of mean arterial blood pressure. The jugular vein was exposed and 
cannulated in a similar way, which permitted administration of intravenous 
drugs. Usually, the right carotid artery and jugular vein were cannulated.  
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For tracheal cannulation the muscles overlying the trachea was retracted and a 
small length of trachea was cleared from surrounding tissues and any bleeding 
staunched. A small opening was created using fine micro scissors and the 
tracheal cannula was inserted and tied in position. Secretions from the lungs and 
trachea were aspirated from time to time to maintain patency. All three 
cannulae were secured to skin by threads in order to prevent dislodging and the 
skin incision was closed using Michel clips. 
2.3.3.5 Radial nerve dissection 
For dissection of the radial nerve, the animal was put in a prone position; the 
left forelimb was extended laterally and fixed with adhesive tape and fur 
removed with a clipper. An incision was made on the dorsal aspect extending 
from the shoulder to the elbow joint. The tendon of the triceps brachii muscle 
was cut with the help of an electro-cautery to expose the superficial branches of 
the radial nerve. Approximately 2 cm of the superficial radial nerve was cleared 
of the surrounding tissue with careful blunt dissection and sectioned distally. A 
suture was attached to the distal end in order to lift the nerve without damaging 
it (shown in Figure 2-4). The exposed nerve was then covered with cotton soaked 
in saline to prevent it from drying. 
2.3.3.6 Laminectomy  
In order to expose the cervical spinal cord a laminectomy was performed from 
C2-T1 segments of the spinal cord. A midline incision was made on the dorsal 
surface extending from the skull to the upper thoracic region of the back. The 
skin was retracted; the cervicoauricular and trapezius muscles were separated 
and partially removed from both side of the vertebral column. With the help of 
bone rongeurs, the posterior arch was cautiously removed to expose the dorsal 
surface of the spinal cord. In lesioned animals there was already a partial 
laminectomy done previously at the time of contusion. The cervical spinal cord 
was exposed from C2-T1 segments and in the case of the injured animals, the 
injury cavity was obvious as a greyish area at the level of the C6 segment. For 
preventing bleeding from bone edges bone wax and gel foam were used. 
Extreme caution was exercised in order to avoid any damage to the cord which is 
crucial to retaining good function. To prevent the cord and dura from drying out 
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before making the recordings, cotton soaked in saline was placed over the 
exposed cord. 
2.3.3.7 Transferring the animal to the recording frame 
After the initial preparatory surgery, the animal was transferred to the recording 
frame. The animal’s head was placed in the head holder and secured by an 
incisor bar and ear bars. The spinal cord was straightened and fixed with the 
help of a clamp that gripped the T2 dorsal bony process. Securing the animal 
with bars and clamps provided a steady horizontal position for recordings.  
2.3.3.8 Artificial ventilation 
In order to prevent movement when stimulating the radial nerve and CST at the 
level of the pyramids, it was necessary to paralyse the animal using a 
neuromuscular blocker. The animal was given Pancuronium Bromide (Sigma, UK) 
in a dose of 0.3 mg/kg i.v. with regular top up doses every 30-40 minutes or as 
required. Immediately afterwards, the animal was put on an artificial ventilator 
(Ventilator, UGO, Italy) and carbon dioxide levels were monitored in expired 
breath using a micro-capnometer (Columbus Instruments, USA). The CO2 levels 
were maintained around 4% throughout the experiment by adjusting the 
ventilation rate and stroke volume. The tracheal cannula was cleared of any 
fluid accumulation due to secretions from lungs. 
2.3.3.9 Craniotomy 
In order to insert a stimulating electrode into the brain to stimulate the CST 
bundle in the pyramid a small craniotomy was performed in the skull. The CST 
fibres within the pyramids were stimulated by a dorsal approach. Co-ordinates 
for stimulation of the CST were calculated before making the craniotomy (see 
below).   
A bipolar electrode was used to maximise the current density close to the tip 
and reduce stimulus spread. The electrode was mounted on a Kopf U-frame at an 
angle of 20 degree and the tip of the electrode was calibrated before the 
experiment with an ear bar set in the frame. Calculation were made from a 
stereotaxic atlas of the rat brain and the following co-ordinates were chosen 
Chapter 2  85 
 
 
(medio-lateral: 0.7 mm to the right; anterio-posterior: slightly rostral to intra-
aural line, depth approximately 1 mm below the intra-aural line) with the aim of 
targeting the middle of the right pyramidal tract (Paxinos and Watson, 1998). 
The positions of the co-ordinates on the Vernier scales of the electrode carrier 
were noted. During the experiment the electrode was lowered with animal’s 
head fixed in the head holder the electrode was lowered and the point where 
the tip would be touching the skull was noted. A small craniotomy was then 
created allowing room for the electrode to be moved a few mm lateral or medial 
if needed in order to reach the middle of the pyramidal bundle. 
2.3.3.10 Paraffin pools 
Paraffin pools were created around the posterior side of the left forelimb and 
the laminectomy using flaps of incised skin. These were secured with threads 
passed through the skin incision edges tied firmly to the recording frame. The 
pools were filled with liquid paraffin maintained at close to 37 ºC using a radiant 
heat source. This insulation prevented current spread to the surrounding tissue 
when stimulating the peripheral nerves. Paraffin pools also helped to prevent 
tissue from drying and heat loss. A small strip of mm paper was put alongside 
the cord and the C5/C6 border was identified to provide a reference point for 
positioning of the recording electrode.  
2.3.3.11 Stimulation of the radial nerve 
The radial nerve was carefully mounted on a bipolar silver stimulating electrode 
immersed in the liquid paraffin pool. Care was taken to avoid any contact 
between the nerve and the surrounding tissue. Cathodal stimuli were applied by 
positioning the cathode of the stimulating electrode proximally and the anode 
distally. Once the nerve was in position, the electrode was secured firmly in 
position. The nerve was stimulated with single square wave electrical pulses of 
0.2 ms duration and up to 50-100 µA. 
2.3.3.11.1 Technical considerations for supramaximal stimulation of the 
radial nerve 
In order to obtain a quantitative measure of the strength of CDPs evoked by 
stimulation of the primary afferent pathways which can be comparable between 
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animals it is essential to activate the same pathways to an equal extent in each 
animal. To obtain maximal activity in myelinated cutaneous A-α and A-β fibres, 
a supra-maximal stimulus intensity was applied to the radial nerve. Recordings 
were made at a point 2 mm rostral to the C5/C6 border, where maximum radial 
evoked CDPs were obtained in an injured animal. For each animal, a 
supramaximal stimulus intensity was determined by finding the threshold for 
activation and then increasing the stimulus intensity until a maximal CDP 
amplitude was seen (i.e. maximum A-α and A-β postsynaptic response).This was 
typically between 20-50 µA and supra-maximal intensity used for stimulation was 
typically set at 50-100 µA. 
2.3.3.12 Stimulation of the corticospinal tract 
The corticospinal tract was activated by stimulating corticospinal bundles within 
the pyramids using a dorsal approach. A concentric bipolar microelectrode was 
used to maximise the current density close to the tip of the electrode and 
reduce stimulus spread. The electrode shaft diameter was 0.25 mm with a 50 
mm length (SNE-100X, Kopf instruments, Tujunga, CA, USA). The impedance and 
insulation of each electrode was checked before each experiment (typically less 
than 100-200 kΩ).  
After adjusting the sterotaxic co-ordinates and securing the holder the electrode 
was lowered through a small opening made in the dura into the brain. It was 
lowered to a position 1 mm above the inter-aural line. Initial electrical stimuli of 
0.2 ms duration and 500 µA amplitude were applied until the optimum position 
of the electrode was found while monitoring the CDPs and examining the 
recruitment characteristics. Typically, the final stimulation amplitude was 
between 200-500 µA. The usual initial location for recording CDPs while 
examining recruitment was 4 mm rostral to the C5/C6 border. The electrode was 
initially lowered in 0.5 mm steps, followed by 0.2 and 0.1 mm steps while 
monitoring the size of the CDP and determining the threshold.  Sometimes the 
base of the skull was reached without seeing optimum conditions for eliciting 
pyramidal evoked CDPs. In that situation the electrode was withdrawn to the 
surface and after moving the electrode either medial or lateral 0.5 mm, the 
electrode was lowered again to find the most accurate position. 
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2.3.3.12.1 Technical considerations for CST stimulation 
To be sure that only the right CST bundle was activated, a stimulus recruitment 
curve for pyramidal-evoked CDPs was collected. This was done firstly by finding 
the minimum strength of current at which the pyramidal-evoked CDP could be 
detected (usually equal to or less than 10 µA). Recordings of the CDP were then 
made while increasing the intensity of the stimuli applied within the pyramids in 
graduated steps from threshold to values that were supramaximal. When the 
electrode was appropriately placed the stimulus-recruitment curve would show a 
sharp rise in CDP response, with increasing stimulus intensity, followed by a 
plateau. The value producing a maximal CDP response was determined with this 
procedure and a supramaximal value was then chosen for that particular 
experiment. In cases where the stimulating electrode was too close to the 
midline, the stimulus-response curve would show a consistent rise with 
increasing stimulus intensity. In cases where the electrode was too far lateral, 
the maximal CDP response would likely be low but the threshold high.  
A further reason for the reduced amplitudes of CDPs in the injured spinal cord 
may be that the current flow produced by synaptic activity is conducted away 
more rapidly through the fluid in the injury cavity than in the solid spinal cord 
tissue which may have greater resistance. 
2.3.3.13 Recording of cord dorsum potentials 
In order to assess spinal cord function in the vicinity of the injury, CDPs evoked 
by stimulation of the radial nerve and corticospinal tract were recorded. A 
bipolar silver ball electrode was used to make these recordings by placing one 
pole on the dorsal surface of the cord. The indifferent pole was placed on the 
nearby muscles. CDP recordings were made at 1 mm intervals, from 8 mm rostral 
to 8 mm caudal of the C5/C6 border (Figure 2-5). The electrode was aligned 
according to the mm paper strip placed alongside the exposed cord. At each 
position the electrode was placed just medial to the dorsal root entry zone on 
the left side. 
CDP recordings were made by either stimulating the radial nerve or CST fibres 
within the pyramids with a stimulus repetition rate of approximately 3 Hz. An 
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average of 25 sweeps were recorded for radial nerve stimulation, while 50 
sweeps were averaged for the smaller CDPs collected during pyramidal 
stimulation. A typical CDP trace for radial and pyramidal CDPs is shown in Figure 
2-8. 
During the recordings, great care was taken to remove any cerebrospinal fluid 
accumulation on the surface of the cord. CSF accumulation tended to short 
circuit the recording electrode and results in smaller amplitude potentials which 
is a potential source of inaccuracy. Therefore, the fluid was removed regularly 
between the recordings after moving the electrode to new a recording position, 
before making the recordings and also during the recordings if CDPs tended to 
decrease in amplitude.  
The recordings of all electrical potentials were digitised using a CED 1401+ 
interface (Cambridge Electronic Design, Cambridge, UK) and stored on a 
computer at a sampling rate of 26 kHz. Signal software version 2.1 (Cambridge 
Electronic Design, Cambridge, UK) was used for offline analysis to average and 
measure the amplitudes of electrical potentials. A schematic of the radial CDP 
recording procedure is shown in Figure 2-6. 
2.3.3.14 Recording of cord dorsum potentials immediately after injury 
(acute experiment group) 
After the initial set up for the electrophysiology experiment, up to the point of 
making the paraffin pools (without adding the paraffin) the procedure for 
recording immediately after injury in the acute time point group was the same 
as described above. At this point the cord was firmly fixed in position using 
Adson forceps prior to injury. The injury procedure was identical to that for 
contusion injuries in the animal house. The injury was made using the IHI 
impactor at 175 kdyn force, with the dura intact. The exact time at which the 
impact occurred was noted; then the Adson forceps were removed and the dura 
was opened. The laminectomy pool was filled with paraffin, the CDP recording 
electrode was placed in position and the pyramidal stimulating electrode was 
inserted into the brain through the craniotomy. The position of the pyramidal 
electrode was then optimised (as described above in 2.3.3.12).  
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The time required to complete this procedure was close to 20 minutes. 
Therefore after the initial 2 experiments it was decided to standardise the start 
of the first recordings at 20 minutes post-injury. Each recording map (+8 to -8) 
took about 20-30 minutes and therefore it was feasible to record every 30 
minutes after injury. This was continued for approximately 4 hours. Both 
pyramidal and radial recordings were obtained for each recording location. A 
schematic diagram showing the arrangement for recording of pyramidal evoked 
CDPs is shown in Figure 2-7.  
2.3.4 Perfusion fixation   
At the end of the experiment animals were transcardially perfused with 
mammalian Ringer’s solution followed by paraformaldehyde solution. Animals 
were perfused by inserting a 20 g needle into the left ventricle and perfusing 
with mammalian Ringer’s solution containing 0.1 % lidocaine in order to dilate 
the blood vessels. This was followed by 1 litre of 4 % paraformaldehyde in 0.1 M 
phosphate buffer, pH 7.4. The cervical spinal cord and brain stem were then 
carefully dissected out for post-fixation and cryoprotection. This was achieved 
by placing the tissue overnight in the same paraformaldehye solution with 30 % 
sucrose added.    
2.3.5 Histological processing   
2.3.5.1 Histological processing of brainstem CST stimulation site 
After washing in 0.1 M PB solution, the electrode track was identified and a 
tissue block was prepared carefully. The block was notched at the ventral aspect 
of the spinal cord on the left side (opposite to the site of insertion of the 
electrode). The blocks were sectioned transversely at 100 µm using a freezing 
microtome (Ernst Leitz Wetzlar, Germany). Sections with electrode tracks were 
then mounted on plain glass slides in vectashield mounting medium (Vector 
laboratories, UK). These were then covered with a glass cover-slip, sealed with 
nail varnish and stored at -20 ºC. 
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2.3.5.2 Histological processing of spinal cord injury site 
The spinal cord tissue was washed with 0.1 M PB and the injury site was 
identified and cut into a 6 or 7 mm long block. Dorsal and ventral roots were 
carefully trimmed using fine scissors without damaging the lesion site. The block 
was notched at the ventro-caudal aspect (for orientation purposes when 
sectioned) and the block was then cut into 60 µm parasagital sections using a 
Leica CM1850 cryostat (Leica Microsystems GmbH, Wetzlar, Germany) at -20 ºC. 
Occasionally, when cutting through the cavity at the point where the cavity was 
very extensive, some of the fragile sections would break into pieces and could 
not be recovered for analysis. This happened rarely. Afterwards, sections were 
washed in 0.3 M PBS double salt (PBSD) twice for 10 minutes and incubated in 50 
% ethanol for 30 minutes. The sections were then washed three times for 10 
minutes each in 0.3 M PBS and treated with different primary antibodies. 
Sections were incubated with anti-NF200 (1:1000, Sigma)/anti-GFAP (1:1000, 
Dako) and anti-Laminin (1:100)/anti-GFAP (1:1000) primary antibodies for 72 
hours at 4 ºC, diluted in 0.3 M PBS plus 0.3 % triton detergent to label 
axons/astrocytes and basal lamina/astrocytes respectively. This was followed by 
appropriate species specific secondary antibodies conjugated to fluorophores; 
Alexa 488 (1:500) and Rhodamine (1:100) diluted in 0.3 M PBS plus 0.3 % triton 
detergent, for 3-4 hours at room temperature and covered to protect from 
sunlight. These were then washed with 0.3M PBS three times for 10 minutes 
each, followed by mounting on plain glass slides in anti-fade medium 
(Vectashield). Sections were coverslipped, the edges sealed with nail varnish and 
stored at -20 ºC in darkness.  
2.3.6 Cortical tracer injection 
In order to investigate the effects of the injury on the integrity of the 
corticospinal pathway 3 animals were subjected to injury in the same way as the 
animals prepared for electrophysiological recording. Cortical tracer injection 
using biotinylated dextran amine (BDA; 10,000 MW, product no. D-1956, Life 
Technologies) was performed 2 weeks after the C6 contusion injury in order to 
label the CST.  The tracer was prepared as 20 % BDA in 0.1 M phosphate buffer 
with 2 % fast green dye (R.A. Lamb supplies, UK; product 42053) in order to 
detect spillage of tracer during injection into the cortex. BDA cortical injections 
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were performed by Mr. Andrew Toft with my assistance. The scalp was incised 
and craniotomy was performed through the skull to expose the right 
sensorimotor cortex using bregma as a reference point. A glass micropipette of 
30-40 µm tip diameter was filled with BDA tracer and mounted on a stereotaxic 
manipulator. Injections were performed at 10 sites 1 mm apart in a grid pattern 
ranging from 1 mm rostral of bregma and 2 mm caudal and up to 4 mm laterally. 
Approximately 300 nl of BDA was injected at each injection site from 1.8 mm 
below the surface up to a depth of 1.0 mm. The scalp incision was sutured 
closed. Animals were recovered and allowed to survive for 2 week after the 
injections to allow the time needed for movement of tracer along the CST 
fibres. 
2.3.7 Microscopy   
2.3.7.1 Verification of stimulation site in the pyramids 
Sections containing stimulating electrode tracks were reviewed under a light 
microscope (Zeiss Axioplan 2 Imaging) to confirm the appropriateness of the 
location of the electrode in the pyramids. 
2.3.7.2 Verification of contusion injury  
Sections containing the injury cavity were viewed by phase contrast light 
microscopy to determine the cavity perimeters and the relationship between the 
grey and white matter boundaries. In general all sections with the injury site 
were also examined under the epifluorescence microscope (Zeiss Axioplan 2 
Imaging) to observe neurofilament/GFAP and laminin/GFAP immunolabelling and 
parasagittal sections passing through the injury area close to the midline were 
selected for confocal scanning and illustration. Selected sections were scanned 
with a Zeiss LSM 710 confocal system using X20 objective lenses. Laser excitation 
wavelengths used for scanning were 488 nm fluorescent (Alexa 488) and 561 nm 
fluorescent (Rhodamine). Tissue sections were scanned as a tiled composite of 
multiple fields to cover the whole section. All sections were scanned through a 
14-18 µm thickness of the stained tissue to accumulate a series of optical 
sections at 2 µm intervals. Stacked images were projected into 2D builds 
(maximum intensity projection image) using Zeiss Zen software (Zeiss, 
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Germany). Images were exported to Adobe Photoshop CS3 (Adobe Systems, USA) 
and prepared for illustration by making minor changes to brightness and 
contrast. 
2.3.7.3 Quantification of cavity dimensions 
To investigate difference in the extent of the cavity between 7 weeks and 6 
months survival animals, calculations of cavity length and width were carried 
out. For calculation of the cavity length all parasagittal sections containing the 
injury site were examined under epiflourescence with X2.5 objective lenses, 
projected on the monitor connected to the microscope. Most rostral and caudal 
points in the cavity were noted and distances between the 2 points were 
measured using a ruler calibrated with the graticule. Most rostral and caudal 
borders of the injury cavity identified and the distance was measured with the 
ruler. Similarly, for the width of the cavity all the sections with cavities were 
counted under the microscope and multiplied by 60 (each section has 60 µm 
thickness) to get measurement in micrometres. Cavity length and width were 
expressed in mm.  
2.3.8 Off-line analysis of electrophysiological data   
Averaged records of CDPs were examined offline to measure the amplitude of 
CDPs with the help of Signal software V2.1. The maximum amplitude at each 
location was measured and data collected in a Microsoft Excel spread sheet 
before being transported into GraphPad Prism 4 software (GraphPad Software 
Inc, USA), to create graphs.  
2.3.9 Statistical analysis   
The statistical analysis was performed using GraphPad Prism 4 software. One-
way Analysis of variance and post-hoc Tukey’s multiple comparison tests were 
performed for each recording location (+8 to -8) among all the experimental 
groups in the study to reveal any differences among the groups in each recording 
location. A paired Student’s t-test was applied to compare the cavity length and 
width between 7 weeks and 6 month survival animals.   
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Time point 
investigated 
Total number of 
animals (n) 
 Animals for 
radial 
recordings (n) 
Animals for 
pyramidal 
recordings (n) 
Normal 24 23 13 
Acute 17 14 12 
3 days 15 15 14 
2 weeks 24 15 13 
4 weeks 21 15 15 
7 weeks 14 13 12 
3 months 19 14 14 
6 months 23 15 14 
Total (n) 158 124 107 
 
Table 2-1. Table showing number of animals used at each time point. 
Total number of animals assigned to different groups at each time point is shown on the left. 
Numbers from which radial-nerve evoked CDP data was obtained are shown in the middle and 
numbers from which pyramidal-evoked CDP data was obtained are shown on the right.  
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Figure 2-1. The Infinite Horizon Impactor.  
The adjustable support arms were used to position the adson forceps. The forceps were lockable 
and could be used to stabilize the animal. The impactor tip was then lowered and moved over the 
exposed spinal cord to be positioned over the C6 segment. After positioning, the computer 
controlled stepping motor was activated which drove down the impactor rack. The force and 
position sensor were connected to the lower end of the impactor rack and signals were passed to 
the control unit via cable connected to the control unit (image taken from the PSI-IH Impactor user 
manual 2007).  
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Figure 2-2. Contusion injury set up.  
The C6 contusion injury involved performing a laminectomy between C5-C7 vertebrae and firmly 
fixing the C5 and C7 vertebrae with Adson forceps. The Infinite Horizon Imapctor was then 
positioned over the exposed C6 spinal cord segment and a computer controlled contusion of 175 
Kdyn force was performed (Image taken from Mohamad 2014).  
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Figure 2-3. Screen shot of the Infinite Horizon Impactor software.  
Example of the information provided by the IHI software immediately after each contusion. The 
upper graph shows the displacement vs. time and lower graph shows force vs. time for a 175 Kdyn 
impact. The actual displacement and force are shown numerically in the boxes on the left of the 
window.   
Chapter 2  97 
 
 
 
 
 
 
 
 
 
 
Figure 2-4. Radial nerve dissection and stimulation.  
This set of images shows the stages in dissection and presentation of the radial nerve for electrical 
stimulation. The upper image shows the exposed superficial branches of the radial nerve. The 
middle image shows the branches of the radial nerve dissected out, sectioned, and with a suture 
loop attached to the distal end. The lower image shows the radial nerve placed on bipolar silver 
wire electrodes immersed in a paraffin pool (Image adapted from (Meng, 2009).  
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Figure 2-5. Schematic diagram showing locations for CDP measurements.  
A silver ball electrode was positioned just medial to the dorsal root entry zone. Recordings were 
made in 1 mm steps rostral and caudal to injury location with C5/C6 border taken as 0 reference 
point. Positive sign indicates rostral while negative sign indicates caudal to C5/C6 border. (Image 
adapted from original images from Dr John Riddell).   
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Figure 2-6. Schematic diagram showing the set up for recording of radial evoked CDPs.  
The radial nerve was stimulating using a bipolar silver electrode and CDP recordings made from 
the dorsal surface of the spinal cord. (Image adapted from original images from Dr John Riddell).  
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Figure 2-7. Schematic diagram showing set up for recording of pyramidal evoked CDPs. 
 Pyramidal bundles at the level of the pyramid were stimulated using a concentric bipolar electrode. 
The electrode was inserted stereotaxically by a dorsal approach through a hole made in the back of 
the skull. (Image adapted from original images from Dr John Riddell).    
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Figure 2-8. Examples of typical CDP traces.  
Upper trace shows CDP evoked by pyramidal stimulation. Lower trace shows CDP evoked by 
radial nerve stimulation.   
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2.4 Results 
2.4.1 Electrophysiological assessment of local circuit functions 
following contusion injury  
In this study, cord dorsum potentials (CDPs) evoked by stimulating the radial 
nerve and CST stimulation within the pyramids were used to assess function in 
the cervical spinal cord. Recordings made from normal animals (n=23) and 
animals with a contusion injury (n=101) at the C6 level of the spinal cord were 
investigated at different time points. The different experimental groups and the 
number of animals used in each group are summarized in Table 2-1.  
2.4.1.1 Comparison of body weights and injury severities 
It was essential to limit the variable parameters in all the experiments, in order 
to ensure that any differences observed in the electrophysiological recordings 
were only due to differences in the survival time. Animals from the different 
experimental groups investigated at different survival times received the same 
injuries. A moderate severity injury was selected and a force of 175 kdyn was 
used for all animals. All the injuries were made with the IHI device (as described 
previously) and the injury parameters provided by IHI software were recorded 
and graphed for comparison, so that any atypical animals could be excluded 
from the study. IHI software is capable of recording the actual force pushing on 
the cord at the time of impact and the displacement of the impactor tip. These 
recordings were used to confirm that all animals received similar injuries. These 
comparisons for actual force and displacement were graphed and are shown in 
Figure 2-12 and Figure 2-13 respectively. 
However, contusion injuries of the same impact force with the same sized 
impactor tip produce different degrees of damage depending on the size of the 
cord. The weights of animals used in most of the groups was broadly similar at 
the time of the injury (see Figure 2-9). An exception to this was the animals 
used to investigate the effect of acute injuries. The animals used in this group 
were larger and more closely matched those of the normal animals and the 
animals in the other groups at the time of the electrophysiological recording 
(see Figure 2-10). 
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The size of the animals at the time of the electrophysiology is also relevant as it 
is important that the length of the cord and hence the recording locations 
(which were at 1 mm intervals for 8 mm above and below the injury) should be 
the same relative to segmental location for animals in each of the groups. The 
weights of the animals at electrophysiology are shown in Figure 2-10. Because of 
the different survival times of each of the groups there are differences in the 
weights of the animals in each group. The lowest weights are for the animals in 
the 3 day group because this is the shorter survival time and because the animals 
lose weight in the first few days after the injury operation. However, because all 
of the animals are fully mature adults these differences in weight are not 
associated with significant differences in spinal cord length. This is shown in 
Figure 2-11 where the segmental location corresponding to the -8 recording 
location is indicated for each of the groups. This is the recording location 
farthest from the 0 mm reference point and should therefore show the largest 
discrepancy. As can be seen the segmental location of this recording position in 
each group shows a very similar distribution and all lay between rostral T1 and 
caudal C8. 
Minimising the variables such as the weights, injury severities and cord 
displacements, mean that any changes in the electrophysiological recordings 
seen in the different groups can be attributed to genuine effects of survival time 
of the animal after injury.   
2.4.1.2 Assessment of radial nerve evoked CDPs after contusion injury  
Radial evoked CDP recordings were made from normal animals (n=23), acutely 
injured animals (n=14), 3 day survival animals (n=15), 2 week survival animals 
(n=15), 4 week survival animals (n=15), 7 week survival animals (n=13), 3 month 
survival animals (n=14) and 6 month survival animals (n=15) (Table 2-1). 
2.4.1.2.1 Components of surface recordings evoked by radial nerve 
stimulation 
Potentials evoked by radial nerve stimulation were recorded with a silver ball 
electrode positioned on the dorsal surface of the spinal cord at a 1 mm intervals, 
from 8 mm rostral to 8 mm caudal to the C5/6 border (Figure 2-5). Different 
components of a CDP recording are shown in Figure 2-14. Electrical stimulation 
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of the radial nerve produces an afferent volley followed by a distinct negative 
CDP. The afferent volley is the first (shortest latency) deflection in the surface 
recording and is a short duration wave which represents action potentials 
travelling along the afferent fibres of the radial nerve. The afferent volley is 
seen clearly at locations close to the segment of entry of the stimulated root 
and it becomes dispersed at locations more rostral and caudal. The afferent 
volley is followed by a longer duration wave called the CDP. CDPs represent the 
synaptic activity generated by connections between the collaterals of the 
primary afferent fibres and spinal cord neurons and these provide a measure of 
the strength of these connections. The height of the CDP from the start of the 
volley is the amplitude of the CDP and is measured using Signal software. 
Examples of radial evoked CDPs recorded from a normal animal and from animals 
at 4 weeks and 6 months after injury are shown in Figure 2-15.  
In order to test the contribution of each spinal root to the CDPs evoked by the 
radial nerve stimulation (i.e. the level of entry of radial nerve afferents 
producing the CDPs), dorsal roots were sequentially sectioned in 4 animals, 
while recording the CDPs from a fixed position. The CDP amplitudes after 
sectioning the roots were measured and expressed as a percentage of the CDP 
amplitudes before dorsal root cutting. The contribution of afferents from the 
radial nerve to the CDPs evoked at different locations is shown in Figure 2-16. 
The main contribution is from afferents entering through the C6 root (87.1 – 50.3 
%) followed by afferents entering via the C7 root (31.4 – 6.5 %). There is minimal 
contribution from afferents entering more rostrally via the C5 root. This means 
that the afferents generating radial nerve CDPs enter at or below the level of 
the contusion injury. 
2.4.1.2.2 Radial evoked CDP recordings from normal animals  
The CDPs evoked by radial nerve stimulation were investigated in 23 normal 
animals. Examples of CDPs recorded from a normal animal are shown in Figure 
2-15. The rostro-caudal distribution of CDPs for the entire normal animal group 
is shown in Figure 2-17, where the mean CDP amplitude at each recording 
location is plotted. In normal animals the largest CDPs were recorded at around 
2 mm above and 2 mm below the C5/6 border. This region represents the C6 
spinal segment and most of the input of the primary afferents from the radial 
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nerve enter via the C6 root so that, as expected, the amplitudes are greatest 
close to where the sensory fibres enter the cord. The mean maximal amplitudes 
in this region were around 0.95 mV. CDPs further rostral and caudal of the C5/6 
border gradually declined in amplitude but could still be detected even at the 
most rostral and caudal recording locations (i.e. +8 and -8 mm).  
2.4.1.2.3 Acute effects of contusion injury on radial nerve evoked CDPs  
Mapping of the distribution of the radial evoked CDPs was performed in these 
animals at 30 minute intervals. The first mapping was started 20 minutes after 
injury and the last mapping was performed at 3 hours 50 minutes after injury. 
Examples of CDPs recorded from one acutely injured animal at 8 different time 
points after injury from 20 minutes to 3 hours 50 minutes are shown in 
Figure 2-18. Recordings at the earliest time point after injury (20 minutes) 
showed that the contusion injury had a substantial effect on the amplitudes of 
radial nerve evoked CDPs when compared to those recorded from normal 
animals. Figure 2-19 shows a plot of CDP amplitudes for recordings from acute 
animals at 20 minutes compared to those recorded from the group of normal 
animals. As can be seen, the contusion leads to a reduction in amplitude of the 
CDPs at most of the recording locations with the most substantial reduction 
being produced in the region of impact (approximately 0 mm to -2 mm). Rostral 
and caudal to this region of impact the CDPs are much less affected. Figure 2-20 
shows plots of the amplitudes of CDPs recorded from acute animals at 5 
locations, expressed as a percentage of normal CDP amplitude at the same 
location. This shows that the amplitudes of CDPs at the centre of the impact (-1 
mm) were reduced to less than 20 % of normal (a highly significant difference), 
while at locations 2 mm either side of the injury epicentre (i.e. at -3 or +1), 
CDPs were reduced to 60 – 70 % (also highly significant difference). Amplitudes 5 
mm away from the centre were less affected still being 70 % (significant 
difference, p < 0.05) at +4 and 95 % at -6 mm (non-significant). 
The fact that potentials rostral to the injury are affected similarly compared to 
potentials below the injury, suggests that the main sensory axons in the dorsal 
column which carry sensory impulses past the level of the injury are not 
substantially affected. This in turn suggests that most of the reduction in the 
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amplitudes is due to damage to neurons and axons collaterals at the injury 
centre. 
Figure 2-21 shows plots of CDP amplitudes for all of the CDP mapping from 
acutely injured animals which has commenced at 30 minute intervals throughout 
the period of recording. Figure 2-22 shows selected plots from the beginning (20 
minutes), middle (2 hours 50 minutes) and end (3 hours 50 minutes) of the 
recording period. By recording every 30 minutes it could be seen that the 
amplitudes of CDPs continued to show changes with time after injury. These 
affected mainly the potentials recorded at the margins of the injury both 
rostrally (+1 to +3) and caudally (-3 to -5). The amplitudes of the CDPs at the 
centre of the impact (-1), which were already strongly affected by the initial 
impact, showed little further change. Figure 2-20 shows plots of the amplitudes 
of CDPs recorded from acute animals at 5 locations at the beginning, middle and 
end of the recording period (as in Figure 2-22), expressed as a percentage of 
control. As can be seen there is little change in the amplitudes of the potentials 
at -1 (injury centre) but a progressive reduction in the amplitude at +1 and -3, 
either side of the injury epicentre. Between the first (20 minute) and last (3 
hours 50 minutes) CDP mapping there was further reduction in amplitudes. At 
the +1 site this was further declined by approximately 17 % and at -3 it was 20 % 
of normal. However, none of these changes in amplitude in the course of the 
acute experiment reached significance (i.e. there were no significant differences 
at any recording location). 
2.4.1.2.4 Assessment of radial nerve evoked CDPs 3 days after injury  
The distribution of radial evoked CDPs was mapped in fifteen animals at 3 days 
after contusion injury, the earliest time point investigated in recovery 
experiments. Figure 2-23 shows plots of radial nerve evoked CDPs where those 
recorded from 3 day survival animals are compared with those recorded at the 
beginning (20 minute) and end (3 hours 50 minutes) of the acute experiments. 
Compared to the last recording made in the acute experiments (approximately 4 
hours after injury) there was a further reduction in CDP amplitudes at 3 days but 
this was only rostral to the injury.  
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CDPs at the injury centre (-1) were also reduced in amplitude in 3 day animals 
compared to the last recording in the acute animals while CDPs caudal to the 
injury (-4 to -8) were larger in amplitude and those farthest from the injury 
centre (-5 to -8) were restored to the same amplitude as seen in animals 
immediately following the injury. Figure 2-24 shows plots of amplitudes of CDPs 
recorded at 5 locations from 3 day survival and acute injury animals. Above the 
injury at +4 and +1, CDPs were reduced in amplitude by approximately a further 
20 % of normal in 3 day animals compared to recording made 20 minutes after 
injury  while at the injury centre the decrease was much more modest (5 % at -
1). The reduction in CDP amplitudes above the injury were significant at +2 (p 
<0.05), +1 (p <0.001) and 0 (p <0.01). In contrast, at the location -6 which is 
well caudal to the injury, the CDP amplitude increased by approximately 25 % of 
normal compared to the latest acute recording time point. Therefore the CDP 
amplitude here was restored to that seen in normal animals. 
The reduction in CDP amplitudes above the injury could be explained by reduced 
conduction in the main sensory axons which carry impulses from the entry level 
of radial afferents (C6 and C7) past the injury to C5 and C4. This might reflect a 
secondary injury mechanism such as demyelination of the radial nerve fibres in 
the dorsal columns. In contrast, the increase in CDP amplitudes seen below the 
injury suggests that some reparative process has occurred within the first few 
days of injury. 
2.4.1.2.5 Assessment of radial nerve evoked CDPs 2 weeks after injury 
The distribution of radial evoked CDPs was mapped in fifteen animals at 2 weeks 
after contusion injury. Figure 2-25 shows a comparison of radial nerve evoked 
CDPs recorded from 3 day and 2 week survival animals and immediately 
following injury in the acute experiments. There was a substantial increase in 
CDP amplitudes at 2 weeks compared to 3 days after injury. The increase was 
particularly marked at rostral locations where CDP amplitudes had deteriorated 
at 3 days (0 to +8 locations). The increase in amplitudes was such that at most 
locations CDPs were returned to values closely similar to those recorded 
immediately after injury (20 minute recordings in acute animals).  
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Figure 2-26 shows a plot in which the amplitudes of CDPs recorded 2 weeks after 
injury at 5 locations are compared to those recorded at 3 days and immediately 
after injury in the acute animals. At location rostral to the injury (+4 and +1) the 
increase in amplitude between 3 day and 2 week survival animals is about 30 % 
(+4) and 25 % (+1). The increase in CDP amplitudes above the injury at 2 weeks 
compared to 3 days is significant at +3 (p <0.05), +2 (p <0.05) and +1 (p <0.01). 
There was a modest improvement of approximately 5 % at the injury epicentre (-
1) and caudally at -3. In contrast, at location -6, which is well caudal to the 
injury, the amplitudes were not affected and remained similar to those recorded 
at 3 days.    
The return in CDP amplitudes rostrally is most likely explained by a repair 
mechanism affecting the main sensory axons, possibly remyelination of the 
affected axons.   
2.4.1.2.6 Assessment of radial nerve evoked CDPs between 4 weeks and 6 
months 
To investigate changes in function from sub-acute out to chronic time points, 
the distribution of radial evoked CDPs was mapped in groups of animals 
maintained for 4 weeks (n=15), 7 weeks (n=13), 3 months (n=14) and 6 months 
(n=15) after injury. Figure 2-27 shows plots of CDPs recorded 4 weeks and at the 
time points between 3 months and for comparison the CDP mapping performed 2 
week after the injury. The CDP amplitudes recorded at each of these time points 
were very similar. CDP amplitudes recorded at 2 weeks change very little at 4 
weeks and 7 weeks indicating that function in local circuits has largely stabilized 
by 2 weeks after the injury. At 3 months, however, there is a tendency for CDP 
amplitudes below the injury to be smaller than at 7 weeks but this was not 
significant. 
Figure 2-28 shows the distribution of CDPs mapped at 6 months compared to 2 
weeks and 3 months after injury. Above the injury CDPs remained remarkably 
stable between 2 weeks and 6 months after injury. However, below the injury, 
the trend towards a reduction in amplitude seen in the recordings made at 3 
months had progressed further and was clearly evident in the animals 
investigated at 6 months. 
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Figure 2-29 shows a plot in which the amplitudes of CDPs recorded 6 months 
after injury at 5 locations are compared to those recorded at 2 weeks and 3 
months after the injury. The bar graphs show the trend for a small (5-10 %) 
reduction in amplitude between 2 weeks and 6 months after injury which is 
insignificant at most locations. However, caudal to the injury at -3 mm, CDPs are 
reduced by 20 % of normal. There is therefore a localized deterioration in 
function below the injury level at the 6 month time point. However, this trend 
was not statistically significant. 
2.4.1.3 Assessment of pyramidal-evoked CDPs after contusion injury  
Pyramidal-evoked CDP recordings were made from normal animals (n=13), 
acutely injured animals (n=12), 3 day survival animals (n=14), 2 week survival 
animals (n=13), 4 week survival animals (n=15), 7 week survival animals (n=12), 
3 month survival animals (n=14) and 6 month survival animals (n=14) (Table 2-1). 
2.4.1.3.1 Components of CDPs evoked by pyramidal stimulation 
A concentric bipolar stimulating electrode was used to stimulate the pyramids 
(as described in methods) and potentials were detected with a recording 
electrode on the surface of the spinal cord. Recordings were made with the 
same silver ball electrode as for the radial nerve evoked CDPs and recordings 
were made on the dorsal surface at 1 mm intervals, from 8 mm rostral to 8 mm 
caudal of the C5/6 segmental border (Figure 2-5). Examples of pyramidal evoked 
CDPs recorded from a normal animal and from animals injured at 4 weeks and 6 
months after injury are shown in Figure 2-30. CDPs consist of a stimulus artefact 
which indicates the onset of stimulation, followed by a small afferent volley 
which represents the action potentials travelling along the CST fibres. This is 
much less distinct that for radial nerve stimulation and is only seen at locations 
close to the stimulation site and becomes dispersed further away from the 
stimulation site. A CDP follows the afferent volley. The height of the CDP from 
the start of the afferent volley is the amplitude of the CDP. This represents the 
strength of the synaptic activity generated by the connections between 
collaterals of the CST fibres and spinal neurons in the grey matter.  
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2.4.1.3.2 Pyramidal evoked CDP recordings from normal animals  
CDPs evoked by pyramidal stimulation were investigated in 13 normal animals. 
The rostro-caudal distribution of CDPs for the entire normal animal group is 
shown in Figure 2-31. Pyramidal evoked CDPs are smaller in amplitude than 
those evoked by radial nerve stimulation and are more evenly distributed over 
the length of the cervical spinal cord. The largest potentials occur close to the 
C5/6 border where mean maximal amplitudes were around 0.35 mV. Amplitudes 
declined above and below this but the decline is more marked caudally probably 
because the descending volley becomes more dispersed the farther caudally it 
has to travel. 
2.4.1.3.3 Acute effects of contusion injury on pyramidal evoked CDPs  
Mapping of the distribution of the pyramidal evoked CDPs was performed at 30 
minutes intervals (as carried out for radial nerve evoked CDPs). The first 
mapping was started 20 minutes after injury and the last mapping was 
performed at 3 hours 50 minutes after injury. Recordings at the earliest time 
point after injury (20 minutes) showed that the contusion injury had a 
substantial effect on the amplitudes of pyramidal evoked CDPs when compared 
to those recorded from normal animals. Figure 2-32 shows a plot of CDP 
amplitudes for recordings from acute animals at 20 minutes compared to those 
recorded from the group of normal animals. As can be seen, the contusion leads 
to a reduction in amplitude of CDPs at most of the recording locations with most 
substantial reduction being produced in the area caudal (-2 to -8) to the region 
of the impact, followed by those in the region immediately rostral to the injury 
centre (0 to +2). However, farther rostral to the impact area (+3 to +8) CDPs 
were largely unaffected. Figure 2-33 shows a plot of the amplitudes of CDPs 
recorded from acutely injured animals at 20 minutes after the injury at 5 
locations, expressed as a percentage of normal CDP amplitude at the same 
location. The CDP amplitudes at caudal locations (-4 and -6) were reduced to 
less than 8 % of normal and at injury centre (-1) to approximately 20 % of 
normal. CDPs rostral to the injury epicentre at +4 mm and +6 mm were less 
affected with a modest reduction of approximately 3 % and 10 % of normal, 
respectively. The reductions in amplitude at +1 mm and more caudally were all 
highly significant. 
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The fact that potentials caudal to the injury are substantially reduced by the 
injury, suggests the main component of the CST (located in dorsal columns) on 
which these potentials largely depend is extensively damaged immediately after 
the injury. The smaller amplitude CDPs evoked caudal to the injury are 
considered mainly due to stimulation of the minor CST components (the lateral 
and ventral CST). This is consistent with anatomical findings (see 2.4.3). 
Figure 2-34 shows plots of CDP amplitudes for all of the CDP mapping 
commenced at 30 minute intervals throughout the period of recording from 
acutely injured animals. By recording every 30 minutes it could be seen that the 
amplitudes of CDPs remained almost unchanged throughout the acute recording 
period (20 minutes to 3 hours 50 minutes) at most of the recording locations 
after the injury.  
2.4.1.3.4 Assessment of pyramidal evoked CDPs 3 days after injury 
The distribution of CDPs evoked by pyramidal stimulation was mapped in 
fourteen animals 3 days after contusion injury, the earliest recording time point 
examined in recovery experiments. Figure 2-35 shows plots of pyramidal evoked 
CDPs where those recorded from 3 day survival animals are compared with those 
recorded at the beginning (20 minute) and end (3 hours 50 minutes) of acute 
experiments. Compared to the recordings made in the acute experiments there 
was a further reduction in CDP amplitudes at 3 days, which was more marked 
rostral to the injury where potentials were not changed immediately after 
injury. This worsening of CDPs suggests reduced conduction in the intact CST 
fibres rostral to the injury and might reflect some contribution by secondary 
injury mechanism such as demyelination or die back of these fibres in the dorsal 
column.  
Comparison of CDPs recorded at 5 locations from 3 day survival animals and 
acute injury animals at 20 minutes is shown in Figure 2-33. Compared to the 
acute injury animals, CDPs recorded from the 3 day survival animals were 
reduced by a further 20 % of normal above the injury at +6 mm and +4 mm and 
by 15 % at the injury centre (-1 mm). CDPs below the injury were also reduced in 
amplitude in the 3 day animals compared to the acute. The reductions were only 
a small proportion of normal (approximately 2 %) because they were already 
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markedly affected by the injury in the acute animals. However, the changes 
here were significant between +2 and -1 when compared between the two 
groups of injured animals.     
2.4.1.3.5 Assessment of pyramidal evoked CDPs 2 weeks after injury 
The distribution of pyramidal evoked CDPs was mapped in thirteen animals at 2 
weeks after contusion injury. Figure 2-36 shows plots of pyramidal evoked CDPs 
where those recorded from 2 week animals are compared to 3 day animals and 
immediately following the injury in acute experiments. There was a substantial 
increase in CDP amplitudes at 2 weeks compared to 3 days after injury such that 
at most locations CDPs were returned to values closely similar to those recorded 
immediately after injury at 20 minute. An exception to this was the region at 
the most rostral extent of the mapped region (+6 to +8 mm). 
Figure 2-37 shows a plot in which the amplitudes of CDPs recorded 2 weeks after 
injury at 5 locations are compared to those recorded at 3 days and immediately 
after injury in the acute animals. The restoration of CDP amplitudes in 2 week 
animals to those seen acutely can be seen at all locations except +6 where the 
CDP amplitudes remain closer to that seen in the 3 day survival animal. 
However, the change was only significant at +1 mm.  
2.4.1.3.6 Assessment of pyramidal evoked CDPs between 4 weeks and 6 
months after injury 
The distribution of pyramidal evoked CDPs was investigated in animals surviving 
for 4 weeks (n=15), 7 weeks (n=12), 3 months (n=14) and 6 months (n=14) after 
the injury. Figure 2-38 shows a comparison of CDPs recorded from the animal 
groups investigated between 2 weeks and 3 months after injury. At the injury 
centre and above the injury there was very little change in CDPs with amplitudes 
remaining remarkably stable between 2 weeks and 3 months. However, below 
the injury (-3 to -7) there was clear evidence of an increase in the strength of 
corticospinal actions with an increase in CDP amplitudes being evident in the 7 
week survival animals and a further clear increase in the 3 month survival group.  
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Figure 2-39 shows the CDP distributions with 6 month survival animals added. 
From this it can be seen that there is little change between 3 months and 6 
months after the injury.  
Figure 2-40 shows a plot in which amplitudes of CDPs recorded 3 months after 
injury at 5 locations are compared to those recorded at 2 weeks and 6 months 
after the injury. Caudal to the injury at -4 and -6, CDP amplitudes increased at 
the 3 month time point to approximately 10 % of normal compared to recordings 
at 2 weeks after injury as a proportion of the amplitudes at these locations of 2 
weeks this represents an increase of 110 %. However, none of these increases 
reached significance. However, the amplitudes at injury centre (-1) and rostral 
to the injury remained approximately similar to 2 weeks surviving animals.  
2.4.2 Injury site 
The appropriate location of the contusion injury was confirmed in all injured 
animals at the end of the electrophysiological experiments included in this 
study.  
Examples of sections containing lesion cavities from different animal groups are 
shown in Figure 2-41 to Figure 2-47. Typically between 20 and 25 parasagittal 
sections were found to contain areas of damaged tissue when examined under 
the light microscope.  
In acutely injured animals, the damage to the spinal cord tissue was mostly 
observed at the core. Examples of parasagittal sections obtained from animals 
perfused approximately 4 hours after the injury are shown in Figure 2-41. 
Sections near the midline of the injury show extensive disruption and damage to 
the spinal cord parenchyma and loss of variable amount of tissue at the central 
part of the section. This loss of tissue occurred during tissue processing due to 
the area of damaged parenchyma being extremely delicate and lacking normal 
integrity.  
Injury sites at 3 days after injury showed more consistent damage to the spinal 
tissue extending several mm from the centre both in rostral and caudal 
directions. Examples of parasagittal sections 3 day after injury are shown in 
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Figure 2-42. Some loss of tissue at the core of the sections may be due to loss of 
badly disrupted tissue during processing.  
Histology from the 2 weeks (Figure 2-43) survival animals showed consistent 
cavities which in some cases were partly filled with laminin and in some sections 
there was clear up regulation of GFAP associated with the glial scar around the 
injury. 
At later time point the cavitation become progressively more extensive and 
variable in morphology. At 4 weeks (Figure 2-44) some animals showed single 
continuous cavities while others showed multiple cavities separated by fine 
septae that tended to be rich in laminin. 
At seven weeks (Figure 2-45) and at 3 months (Figure 2-46) the cavities were 
more elongated than at 4 weeks and only their septae and matrix infilling 
tended to occur in the most ventral part of the injury site. 
At six months (Figure 2-47) the cavities were further expanded in the rostro-
caudal direction. 
2.4.2.1 Injury extent 
Results obtained from radial CDP measurements suggest that there might be 
some on-going degeneration late in the course of the injury. To determine 
whether this might be due to an expansion of the injury cavity measurements of 
the cavity extent in rostro-caudal and lateral direction were performed. For this 
purpose tissue from survival animals of 7 weeks and 6 months groups were 
selected. This selection was based on electrophysiology data as the amplitudes 
of CDPs evoked by radial nerve stimulation had stabilized by 7 weeks but then 
showed further deterioration at 6 months suggesting a late phase of tissue loss.  
Cavity length and width was determined from the histology from seven animals 
in the 7 week group and eight animals in the 6 month group. 7 weeks and 6 
months animals are shown in Table 2-2. Comparison of cavity extent in rostro-
caudal (length) and lateral (width) directions is shown in Figure 2-48. Paired 
Student’s t-test analysis showed that there was a significant increase in the 
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cavity length in 6 month animals compared to the 7 week animals. However, no 
difference was observed in cavity width formation. This suggests increased 
cavity length and further loss of neuronal tissue at this chronic time point is 
responsible for late deterioration in the amplitudes of the CDPs.  
2.4.3 BDA labelling of CST fibres 
Figure 2-49 shows BDA labelled CST fibres above and below the level of the 
injury.  The main CST located in the dorsal column was intact above the injury 
along with the minor lateral and ventral components of the CST evident from the 
BDA labelled axons. However, caudal to the injury level there is no labelling of 
fibres in the dorsal column indicating the main CST fibres are completely 
interrupted. However, BDA labelled minor components of CST can be observed in 
the lateral and ventral white matter similar to those observed rostral to the 
injury.  
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Cavity length (mm) Cavity width (mm) 
7 weeks 6 months 7 weeks 6 months 
4.33 4.33 2.10 2.34 
3.36 4.16 2.46 2.04 
4.53 5.20 2.34 2.34 
2.50 4.83 2.22 2.34 
3.46 5.16 2.58 2.46 
3.73 5.13 2.64 2.52 
4.03 3.66 2.70 1.92 
 5.83  3.00 
Mean (3.71) Mean (4.79) Mean (2.43) Mean (2.37) 
Table 2-2. Table showing the maximum cavity length and width in 7 weeks and 6 month 
animal groups. 
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Figure 2-9. Body weights of individual animals at the time of contusion injury. 
Scatter plot showing body weights of individual animals at the time of contusion injury in the groups 
of animals used to investigate the effects of injury on spinal cord function at different survival times 
post-injury. Horizontal bars represent the mean weight in each group.  
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Figure 2-10. Body weights of individual animals at the time of electrophysiology. 
Scatter plot showing body weights of individual animals at the time of electrophysiology in the 
normal group and different post injury recovery groups. Horizontal bars represent the mean weight 
in each group. 
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Figure 2-11. Comparison of segmental locations corresponding to - 8 recording location in 
different animal groups.  
Plot showing the segmental locations corresponding to the - 8 recording location in normal animals 
and the groups of animals investigated at 3 days, 2 weeks, 7 weeks and 6 months after injury. In all 
animals the - 8 location was either rostral T1, T1/C8 or caudal C8.The bar plots show the 
percentage of recording positions corresponding to each of these segmental location. 
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Figure 2-12. Actual force of contusion injury in each of the different post injury recovery 
groups.  
Scatter plot showing the actual force produced by the IH impactor set to deliver 175 kdyn force. 
There was no significant difference between the mean force for any of the groups (one-way 
ANOVA with Tukey’s post-hoc test). Horizontal bars represent the mean force in each group.   
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Figure 2-13. Actual cord displacement as a result of 175 kdyn contusion injury in each of the 
post injury groups.  
Scatter plot showing the displacement of the impactor tip into the cord tissue from the surface. 
There was no significant difference between the mean displacement for any of the groups (one-
way ANOVA with Tukey’s post-hoc test). Horizontal bars represent the mean displacement in each 
group.  
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Figure 2-14. Different components of the surface potentials evoked by radial nerve 
stimulation.  
Example of a CDP trace generated in response to radial nerve stimulation and recorded from the 
surface of the cervical spinal cord. The recording is an average of 25 sweeps. The afferent volley 
represents action potentials travelling along afferent fibres. The CDP represents the synaptic 
activity generated by connections between the collaterals of the primary afferent fibres and spinal 
cord neurons and provides an indication of the strength of these connections. The CDP amplitude 
was measured as shown by the vertical arrow using Signal software.  
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Figure 2-15. Examples of radial evoked CDP traces recorded from a normal animal and from 
injured animals 4 weeks and 6 months after contusion injury.  
Each column of traces shows recordings from one animal. On the left the recording is from a 
normal animal and recordings in the middle and on the right are from 4 week and 6 month survival 
animals respectively. Recordings were made at 1 mm intervals from 8 mm rostral (+8) to 8 mm 
caudal (-8) to C5/6 border. Only every other trace is shown for clarity.  Traces are averages of 25 
sweeps and the calibration applies to all traces.  
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Figure 2-16. Contribution of spinal dorsal roots to radial evoked CDPs. 
To test the contribution of each spinal root to the overall amplitude of radial evoked CDPs, dorsal 
roots were sequentially sectioned in 4 animals while CDPs were recorded. The amplitudes 
following root sectioning are expressed as a percentage of the amplitude before sectioning. In A 
and B recordings were made at +2 mm location, while in C and D recordings were made at -4 mm 
location.  The most substantial reduction in amplitude occurred when the C6 root was cut followed 
by the C7 root. The C5 root contributed very little to the CDP in any of the 4 animals.  
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Figure 2-17. Amplitudes of radial nerve evoked CDPs recorded in normal animals. 
Each data point is the mean CDP amplitude for all animals in the normal (non-injured) group. The 
error bars show +/- SEM. The recordings were made over the cervical spinal cord. Numbers on the 
x-axis represents the recording locations on the surface of the cord relative to the C5/6 border 
(0mm). In normal animals, the biggest radial evoked CDPs were recorded around 2 mm above and 
below the C5/6 border. The mean amplitude of the biggest CDPs were around 0.95 mV. CDPs 
decreased in amplitude more rostrally and caudally.  
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Figure 2-18. Examples of radial evoked CDPs traces recorded in an acutely injured animal. 
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Each column of traces shows recordings from one location, relative to C5/6 border (0 mm). On the 
left of the recordings then time after injury when recordings were made are shown. The mappings 
were made at 30 minutes intervals with first mapping made 20 minutes after contusion injury. 
Traces from only 5 locations are shown for clarity. Traces represent averages of 25 sweeps and 
the calibration applies to all traces. Note that CDPs in each consecutive recording are of 
progressively smaller amplitudes (largest CDPs at 20 minutes compared to smallest at 3 hours 50 
minutes).  
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Figure 2-19. Amplitudes of radial nerve evoked CDPs recorded in acutely injured animals at 
20 minutes after injury. 
The plot shows the mean amplitudes of CDPs recorded 20 minutes after injury from animals in the 
acute injury group (n=14). The plot for normal animals is also shown for comparison. Each data 
point is the mean CDP amplitude for all animals in the group. The error bars show +/- SEM. The 
contusion injury was carried out at C6 segment of the cord with the rostral edge of the impactor tip 
aligned with C5/6 border (0 mm). The recordings were made over the cervical spinal cord. 
Numbers on the x-axis represents the recording locations on the surface of the cord relative to 
C5/6 border (0 mm). After injury, CDPs at the lesion epicentre (-1 mm) and around the vicinity of 
the injury (+2 mm to -3 mm) declined significantly compared to those seen in normal animals. The 
greatest decline was observed at the lesion epicentre (-1 mm). The asterisks (*) represent the 
statistical significance of the difference between CDP amplitudes recorded at 20 minutes compared 
to normal (* = p <0.05, **= p <0.01, ***= p < 0.001). 
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Figure 2-20. Changes in amplitude of radial nerve evoked CDPs at different time points after 
acute injury.  
Plot showing the mean amplitudes of CDPs recorded in acutely injured animals at 20 minutes, 2 
hours 50 minutes and 3 hours 50 minutes after injury at 5 different locations. The CDP amplitudes 
are plotted as a percentage of the mean CDP amplitude in normal animals. Normal CDP 
amplitudes are represented as a dotted line (100 %). The asterisks (*) represent the statistical 
significance of the difference between CDP amplitudes recorded at different stages in the acute 
experiment compared to normal (* = p <0.05, **= p <0.01, ***= p < 0.001). There were no 
significant differences between recordings made at 20 minutes and other acute time points at any 
of the recording locations.   
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Figure 2-21. Amplitudes of radial nerve evoked CDPs recorded in acutely injured animals at 
all acute recording time points.  
The plot shows the mean amplitudes of CDPs recorded at 30 minute intervals from 20 minutes to 3 
hour 50 minutes after injury. The plot for normal animals is also shown for comparison. Each data 
point is the mean CDP amplitude for all animals in the group (n=14 for all acute data points shown). 
The error bars show +/- SEM. The contusion injury was carried out with the rostral edge of the 
impactor tip aligned with C5/6 border (0 mm). The recordings were made over the cervical spinal 
cord. Numbers on the x-axis represents the recording locations on the surface of the cord relative 
to C5/6 border (0 mm). CDPs at the lesion epicentre (-1 mm) in all acute recording time points 
remained almost the same. However, the amplitudes of those in the vicinity of the injury both 
rostrally (0 mm to +4 mm) and caudally (-2 mm to -5 mm) showed a gradual decline in amplitude 
with each successive recording time point. The maximum decline was seen at the latest time point 
(3 hour 50 minutes).  
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Figure 2-22. Amplitudes of radial nerve evoked CDPs recorded in acutely injured animals at 
20 minutes, 2 hours and 50 minutes and 3 hours and 50 minutes after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded at 20 minutes, 2 hours 
and 50 minutes and 3 hours and 50 minutes after injury. The plot for normal animals is also shown 
for comparison. Each data point is the mean CDP amplitude for all animals in the group (n=14). 
The error bars show +/- SEM. The contusion injury was carried out with the rostral edge of the 
impactor tip aligned with C5/6 border (0 mm). The recordings were made over the cervical spinal 
cord. Numbers on the x-axis represents the recording locations on the surface of the cord relative 
to C5/6 border (0 mm). CDPs at the lesion epicentre (-1 mm) remained almost unchanged. Those 
closed to the vicinity of the injury both rostrally (0 mm to +2 mm) and caudally (-3 mm to -5 mm) 
showed a gradual decline from 20 minutes to 3 hours 50 minutes. There were no significant 
differences between CDPs recorded at the different time points.   
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Figure 2-23. Amplitudes of radial nerve evoked CDPs recorded at the beginning and end of 
the acute experiments and from animals surviving 3 days after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded in acutely injured animals 
at 20 minutes (n=14) and 3 hours and 50 minutes (n=14) and at 3 days (n=15) after injury. The plot 
for normal animals is also shown for comparison. Each data point is the mean CDP amplitude for 
all animals in the group. The errors bar show +/- SEM. The contusion injury was carried out with 
the rostral edge of the impactor tip aligned with C5/6 border (0 mm). The recordings were made 
over the cervical spinal cord. Numbers on the x-axis represents the recording locations on the 
surface of the cord relative to C5/6 border (0 mm). In the 3 day survival animals CDPs at the lesion 
epicentre (-1 mm) and rostral to the injury (0 mm to +8 mm) declined in amplitude compared to 
those recorded in the acutely injured animals at 20 minutes and 3 hours 50 minutes after injury. 
Below the injury (-3 mm to -8 mm) CDPs recorded from the 3 day survival animals showed 
recovery of amplitudes almost equal to those seen acutely at 20 minutes after the injury. The 
asterisks (*) represent the statistical significance of the difference between CDP amplitudes 
recorded acutely at 20 minutes compared to 3 days (* = p <0.05, **= p <0.01, ***= p < 0.001).  
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Figure 2-24. Changes in amplitude of radial nerve evoked CDPs in acutely injured animals 
and 3 day survival animals.  
Plot showing the mean amplitudes of radial nerve evoked CDPs recorded in acutely injured 
animals at two time points; 20 minutes and 3 hours and 50 minutes and in 3 days survival animals 
after injury at 5 different locations. The CDP amplitudes are plotted as a percentage of the mean 
CDP amplitude in normal animals. Normal CDP amplitudes are represented as a dotted line (100 
%). * = p <0.05, **= p <0.01, ***= p < 0.001. The asterisks (*) represent the statistical significance 
of the difference between CDP amplitudes recorded acutely at 20 minutes compared to 3 days (* = 
p <0.05, **= p <0.01, ***= p < 0.001).    
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Figure 2-25. Amplitudes of radial nerve evoked CDPs recorded in acutely injured animals at 
20 minutes and from animals surviving 3 days and 2 weeks after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded in acutely injured animals 
at 20 minutes (n=14) and surviving animals at 3 days (n=15) and 2 weeks (n=15) after injury. The 
plot for normal animals is also shown for comparison. Each data point is the mean CDP amplitude 
for all animals in the group. The error bars show +/- SEM. The contusion injury was carried out with 
the rostral edge of the impactor tip aligned with C5/6 border (0 mm). The recordings were made 
over the cervical spinal cord. Numbers on the x-axis represent the recording locations on the 
surface of the cord relative to C5/6 border (0 mm). In the 2 week survival animals CDPs at the 
injury epicentre (-1 mm), rostral (0 mm to +8 mm) and caudal (-4 mm to -8 mm) to the injury 
showed recovery of CDP amplitudes almost equal to those seen in acutely injured animals at 20 
minutes after injury. The asterisks (*) represent the statistical significance of the difference between 
CDP amplitudes recorded at 3 days compared to 2 weeks (* = p <0.05, **= p <0.01, ***= p < 
0.001). 
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Figure 2-26. Comparison of the amplitudes of radial nerve evoked CDPs in acutely injured 
animals and animals surviving 3 days and 2 weeks after injury.  
Plot showing the mean amplitudes of radial nerve evoked CDPs recorded 20 minutes after an 
acute injury compared to 3 days and 2 weeks after injury. The plots show amplitudes at 5 different 
locations as a percentage of the mean CDP amplitude in normal animals. Normal CDP amplitudes 
are represented as a dotted line (100 %). The asterisks (*) represent the statistical significance of 
the difference between CDP amplitudes recorded at 3 days compared to 2 weeks (* = p <0.05, **= 
p <0.01, ***= p < 0.001).  
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Figure 2-27. Amplitudes of radial nerve evoked CDPs recorded from animals surviving 2 
weeks, 4 weeks, 7 weeks and 3 months after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded from the groups of 
animals investigated at 2 weeks (n=15), 4 weeks (n=15), 7 weeks (n=13) and 3 months (n=14) 
after injury. The plot for normal animals is also shown for comparison. Each data point is the mean 
CDP amplitude for all animals in the group. The error bars show +/- SEM. The contusion injury was 
carried out with the rostral edge of the impactor tip aligned with C5/6 border (0 mm). The 
recordings were made over the cervical spinal cord. Numbers on the x-axis represent the recording 
locations on the surface of the cord relative to C5/6 border (0 mm). CDPs remained almost stable 
between 2 weeks and 3 months after injury. There were no significant differences between the 
groups at any recording location (+8 mm to -8 mm). There were no significant differences between 
CDPs recorded at the different time points.  
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Figure 2-28. Amplitudes of radial nerve evoked CDPs recorded from animals investigating 2 
weeks, 3 and 6 months after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded from the animal groups 
investigated 2 weeks (n=15), 3 months (n=14) and 6 months (n=15) after injury. The plot for normal 
animals is also shown for comparison. Each data point is the mean CDP amplitude for all animals 
in the group. The error bars show +/- SEM. The contusion injury was carried out with the rostral 
edge of the impactor tip aligned with C5/6 border (0 mm). The recordings were made over the 
cervical spinal cord. Numbers on the x-axis represent the recording locations on the surface of the 
cord relative to C5/6 border (0 mm).  In the 6 month survival animals a decrease in CDP 
amplitudes was see mainly caudal to the injury (-1 mm to -5 mm) (compared to 2 weeks and 3 
months survival animals). There were no significant differences between CDPs recorded at the 
different time points. 
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Figure 2-29. Changes in amplitude of radial nerve evoked CDPs in animals investigated 2 
weeks, 3 months and 6 months after injury.  
Plot showing the mean amplitudes of radial nerve evoked CDPs recorded from the animal groups 
investigated at 2 weeks, 3 months and 6 months after injury. The plot shows CDP amplitudes 
recorded at 5 different locations expressed as a percentage of the mean CDP amplitude in normal 
animals. Normal CDP amplitudes are represented as a dotted line (100 %). There were no 
significant differences between CDPs recorded at the different time points. 
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Figure 2-30. Examples of pyramidal evoked CDP traces recorded from a normal animal and 
from injured animals 4 weeks and 6 months after contusion.  
Each column of traces shows recordings from one animal. On the left the recording is from a 
normal animal and recordings in the middle and on the right are from animals investigated at 4 
weeks and 6 months after injury respectively. Recordings were made at 1 mm intervals from 8mm 
rostral (+8) to 8 mm caudal (-8) to C5/6 border. Only every other trace is shown for clarity.  Traces 
represent averages of 25 sweeps and the calibration applies to all traces.  
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Figure 2-31. Amplitudes of pyramidal evoked CDPs recorded in normal animals. 
Each data point is the mean CDP amplitude for all animals in the normal (non-injured) (n=13) 
group. The error bars show +/- SEM. The recordings were made over the cervical spinal cord. 
Numbers on the x-axis represents the recording locations on the surface of the cord relative to the 
C5/6 border (0 mm). In normal animals, the biggest pyramidal evoked CDPs were recorded around 
4 mm above to 3 mm below the C5/6 border. The mean amplitudes of the largest CDPs were 
around 0.37 mV (at 0 mm and -1 mm). CDPs at the caudal end (-5 mm to -8 mm) were smaller in 
amplitude compared to the rostral end (+6 mm to +8 mm).  
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Figure 2-32. Amplitudes of pyramidal evoked CDPs recorded in acutely injured animals at 20 
minutes after injury. 
The plot shows the mean amplitudes of CDPs recorded 20 minutes after injury from animals in the 
acute injury group (n=12). The plot for normal animals is also shown for comparison. Each data 
point is the mean CDP amplitude for all animals in the group. The error bars show +/- SEM. The 
contusion injury was carried out with the rostral edge of the impactor tip aligned with C5/6 border (0 
mm). The recordings were made over the cervical spinal cord. Numbers on the x-axis represent the 
recording locations on the surface of the cord relative to C5/6 border (0 mm). Twenty minutes after 
injury CDP amplitudes below the lesion epicentre (-2 mm to -8 mm) were virtually absent, while 
those above the injury (+3 mm to +8 mm) were largely unaffected. The asterisks (*) represent the 
statistical significance of the difference between CDP amplitudes recorded at 20 minutes compared 
to normal (* = p <0.05, **= p <0.01, ***= p < 0.001).  
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Figure 2-33. Changes in amplitude of pyramidal evoked CDPs in acutely injured animals and 
3 day survival animals. 
Plot showing the mean amplitudes of pyramidal evoked CDPs recorded in acutely injured animals 
at 20 minutes and in 3 day survival animals. The plots show amplitudes at 5 different locations 
plotted as a percentage of the mean CDP amplitude in normal animals. Normal CDP amplitudes 
are represented as a dotted line (100 %). The asterisks (*) represent the statistical significance of 
the difference between CDP amplitudes recorded acutely at 20 minutes compared to 3 days (* = p 
<0.05, **= p <0.01, ***= p < 0.001). 
Pyramidal evoked CDPs
6 4 -1 -4 -6
0
10
20
30
40
50
60
70
80
90
100
Acute 20mins
3 days
*
*
Location relative to C5/6 border (mm)
C
D
P
 a
m
p
li
tu
d
e
 (
%
a
g
e
 o
f 
n
o
rm
a
l)
Chapter 2  143 
 
 
 
Figure 2-34. Amplitudes of pyramidal evoked CDPs recorded in acutely injured animals at all 
acute time points. 
The plot shows the mean amplitudes of CDPs recorded at 30 minute intervals from 20 minutes to 3 
hours 50 minutes after injury. The plot for normal animals is also shown for comparison. Each data 
point is the mean CDP amplitude for all animals in the group (n=12 for acute data points shown). 
The error bars show +/- SEM. The contusion injury was carried with the rostral edge of the 
impactor tip aligned with C5/6 border (0 mm). The recordings were made over the cervical spinal 
cord. Numbers on x-axis represent the recording locations on the surface of the cord relative to 
C5/6 border (0 mm). There was little change in the CDPs recorded at the start (20 minutes after 
injury) and end (3 hours 50 minutes) of the recordings made after acute injury. 
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Figure 2-35. Amplitudes of pyramidal evoked CDPs recorded at the beginning and end of the 
acute experiments and from animals surviving 3 days after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded in acutely injured animals 
at 20 minutes (n=12) and 3 hours 50 minutes (n=12) and in animals 3 days (n=14) after injury.  The 
plot for normal animals is also shown for comparison. Each data point is the mean CDP amplitude 
for all animals in the group. The error bars show +/- SEM. Contusion injury was carried out with the 
rostral edge of the impactor tip aligned with C5/6 border (0 mm). The recordings were made over 
the cervical spinal cord. Numbers on x-axis represent the recording locations on the surface of the 
cord relative to C5/6 border (0 mm). CDP amplitudes were smaller in the 3 day survival animals 
compared to acutely injured animals. The asterisks (*) represent the statistical significance of the 
difference between CDP amplitudes recorded acutely at 20 minutes compared to 3 days (* = p 
<0.05, **= p <0.01, ***= p < 0.001). 
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Figure 2-36. Amplitudes of pyramidal evoked CDPs recorded in acutely injured animals and 
from animals investigated 3 days and 2 weeks after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded in acutely injured animals 
at 20 minutes (n=12) and in animals investigated at 3 days (n=14) and 2 weeks (n=13) after injury. 
The plot for normal animals is also shown for comparison. Each data point is the mean CDP 
amplitude for all animals in the group. The error bars show +/- SEM. Contusion injury was carried 
out with the rostral edge of the impactor tip aligned with C5/6 border (0 mm). The recordings were 
made over the cervical spinal cord. Numbers on x-axis represent the recording locations on the 
surface of the cord relative to C5/6 border (0 mm). In the 2 week survival animals CDPs are 
restored at most locations almost to the amplitudes seen in acutely injured animals at 20 minutes 
after injury. The asterisks (*) represent the statistical significance of the difference between CDP 
amplitudes recorded at 3 days compared to 2 weeks (* = p <0.05, **= p <0.01, ***= p < 0.001). 
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Figure 2-37. Comparison of the amplitudes of pyramidal evoked CDPs in acutely injured 
animals and animals investigated at 3 days and at 2 weeks after injury. 
Plot showing the mean amplitudes of pyramidal evoked CDPs recorded 20 minutes after an acute 
injury compared to animals recorded from at 3 days and at 2 weeks after injury. The plot shows 
amplitudes at 5 different locations expressed as a percentage of the mean CDP amplitude in 
normal animals. Normal CDP amplitudes are represented as a dotted line (100 %). There were no 
significant differences between CDPs recorded at the different time points.  
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Figure 2-38. Amplitudes of pyramidal evoked CDPs recorded in surviving animals at 2 
weeks, 4 weeks, 7 weeks and 3 months after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded from the groups of 
animals investigated at 2 weeks (n=13), 4 weeks (n=15), 7 weeks (n=12) and 3 months (n=14) 
after injury. The plot for normal animals is also shown for comparison. Each data point is the mean 
CDP amplitude for all animals in the group. The error bars show +/- SEM. Contusion injury was 
carried out with the rostral edge of the impactor tip aligned with C5/6 border (0 mm). The 
recordings were made over the cervical spinal cord. Numbers on x-axis represent the recording 
locations on the surface of the cord relative to C5/6 border (0 mm). CDPs rostral to the injury and at 
the injury epicentre remained almost stable between 2 weeks and 3 months after injury, however, a 
slight increase in CDP amplitudes was observed  over time caudal (-3 mm to -6 mm) to the injury. 
There were no significant differences between CDPs recorded at the different time points.  
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Figure 2-39. Amplitudes of pyramidal evoked CDPs recorded from animals investigated 2 
weeks, 3 months and 6 months after injury.  
The plot shows a comparison of the mean amplitudes of CDPs recorded from animal groups 
investigated 2 weeks (n=13), 3 months (n=14) and 6 months (n=14) after injury. The plot for normal 
animals is also shown for comparison. Each data point is the mean CDP amplitude for all animals 
in the group. The error bars show +/- SEM. Contusion injury was carried out with the rostral edge of 
the impactor tip aligned with C5/6 border (0 mm). The recordings were made over the cervical 
spinal cord. Numbers on x-axis represent the recording locations on the surface of the cord relative 
to C5/6 border (0 mm). In the 6 month survival animals CDPs below the injury (-3 mm to -7 mm) 
showed increased amplitudes compared to the 2 week survival animals but were similar to those 
recorded from the 3 month group. There were no significant differences between CDPs recorded at 
the different time points. 
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Figure 2-40. Changes in amplitude of pyramidal evoked CDPs in animals investigated 2 
weeks, 3 months and 6 months after injury. 
Plot showing the mean amplitudes of pyramidal evoked CDPs recorded in animals investigated at 2 
weeks, 3 months and 6 months after injury. The plot shows CDP amplitudes recorded at 5 different 
locations expressed as a percentage of the mean CDP amplitude in normal animals. Normal CDP 
amplitudes are represented as a dotted line (100 %). There were no significant differences 
between CDPs recorded at the different time points. 
  
Pyramidal evoked CDPs
6 4 -1 -4 -6
0
10
20
30
40
50
60
70
80
90
100
2 weeks
3 months
6 months
Location relative to C5/6 border (mm)
C
D
P
 a
m
p
li
tu
d
e
 (
%
a
g
e
 o
f 
n
o
rm
a
l)
Chapter 2  150 
 
 
  
Figure 2-41. Examples of injury site histology at an acute time point. 
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The panels show confocal microscope images of the injury site approximately 4 hours after injury. 
Each panel is an example obtained from a parasagittal section passing through the injury area 
close to the midline. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFAP immunolabelling (blue). A-1 and B-1 show NF 200 immunolabelling in addition 
while A-2 and B-2 show laminin distribution. The micrographs are projections of 7-9 optical sections 
and composed from multiple x20 fields of view. All scale bars are 1 mm.  
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Figure 2-42. Examples of injury site histology at 3 days after injury.   
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The panels show confocal microscope images of the injury site in 3 days survival animals after 
injury. Each panel is an example obtained from a parasagittal section passing through the injury 
area close to the midline. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFAP immunolabelling (blue). A-1 and B-1 show NF 200 immunolabelling in addition 
while A-2 and B-2 show laminin distribution. The micrographs are projections of 7-9 optical sections 
and composed from multiple x20 fields of view. All scale bars are 1 mm.  
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Figure 2-43. Examples of injury site histology at 2 weeks after injury.   
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The panels show confocal microscope images of the injury site in 2 weeks survival animals after 
injury. Each panel is an example obtained from a parasagittal section passing through the injury 
area close to the midline. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFAP immunolabelling (blue). A-1 and B-1 show NF 200 immunolabelling in addition 
while A-2 and B-2 show laminin distribution. The micrographs are projections of 7-9 optical sections 
and composed from multiple x20 fields of view. All scale bars are 1 mm. 
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Figure 2-44. Examples of injury site histology at 4 weeks after injury.   
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The panels show confocal microscope images of the injury site in 4 weeks survival animals after 
injury. Each panel is an example obtained from a parasagittal section passing through the injury 
area close to the midline. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFAP immunolabelling (blue). A-1 and B-1 show NF 200 immunolabelling in addition 
while A-2 and B-2 show laminin distribution. The micrographs are projections of 7-9 optical sections 
and from multiple x20 fields of view. All scale bars are 1 mm. 
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Figure 2-45. Examples of injury site histology at 7 weeks after injury.   
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The panels show confocal microscope images of the injury site in 7 weeks survival animals after 
injury. Each panel is an example obtained from a parasagittal section passing through the injury 
area close to the midline. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFAP immunolabelling (blue). A-1 and B-1 show NF 200 immunolabelling in addition 
while A-2 and B-2 show laminin distribution. The micrographs are projections of 7-9 optical sections 
and composed from multiple x20 fields of view. All scale bars are 1 mm. 
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Figure 2-46. Examples of injury site histology at 3 months after injury.   
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The panels show confocal microscope images of the injury site in 3 months survival animals after 
injury. Each panel is an example obtained from a parasagittal section passing through the injury 
area close to the midline. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFAP immunolabelling (blue). A-1 and B-1 show NF 200 immunolabelling in addition 
while A-2 and B-2 show laminin distribution. The micrographs are projections of 7-9 optical sections 
and composed from multiple x20 fields of view. All scale bars are 1 mm.  
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Figure 2-47. Examples of injury site histology at 6 months after injury.   
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The panels show confocal microscope images of the injury site in 6 months survival animals after 
injury. Each panel is an example obtained from a parasagittal section passing through the injury 
area close to the midline. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFAP immunolabelling (blue). A-1 and B-1 show NF 200 immunolabelling in addition 
while A-2 and B-2 show laminin distribution. The micrographs are projections of 7-9 optical sections 
and composed from multiple x20 fields of view. All scale bars are 1 mm.  
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Figure 2-48. Comparison of injury cavity extent in animals at 7 weeks and 6 months after 
injury.  
The bar plots represent the total rostro-caudal (length) and lateral (width) extent of the injury cavity 
measured from histology of the injury site from the groups of animals investigated 7 weeks (red) 
after injury and 6 months (blue) after injury. The error bars represent standard error of the mean 
(Fujimoto et al.). The cavity was significantly longer in the 6 month animals than the 7 week group. 
Statistical analysis used was students t-test and asterisk (*) indicates p value of <0.05. 
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Figure 2-49. Example of BDA-labelled corticospinal tract after C6 contusion.  
The panels show confocal images of anterograde labelling of left CST 4 weeks after contusion 
injury.  Panels represent section rostral (A) and caudal (B) to the injury site. A-1 and B-1 show BDA 
labelled CST fibres in the lateral white matter, while A-2 and B-2 show the ventral CST fibres (scale 
bar=0.5 mm). BDA labelled CST fibres are absent in the dorsal column suggests complete 
axotomy after contusion injury.   
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2.5 Discussion 
2.5.1 Rationale for using cord dorsum potentials as a measure of 
function in the spinal cord  
In this chapter an electrophysiological approach has been used to investigate the 
time course of functional changes in grey matter of the spinal cord following a 
contusion injury. The main approach has been to maximally stimulate the 
sensory afferent fibres from the radial nerve and descending corticospinal 
pathways and record the surface potentials generated by these pathways in the 
vicinity of the injury. Measuring the surface potentials in the form of cord 
dorsum potentials provides a sensitive method to measure the global activity 
produced at connections within the spinal cord in order to quantify the efficacy 
of these pathways. Therefore, such recordings can be used to directly 
investigate functional changes in the spinal cord following injury. However, CDP 
measurements are biased towards detection of activity in the dorsal grey matter 
as this is closer to the electrode on the dorsal surface. This makes them 
particularly suitable for measuring the synaptic connections of sensory afferents 
and the corticospinal tract which terminate predominantly in the dorsal grey 
matter (Casale et al., 1988, Willis and Coggeshall, 2004).  
Impact to the dorsal surface of the cord causes damage to axons in the dorsal 
column and neurons and their connections in the dorsal grey matter. However, 
the midline injuries cause damage to axons located more medially in the white 
matter and those located more laterally are spared. Our model of C6 injury is 
made at the centre of the cord length where stimulation of sensory afferents of 
the radial nerve produces CDPs. The CDPs at this location represent the synaptic 
current generated at the connections between the sensory afferents from the 
radial nerve and the neurons within the grey matter of the spinal cord. 
Measurements of the amplitudes of CDPs therefore provide a measure of the 
strength of the connections between the sensory afferents and the neurons in 
the spinal cord. Hence CDP amplitudes provide a direct measure of function at 
the level of the spinal cord and loss of connections caused by the injury at the 
C6 level can be expected to lead to a decrease in CDP amplitudes.   
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2.5.2 Loss of sensory function at the site of impact immediately 
after contusion injury 
Investigation of the recordings made immediately after the contusion injury 
show that there is profound loss of sensory potentials localised to the area of the 
impact which is evident by a dip in the distribution of CDPs evoked by radial 
nerve stimulation compared to normal. In this injury model of midline contusion, 
CDPs can still be evoked at close to normal amplitudes both above and below the 
injury. The relatively normal amplitudes of CDPs at positions farthest from the 
injury and especially of those above the injury suggests that the main sensory 
dorsal columns axons from the radial nerve are not substantially damaged. The 
radial afferents enter mainly at the C6 and C7 levels and if they were damaged 
then the potentials above the injury in particular would be reduced in amplitude 
or abolished as following a wire knife injury to the dorsal columns (Toft et al., 
2007). Since there is no evidence that dorsal column axons are damaged in the 
immediately acute phase of the injury. This in turn suggests that significant 
decline in the CDP amplitudes at the injury epicentre is mainly due to disruption 
of the neurons and local axon collaterals by which these potentials are 
generated.  Acute recordings show that most of the damage or functional loss at 
the centre of the impact occurs at the time of the impact but to each side of the 
injury there is gradual worsening of function with each consecutive recording 
made at 30 minute intervals for the first 4 hours.  
The fact that parent dorsal column axons from the radial nerve are spared in the 
midline cervical injury is probably due to the fact that sensory axons in the 
dorsal columns are topographically organised so that sensory afferents from the 
forelimbs, including those from the radial nerve, occupy locations that lie 
laterally (fasiculus cuneatus). In comparison dorsal column axons from hindlimbs 
(e.g. sciatic nerve) are located in the medial portion (fasiculus gracilis) of the 
dorsal column. Thus by centering the impactor tip on the midline of the C6 
segment of the spinal cord the forelimb afferents would be relatively spared 
compared to those from the hindlimbs. In addition, Anderson and colleagues 
(2009) reported more severe impairment of sensory function (by using von Frey 
test) in the hindlimbs compared to forelimbs following a midline cervical 
contusion (Anderson et al., 2009b). However, these findings have not been 
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confirmed with anatomical methods and electrophysiological techniques. 
Confirmatory anatomical evidence to show that primary afferents from the 
radial nerve are spared in this injury model could be provided by injecting 
Cholera toxin b (Ctb) tracer into the forelimb nerves. In addition, 
electrophysiological evidence that primary afferents from the forelimbs 
projecting in the dorsal column are not affected by the midline cervical injury 
could be obtained by recordings sensory evoked potentials (SEPs) on stimulation 
of forelimb (i.e. radial) nerves.  
This loss of function attributed to disruption of neurons at the injury centre 
correlates with observations by Liu et al. (1997) who reported electron 
microscopic evidence of disappearance of cytoplasmic Nissl substance at the 
injury epicentre 5 minutes after a weight drop injury at the thoracic level and 
that there is formation of a clear boundary between damaged and normal 
neurons in the grey matter (Liu et al., 1997). Extensive haemorrhage with 
marked disruption of neuropil evident by swollen cell processes, ruptured cell 
and basement membranes and degenerative changes in neurons is observed 
within 10 minutes after weight drop injuries in cats (Griffiths et al., 1978). In 
addition, immediately after a contusion to the cervical cord there is reported to 
be damage to grey matter vasculature and disruption to the membranes of 
neuronal cell bodies and axons localized within 1 mm of the lesion epicentre 
(Choo et al., 2007). Furthermore, TUNEL (terminal deoxynucleotidyl transferase 
dUTP nick end labelling) positive neurons are first evident 4 hours after injury 
and were primarily restricted to the gross lesion area (Liu et al., 1997). 
Immediate disruption of membranes and appearance of apoptotic cell markers 
acutely after injury provides an indirect assessment of loss of functional 
integrity in neurons at the site of impact. However, to our knowledge this is the 
first time that electrophysiological evidence has been obtained for loss of 
function due to damaged neurons after a contusion injury. In addition, using a 
weight drop injury model at thoracic level maximum neuronal loss is observed 8 
hours after impact and apoptotic neurons are no longer evident 24 hours after 
injury (Crowe et al., 1997, Liu et al., 1997). Furthermore, in cervical contusion 
injuries made with Ohio State University device, it has been reported that 
maximum grey matter damage occurs at the injury epicentre and this is not 
progressive between 3 days and 9 weeks after injury (Pearse et al., 2005). This 
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suggests that neuronal death occurs within the first few hours after injury and is 
not an ongoing process in contusion injury due to a high velocity impact. This 
supports our findings of a similar level of function at the injury epicentre at all 
the recording time points studied (i.e. immediately after injury up to 6 months). 
The gradual decline of CDP amplitudes within the first few hours either side of 
the injury reflects reduction of function in neurons located close to the injury 
centre. However, this impairment of function is likely transient as CDP 
amplitudes below the injury recover at the 3 day time point to levels seen 
acutely. This implicates neurons in the vicinity of the injury which loss transient 
function is not a therapeutic target in contusion injury model.  In contrast, 
above the injury function worsens by 3 days and recovers more slowly possibly 
reflecting secondary injury mechanism affecting oligodendrocytes followed by 
repair of parent axon myelination is discussed below.  
2.5.3 Contribution of secondary injury mechanisms to loss of 
sensory function 
Results from the group of animals investigated at 3 days after injury show 
additional loss of function compared to within hours of injury. This loss of 
function was particularly marked in the recordings rostral to the injury site. As 
this decrease in function was observed selectively above the injury it suggests 
that it may mainly involve the parent axons in the dorsal columns. For example 
it may reflect demyelination of these axons. Weight drop injuries can lead to 
complete or partial destruction of myelin sheath while axons are relatively 
intact and mixture of demyelinated and normal axons are observed at 1 and 3 
days after injury (Griffiths and McCulloch, 1983). Quantitative analysis using 
electron microscopy has shown that maximum numbers of demyelinated axons 
are observed 1 day after thoracic contusion injuries made with Infinite Horizon 
Impactor apparatus. The demyelinated axons are mostly concentrated around 
the injury site and they reduce in number by 7-14 days (Totoiu and Keirstead, 
2005). Similarly maximum numbers of TUNEL positive glial cells are observed 24 
hours after injury as reported by Liu et al. (1997) and would be expected for 
demyelination of the spared axons. Although, myelin pathology has not been 
studied extensively in cervical injuries, Siegenthaler et al, (2007) have reported 
that there is no significant difference in the number of demyelinated axons 
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caused by cervical and thoracic contusion injuries. Injuries were produced using 
IHI device in their study (Siegenthaler et al., 2007).  
2.5.4 Repair and stability in sensory pathways 
CDP recordings at 2 weeks after injury show that potentials in the sensory 
system have largely stabilized and the amplitudes of the potentials above the 
injury have been restored to the levels observed acutely after injury. This 
reflects a repair process in the sensory system and this is possibly remyelination 
of the parent axons that were affected due to secondary damage. In addition, 
restoration of amplitudes to the levels observed immediately after injury suggest 
that this process would appear to be very efficient and almost complete 
(maximal) by 2 weeks after injury. The fact that CDPs are largely of stable 
amplitude from 2 weeks onwards suggests that most of the secondary damage 
observed at 3 days has subsided by 2 weeks.  
The process of remyelination in SCI models has been reported in many studies 
(Salgado-Ceballos et al., 1998, Totoiu and Keirstead, 2005, Powers et al., 2012). 
Remyelination is evident after thoracic contusion in rats (Totoiu and Keirstead, 
2005) and also observed after chemically-induced demyelination in mice (Jeffery 
and Blakemore, 1995) within 7 days after injury. Both Schwann cells and 
oligodendrocytes are reported to accomplish spontaneous remyelination in 
injured spinal cord (Beattie et al., 1997, Totoiu and Keirstead, 2005). The 
process of remyelination is reported to be ongoing after injury (Salgado-Ceballos 
et al., 1998) and it is also suggested that remyelination increases in a chronic 
progressive manner (Totoiu and Keirstead, 2005) and maximal remyelination is 
observed by 3 to 4 months (Totoiu and Keirstead, 2005, Powers et al., 2012). 
Furthermore, James et al. (2011) reported spontaneous improvement of 
conduction in ascending dorsal column fibres after thoracic contusion injury. The 
improvement of conduction in the ascending fibres plateaued approximately 4 
weeks after injury. This was also correlated behaviourally with improvement in 
ladder walk test performance (James et al., 2011). In our study we have 
observed restoration of function within 2 weeks after injury and no additional 
functional improvement afterwards. This in turn suggests that the process of 
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ongoing remyelination reported in previous studies may not be adequate to 
promote further recovery of function in the local circuits of the spinal cord.  
2.5.5 Late deterioration of function in sensory pathways 
Although function in sensory circuits appears mainly stable from 2 weeks after 
injury, a late phase of decline in function has been observed. This is evident by 
decrease in CDP amplitudes at the most chronic time point investigated in this 
study (i.e. 6 months after injury). This deterioration of function is seen caudal to 
the injury centre and possibly reflects further loss of neural tissue. This is 
supported by evidence of an extension in cavity dimensions in animals surviving 
6 months after injury compared to cavities in animals at 7 weeks after injury. 
However, it is not clear why this should affect potentials below the injury but 
not above. The observation on cavity expansion are in contrast to the findings 
reported in a thoracic contusion model where no change in cavity extent was 
observed between 14 weeks and 8 months survival animals (Hill et al., 2001). A 
decrease in afferent terminal density is observed caudal to the injury after Ctb 
tracer injections into the forelimb nerves (radial, ulnar and median) and also a 
decrease in neuronal density in animals surviving 6 months after injury compared 
to 7 weeks survival animals (unpublished data from the lab). Byrnes and 
colleagues studied the inflammation related gene up to 6 months after thoracic 
weight drop SCI and found that these genes are up regulated chronically and 
may contribute to further tissue loss in chronic SCI (Byrnes et al., 2011). 
2.5.6 Loss of function in corticospinal pathways immediately after 
contusion injury 
The response of CST to the contusion injury could be examined by stimulating 
the CST fibres within the pyramids and recordings CDPs along the length of the 
cervical segments. Recordings pyramidal evoked CDPs immediately after the 
injury showed that propagation of impulses in the main component of the 
corticospinal tract below the injury are acutely disrupted. The amplitude of 
CDPs caudal to the injury were significantly reduced and did not return during 
the first 4 hour hours of recording after injury. The main CST component located 
in the ventral part of the dorsal column comprises 90 % of the CST fibres (Hicks 
and D'Amato, 1975, Miller, 1987) and pyramidal evoked CDPs are mainly 
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dependant on inputs from the dorsal CST. Substantial reduction in CDP 
amplitudes below the injury level suggests that the dorsal component fibres are 
completely damaged after injury. This is supported by the evidence that BDA 
labelled CST fibres are completely absent in the dorsal column below the injury. 
It was also reported by Anderson and colleagues that the CST in the dorsal 
columns is completely severed after cervical contusion injury using IHI device 
(Anderson et al., 2009b) and in a thoracic weight drop injury by Hill et al. (Hill 
et al., 2001).  
2.5.7 Contribution of secondary injury mechanisms to loss of 
corticospinal function  
At 3 days after the injury corticospinal evoked CDPs show a modest deterioration 
of function. This deterioration of function is more marked above the injury and 
may reflect secondary injury mechanism such as demyelination or die back of 
CST fibres. However, corticospinal CDPs above the injury improved at 2 weeks 
though amplitudes remained smaller than normal, especially close to the injury 
site. This suggests that the proximal end of the severed CST axons in the dorsal 
column may undergo retrograde degeneration and could be responsible for the 
reduction in CDP amplitudes close to the injury site. It should be possible to 
confirm this using tracer injection and quantification of the remaining CST fibres 
rostral to the injury. It has been observed that in contusion injury CST fibres 
terminate in retraction bulbs as far as 5 mm rostral to the injury site, with the 
majority of retraction bulbs within 1-2 mm of the rostral edge of the cavity, 
suggesting die back of some CST fibres which then sprout and grow back up to 
the lesion margins (Hill et al., 2001).  
2.5.8 Evidence of plasticity in the corticospinal pathways below 
the injury 
At 2 weeks after the injury corticospinal CDPs recorded above the injury are 
quite stable over time but there is a gradual increase in the CDP amplitudes 
below the level of the injury. This suggests some plasticity occurs in the spared 
corticospinal projections reaching levels below the injury (i.e. spared by the 
injury) and that this plasticity leads to strengthening of corticospinal actions 
below the injury. This plasticity is most likely from the fibres of the minor 
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component of the CST located in the lateral white matter as these are known to 
connect with neurons in the dorsal horn in a similar region to fibres of the main 
component.The ventral CST fibres project ipsilaterally and they may form 
connections more ventrally nearer to the motonuclei and synaptic activity 
produced by these fibres is less likely to be detected with a dorsally placed 
recording electrode. Furthermore, tracer injections into the sensorimotor cortex 
revealed a higher density of BDA labelled axons projecting caudal to the injury 
in 6 months surviving animals compared to 4 weeks after the injury (unpublished 
data from the lab). Extensive sprouting from the minor components of CST 
following interruption of the main dorsal component of CST is observed by many 
investigators in hemisection and transection models of SCI (Weidner et al., 2001, 
Steward et al., 2008, Rosenzweig et al., 2010). In a contusion injury model CST 
sprouting in the main dorsal component rostral to the injury is reported to be 
initiated 3 weeks after injury and extensive sprouting is observed by 14 weeks 
(Hill et al., 2001). This suggests that following the contusion injury CST fibres 
are amenable to spontaneous plasticity as observed in other models. To our 
knowledge this is the first time that enhancement in amplitudes of CDPs evoked 
by corticospinal stimulation due to plasticity in the minor components has been 
reported after a contusion injury.  
2.5.9 Implications for understanding SCI pathology and 
developing therapies 
The findings in this chapter suggest that most of the damage and functional loss 
in the spinal cord occurs at the time of initial injury. This is evident from the 
substantial decline in CDP amplitudes produced at the time of injury at the 
injury epicentre and the finding that these potentials remain almost constant at 
all the time points investigated. Function either side of the injury worsens 
within the first few hours after injury. This decline in function is not persistent 
and returns to levels close to those seen immediately after contusion but the 
pattern of recovery is different above and below the injury. Function below the 
injury returns to levels close to those seen immediately after contusion within 3 
days. However, above the injury, further deterioration of function is observed at 
3 days suggesting an additional effect of secondary injury mechanism i.e. 
demyelination of the primary afferents in the dorsal column. At 2 weeks 
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improvement of function is observed above the injury where function returns to 
levels close to those seen acutely, indicating a repair process i.e. remyelination. 
This process seems to be very efficient and complete in this injury model.  
These findings suggest functional loss due to a high velocity impact as produced 
by the IHI device is greatest at the centre of the injury, and that it is maximal at 
the time of primary trauma and is irreversible at this location. Function above 
and below the injury deteriorates soon after the initial trauma but returns to 
levels seen acutely within a relatively short period of time (2 weeks). This 
indicates neurons close to the injury centre (i.e. immediately above and below) 
show only transient impairment of function and may also not benefit from 
treatment. It is possible that remyelination is part of the repair process and if so 
the return of function to acute levels suggests that demyelination does not 
persist permanently in this injury model and this is consistent with previous 
suggestions by Plemel et al. (2014) that demyelination is not an important 
therapeutic target in SCI (Plemel et al., 2014). 
Conversely, compression injury models cause a more progressive neuronal loss 
after injury (Huang et al., 2007). It is reported that there is approximately 30 % 
additional neuronal loss between 1 and 3 days after compression to the thoracic 
spinal cord applied for 5 minutes (Huang et al., 2007). The ongoing neuronal loss 
suggests that secondary mechanisms are more pronounced in compression injury 
compared to contusion injury. Many neuroprotective therapies have been tested 
with the hope of mitigating secondary damage after SCI and preserving the 
spared neurologic tissue in both contusion and compression injury models (Kwon 
et al., 2011). Erythropoietin has been shown to have a neuroprotective effect 
mainly by reducing apoptosis, inflammation, lipid peroxidation and preserving 
tissue in both weight drop contusion and compression injury models at the 
thoracic level (Gorio et al., 2002). There were also significant improvements in 
the behavioural assessments using BBB scores which returned approximately to 
normal by 28 days in both injury models compared to controls, although the 
pattern of recovery was slightly slower in contusion injured animals (Gorio et 
al., 2002). However, replication of this study using similar injury models in order 
to evaluate the efficacy for clinical translation failed to find any beneficial 
effects in either model (Pinzon et al., 2008a). Mann and colleagues have also 
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failed to show any therapeutic beneficial effects of erythropoietin or its 
derivative darbepoetin administered 1 hour after contusion injury made with the 
Ohio State University apparatus (Mann et al., 2008). Similarly, the broad 
spectrum antibiotic minocycline has been shown to inhibit microglial activation 
and inhibit the release of pro-inflammatory mediators. In addition, it can lead to 
increased axonal sparing, reduced lesion area and improved function in 
behavioural assessments (i.e. BBB and inclined plane test) when administered 
after thoracic compression (Wells et al., 2003). However, the previously 
reported beneficial effects of Minocycline in a weight drop contusion model 
using the NYU device in rats (Lee et al., 2003b) has not been replicated in 
studies with a similar injury model and dosage (Pinzon et al., 2008b). The 
negative outcome after administration of neuroprotective therapies further 
supports the hypothesis that in contusion injury due to a high velocity impact 
the maximum damage is seen due to the primary insult and there is minimal 
contribution from the secondary injury mechanisms. The fact that the 
contribution from secondary damage is minimal in the contusion injury model 
should be taken into consideration in future when investigating neuroprotecitve 
therapies. Furthermore, as suggested by Huang et al. (2007) the ongoing damage 
due to secondary processes in a compression injury model may be more 
amenable to neuroportective therapies (Huang et al., 2007). However, direct 
electrophysiological evidence is needed to assess whether ongoing neuronal loss 
in compression injury is also associated with a continuing reduction of function.  
2.5.10 Technical considerations 
2.5.10.1 Anaesthetic use in contusion injury surgery 
Isoflurane anaesthetic was used for all groups of animals during the contusion 
injury surgery with the exception of the acutely injured group of animals, where 
pentobarbital was used during the contusion injury. This was because the acute 
animals were prepared for the electrophysiological experiment in order to carry 
out CDP measurement immediately after injury. In addition, rats were 
anaesthetised for a longer duration during preparatory surgery for the 
electrophysiology before the contusion. Therefore the duration and use of 
different anaesthetics may affect the outcome of the injury and its effect on 
functioning at the level of the spinal cord. It has been reported that different 
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anaesthetic usage during injury surgery has effects on recovery after injury. 
Behavioural functional outcome is reported to show better recovery of 
locomotion after administration of isoflurane compared to animals injured under 
pentobarbital anaesthesia (Nout et al., 2012). Therefore it is necessary to 
consider that the functional outcome in the acute group of animals may be 
greater than it would have been had isoflurane been used as the anaesthetic as 
in all other group of animals. 
2.5.10.2 Electrophysiology 
During electrophysiological experiments efforts were made to minimise 
variability in the collection of the electrophysiology data. Therefore continuous 
monitoring of the animals physiological condition was carried out including blood 
pressure, tidal expired CO2 and core body temperature.  Electrophysiological 
recordings are very sensitive to level of the anaesthesia and therefore efforts 
were made to maintain this at the same level throughout by continually 
monitoring the withdrawal reflexes and changes in blood pressure and 
administering anaesthetic accordingly during paralysis. Observations in the lab 
suggest that pentobarbital anaesthesia has minimal effects on CDP amplitudes if 
maintained at a steady level. CDP measurements are very sensitive to the 
accumulation of CSF around the recording electrode which leads to reduction in 
the amplitudes of CDPs, therefore fluid was removed regularly. Supramaximal 
stimulation of the afferent fibres and the corticospinal fibres were used in order 
to activate all of the neurons or fibres comprising the system and avoiding the 
stimulus spread to the surrounding structures.  
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3 Investigation of human embryonic stem cell 
derived mesenchymal stem cells (hESC-MSC) as 
a potential therapy for spinal cord injury 
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3.1 Introduction   
MSCs are multipotent cells with the capability to self-replicate and develop into 
many cell types including bone, muscle, cartilage and neural tissue (Minguell et 
al., 2001). As reviewed in chapter 1 (Introduction), the use of MSCs in SCI 
treatment is considered promising as they have been shown to promote repair 
and functional recovery. Also, the relative ease with which these cells can be 
isolated and expanded in culture with only subtle loss of potency makes them a 
promising candidate for use in the treatment of degenerative diseases.  
MSCs have been identified and can be isolated from several tissues and organs of 
both fetal and adult origin (Campagnoli et al., 2001, Meirelles et al., 2006). 
MSCs obtained and harvested from several tissues have been investigated in SCI 
model including those obtained from adipose tissue (Zuk et al., 2001), umbilical 
cord blood (Erices et al., 2000), olfactory mucosa (Tome et al., 2009, Lindsay et 
al., 2013) and embryonic tissue (Thomson et al., 1998, Lee et al., 2010). MSCs 
obtained from bone marrow are the most widely studied (Tetzlaff et al., 2011). 
However, autologous transplantation of bone marrow derived MSCs (BM-MSCs) 
has several disadvantages which may limit their use in the clinical setting. These 
include the need for an invasive procedure for obtaining the cells and variability 
in cell quality and quantity. There can also be limitations as a result of slow 
proliferation, limited life span and gradual loss of stem-like properties during in 
vitro expansion (Ringe et al., 2002).  
However, among the potential sources of these cells is the possibility of 
differentiating them from human embryonic stem cells (hESCs). It has been 
demonstrated that MSCs can be successfully derived from hESCs. Using a 
modified version of the process reported by Olivier et al. (2006) MSCs have been 
successfully derived in several sets of experiments in our lab (from a hESC line) 
with similar properties to BM-MSCs .  
These hESCs derived MSCs were transplanted in animal models of traumatic SCI 
and showed good survival within the injury site and usually filled the injury area 
resulting in a reduction in the size of the injury cavity, when compared to non-
transplanted animals. Numerous blood vessels were found at the injury site in 
transplanted animals, as judged by laminin and smooth muscle actin staining. In 
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addition, the transplants supported regeneration of ascending dorsal column but 
not corticospinal fibres though this regeneration was limited to the transplant 
region. The regenerating fibres also showed signs of acquiring myelin sheaths 
with positive immunolabelling for CASPR being detected at the centre of the 
transplants (Mohamad, 2014).These effects are similar to those reported for 
MSCs of bone marrow origin and suggest that transplants of these cells may help 
repair the injured spinal cord. 
3.2 Aim  
Although numerous studies have investigated bone marrow derived MSCs and 
some have suggested that these cells can help improve function after SCI, hESC 
derived MSCs have not yet been investigated. We hypothesized that since these 
cells appear anatomically to behave similarly to bone marrow MSCs when 
transplanted into a contusion injury that they may also improve functional 
outcome. The aim of this study was therefore to transplant hESC derived MSCs in 
a clinically relevant model of SCI, to investigate their ability to improve 
impaired function. However, it is difficult to compare the SCI model in rodents 
to injuries seen in humans. Contusion injury is considered to be a clinically 
relevant model. The 3 week time point after injury in rodents has been 
considered chronic and could mimic chronic injury in humans. Therefore, the 
aim of this chapter was to combine electrophysiological and behavioural 
approaches to determine whether hESC-MSC transplants promote repair and 
improvement of function after a delayed transplant in a contusive injury model.    
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3.3 Material and Methods  
3.3.1 Experimental Design   
A summary of the experimental design for the experiments reported in this 
chapter is shown in the Figure 3-1. Animals were handled and trained daily to 
perform behavioural tests for 2 weeks prior to a contusion injury (C6 175 kdyn) 
and baseline data was collected 1 day prior to contusion injury (C6 175 kdyn). 
The tests were then performed each week after injury for 9 consecutive weeks. 
hESC-MSCs transplantation were performed at 3 weeks after the injury, a time 
point which is clinically relevant and when the injury has stabilised as indicated 
by the results reported in chapter 2. Immunosuppression with cyclosporine A 
(Sandoz, UK) 20 mg/kg body weight s.c. was started 2 days prior to transplant of 
either hESC-MSC or medium for the rest of the study. At 7 weeks post-transplant, 
animals were subject to electrophysiology experiments under general 
anaesthesia with pentobarbital. After electrophysiological recordings, each 
animal was perfused and histological processing was carried out to assess cell 
survival and the morphology of the injury site using immunochemistry and 
epiflourescence/confocal microscopy.   
3.3.2 Animals   
All of the experiments in this project were approved by the Ethical Review 
Process Application Panel of the University of Glasgow and performed in 
accordance with the UK Animals (Scientific Procedures) Act 1986 (ASPA). 
Findings in this chapter are based on a total of forty-five (44) adult male Sprague 
Dawley rats (Harlan, Loughborough, UK). SD rats are used in this project because 
they are good in performing grip strength and ladder task and reaching task was 
not planned in this project. All of the animals were subjected to 175 kdyn 
contusion injury at the C6 level of the spinal cord. Of these, sixteen (16) were 
transplanted with hESC-MSC at 3 weeks post injury and thirteen (13) were 
injected with media into the injury site at the same time point. All the animals 
injected with cells or medium were allowed to survive for 7 weeks and their 
functional abilities were assessed weekly using behavioural tests. 
Electrophysiological assessment was performed at the end of the study using the 
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same protocol as described in chapter 2. A further 3 animals were perfused at 3 
weeks post injury to assess the nature of the cavity at the time of transplant. 
In addition, 6 animals were transplanted with hESC-MSCs in order to assess the 
outcome of transplantation performed after a short delay following injury. Three 
animals were transplanted 5 days after contusion injury and 3 animals were 
transplanted 7 days after contusion injury. Animals with these sub-acute 
transplants were perfused 3 weeks after transplantation. Similarly in order to 
assess the nature of the injury cavity at 5 days and 7 days after contusion injury 
(the time points at which acute transplants were performed) 6 animals were 
injured with 175 kdyn contusion injury. 3 of these animals were perfused after 5 
days and 3 after 7 days survival.  
3.3.3 Cell culture 
All of the cell culture was performed by Dr. Che Anuar Che Mohamed in Dr. Jo 
Mountford’s laboratory (based in the Davidson building), Institute of 
Cardiovascular and Medical Sciences, University of Glasgow. For full details of 
cell culture procedure see Che Anuar PhD thesis 2014. 
3.3.3.1 Culture of hESC 
Briefly the Wisconsin hESC line H1 (Thomson et al., 1998) was used as the 
starting population to derive MSCs. The method for derivation of MSCs from 
hESCs was based on the method described by (Olivier et al., 2006) which does 
not require any feeder layer of animal origin. The population of cells was grown 
and maintained under feeder free conditions to minimise the involvement of 
animal related products. These cells were initially expanded in culture in order 
to be used as a starting point for differentiation into MSCs.  
hESCs were grown on murine embryonic fibroblast (MEF) cells when originally 
acquired from the source. They were switched to feeder free conditions after 28 
passages and cultured on 6 well plates pre-coated with extracellular matrix 
(ECM; CellStart, Life Technologies) in StemPro hESC HFM media. These cells 
were further passaged 10 to 20 times in feeder-free conditions in order to ensure 
the removal of MEF cells at which point they are suitable as a starting population 
for MSC differentiation. The cells were fed daily with StemPro hESC HFM media 
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until they were 90% confluent. Afterwards, the cells were mechanically 
detached and vigorously pipetted to dissociate the remaining cell clumps. These 
dissociated cells were re-plated and cells from each 6 well plate were split into 
a further 6 wells for maintenance and expansion. All the cultures were 
maintained at 37º C in an incubator with 5% CO2 and 95% O2.  
3.3.3.2 Differentiation of hESCs to MSCs 
In order to differentiate hESCs into MSCs, 2 confluent wells of hESCs were 
selected from a 6 well plate and used as a starting population for 
differentiation. The cells were mechanically detached, dissociated by pipetting 
vigorously and divided into 4 equal portions. Each portion was transferred into a 
T25 flask to obtain 4 flasks from each well. These were kept in an acidic 
environment (7.5% CO2) at 37ºC in an incubator for approximately 28 days in D10 
(DMEM+FBS 10%NEAA+P/S) media. The medium was changed regularly every 7 
days. After 28 days, the cells were dissociated by adding TrypLE Select and 
incubated for 2-4 hours.  
The MSC like cells derived after 28 days differentiation were initially plated in a 
T25-cm2 flasks in D10 media and left to attain 90% confluency, which usually 
took 5-10 days. These cells were then dissociated with 2 ml TrypLE Select, 
returned to the incubator for 5 minutes and replated at 1 x 104 cells/cm2 density 
in a T25 flask. The cells were maintained in D10 media at 37º C and 5% CO2. The 
flasks were examined by light microscopy daily until 90% confluent (usually 
taking 3-4 days). These cells were replated again into T25 flasks and the media 
changed every 2-3 days. After 3 passages sufficient numbers of cells were 
obtained to provide a stock for cryopreservation. To preserve the cells they 
were counted using a haemocytometer (Hawksley BS.748 improved Neubauer 
counting chamber) and 2 x106 cells/ml were re-suspended in 1 ml of MSC media 
and 1 ml of this suspension (cells and medium) transferred to a CryoTubeTM and 
placed into liquid nitrogen for long term storage. 
3.3.3.3 hESC-MSC characterization 
The hESC derived MSCs were characterised for cell surface markers, gene 
expression profiles, and growth and differentiation protocols by Mohamad. The 
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protocols used were similar to those described elsewhere in the literature 
(Olivier et al., 2006, Chamberlain et al., 2007, Uccelli et al., 2008).  
3.3.3.3.1 Morphology 
At the end of differentiation period i.e. by 28 days cells showed a heterogeneous 
spindle shaped morphology under the microscope which is characteristic of 
MSCs. In addition 3-5 days after re-plating following differentiation cells were 
strongly attached to the plastic surface of the culture flasks.  
3.3.3.3.2 Surface markers 
Surface marker expression was analysed using flow cytometry in order to 
examine MSC related markers. The differentiated cells were highly positive (70-
90 %) for CD44, CD73, CD105, HLA ABC, CD13 and CD166 which are markers 
characteristic of MSCs. There was low expression of other MSC markers like CD71 
and CD90 (35-50 %) and CD271, CD106 and Stro-1 (5-20% of cells). Less than 2 % 
of cells expressed the haematopoietic markers, CD45 and CD34.  
3.3.3.3.3 Gene expression  
Quantitative real time PCR (RT-PCR) was performed in order to look for changes 
in the mRNA expression levels of genes specific for MSCs at different stages of 
the differentiation protocol. At day 0 of hESC differentiation pluripotency genes 
OCT4 and Nanog were highly expressed. Their expression levels were 
significantly down-regulated at 28 days. Expression of the mesenchymal genes 
COL1A1, CD105 and Twist1 significantly increased by day 28. Expression of Early 
mesodermal lineage markers Goosecoid (GSC) and Brachury was minimal after 
differentiation. There was also extremely low or no expression of the 
haematopoietic markers CD31 and CD45. 
3.3.3.4 Expansion and preparation of hESC-MSCs for transplantation 
hESC-MSCs were thawed approximately 3 weeks before transplantation. A 
cryotube containing 1 x106 cells was taken out of liquid nitrogen and placed in a 
water bath at 37º C. Once the cells were thawed they were carefully removed, 
transferred into a 15 ml falcon tube and 10 ml of culture media was added. The 
cells were centrifuged and the supernatant discarded; the cells were then re-
suspended in culture media and divided equally into 2 T25 flasks. At 24 hours 
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after the first passage cells were transduced with lentivirus expressing a gene 
that encodes green fluorescent protein (GFP) in order to allow in vivo tracking 
after transplantation. The volume of virus was calculated from the titre derived 
multiplicity of infection and number of cells to be transduced. The cells were 
incubated with virus for 72 hours. The GFP labelled MSCs were then kept at 37º 
C and 5% CO2 and were repeatedly passaged (usually 5 times) to obtain the 
required number of cells for transplantation. Depending on the cell count, the 
cells were re-suspended in 50-100 µl of fresh medium on the day of 
transplantation and transferred into a sterile 200 µl eppendorf tube. These were 
then transported to the operation theatre on ice. The cell suspension was 
concentrated to approximately 200,000 cells/µl prior to filling injection 
pipettes. 
3.3.4 Contusion Injury   
All the contusion injuries and cell/media transplant surgeries in this project 
were carried out by Dr. John Riddell. I provided assistance with the surgery and 
the filling of the cell injection pipettes with hESC-MSC/media for transplants and 
also injections into the injury cavity using the pico-pump.  
The C6 spinal cord segment was subjected to a 175 kdyn contusion injury using 
the same protocol as described previously in chapter 2. A 10/0 silk (Ethicon) 
marking suture was placed in the dura over the injury site for identification 
during subsequent cell transplantation surgery. Peri-operative care and 
medications were the same as described in chapter 2. 
3.3.5 Immunosuppression   
In order to reduce the chances of cellular transplant rejection by the host 
immune system, the animals were immunosuppressed with daily injection of 
cyclosporine A. This was started 2 days prior to cell transplantation and 
continued for the duration of the experiment. Cyclosporine was administered at 
a dose of 20 mg/kg body weight subcutaneously. Control animals injected with 
media were also immunosuppressed using the same regime in order that any 
differnces between transplanted and control animals could be attributed solely 
to the transplantation of hESC-MSCs. Administration of cyclosporine by injection 
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was performed by animal house technical staff on weekdays and by myself or Dr 
Anuar over the weekends.  
3.3.6 Delayed cell transplantation   
Transplantation was performed 3 weeks after injury to coincide with a realistic 
delayed transplantation time-point in a clinical setting after human injury. The 
delayed protocol also helped in minimizing the chances of transplant rejection 
due to the elevated immune response immediately after injury.  
3.3.6.1 Cell injection pipettes 
Glass capillary tubes (GC 100T-10, Harvard Apparatus Ltd, UK) were used to 
prepare pipettes with a suitable diameter for injecting cells. These tubes were 
pulled using a vertical puller (Narishige PE-2, Narishige, Japan) with a 
controllable heating element that melts the glass into fine, tapered tips. Tips 
were cut with blunt micro-scissors to an internal diameter of approximately 60-
70 µm. After measuring the diameter under a microscope the tip was then 
sharpened with the help of a rotating beveller. Pipettes were manually marked 
with a series of permanent marker graduations 1.5 mm apart, graduations being 
made from where the pipettes tapers towards its tip. Each division approximated 
to about 1 µl and these were used to keep track of the volume of cell suspension 
injected. 
3.3.6.2 Transplantation of hESC-MSCs into the injury site 
The hESC-MSCs were transplanted directly into the injury cavity that is formed 
after contusion. The cells were transported to the operating theatre in a PCR 
tube on ice, and were spun down in a mini centrifuge to separate out the media 
and cells. The media that accumulated on the top was removed with the help of 
the glass pipette in order to make a thick, concentrated population of cells. A 
glass micro-pipette was filled with cells by creating negative pressure in the 
pipette by applying suction using a syringe connected by flexible tubing to the 
pipette. The filled pipette was then mounted on a stereotaxic manipulator and 
inserted into the lesion cavity through a slit in the dura. The tip of the pipette 
was lowered to a depth of approximately 1200 µm and cells were injected by 
applying brief pressure pulses of 20-40 ms (Picoinjector, WPI, Sarasota FL, USA) 
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while the tip was slowly raised dorsally, to a depth of approximately 300 µm. 
The cells were injected until there was overflow from the injection site which 
usually required around an average of 40 µl of cell suspension, corresponding 
approximately to 8 x 106 cells per animal. If no overflow was seen then the 
injection was stopped after the introduction of 50 µl of cell suspension. Wounds 
were then closed in layers and the animal was allowed to recover in a warm 
environment with free access to food and water. 
3.3.6.3 Media injection into the injury site   
To provide a control group of animals without treatment an approximately equal 
number of injured animals to those receiving transplants of cells were injected 
with the same media which was used to suspend the cells. D10 Media was used 
containing D-MEM (Dulbecco’s modified eagle medium) with FBS (Fetal Bovine 
Serum) (HyClone, Thermo Scientific, UK), NEAA (Non Essential Amino Acids) and 
antibiotics (penicillin and streptomycin). Glass micro-pipette was filled with 
media and injected using the same procedure as were used for cellular 
transplants described above. 
3.3.7 Behavioural testing   
All the transplanted and control animals were assessed for functional 
improvements using behavioural assessments on a weekly basis for the whole 
period of the experiment. The naive rats were initially acclimatised to the 
experimenter and the testing environment and this was followed by training on 
the equipment before performing the experiment. Grip strength and a horizontal 
ladder walking test were used to assess changes in the rats abilities to perform 
sensorimotor tasks before and after injury, and subsequently after 
transplantation of hESC-MSCs or media.   
3.3.7.1 Animal handling and acclimatisation  
All the animals selected were house pair-wise in cages with a 12 hour light/dark 
cycle. Before collection of pre-operative data each animal was handled for at 
least 10-15 minutes daily in the morning for 5-6 days in order to acclimatise 
them to general handling. During these sessions animals were also subjected to 
test the environment and positioned to acclimatise for the grip strength test. At 
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the end of 5-6 days animals showed no obvious signs of fear and stress with 
minimum urination and defecation. Animals were then trained on the 
behavioural apparatus for the next 5-6 days. The animals were allowed to run 
across the ladder and to grab the bar of the grip strength meter in order to 
become familiar with the testing environment and equipment. 
All the behavioural tests were performed on the same day each week during the 
morning for the whole period of the experiment. The testing environment was 
maintained with similar conditions of temperature, light/dark cycle, and access 
to water, food and bedding.  
3.3.7.1.1 Selection of animals for behavioural testing 
Animals were only subjected to contusion injuries if they could be successfully 
trained to perform the behavioural tests. In order to ensure that the different 
experimental groups were composed of animals that were as comparable as 
possible in every respect, behavioural performance in the grip strength test was 
taken into account. The grip strength scores for all animals at 2 weeks after 
injury were plotted in descending order and alternate animals were assigned to 
the transplant and control groups.  
3.3.7.2 Grip strength test 
A grip strength meter (Andilog, Centor v3.22 apparatus (Figure 3-2) was used to 
assess the force generated by the animals when gripping the force sensor bar 
and while resisting being pulled from the bar (Figure 3-3). The apparatus was 
attached firmly to the edge of the bench with the help of F clamps and a 
grasping bar fixed to the force meter. The force measurements were recorded in 
grams (the final measurements were expressed as a ratio of force to body 
weight).  
Animals body was supported with the right hand held below the forelimbs in such 
a way that both forelimbs were moved forward and with the experimenter’s left 
hand holding the rat’s tail; the animal was allowed to grasp the bar with both 
forepaws. Immediately after grasping the bar, the animal was pulled away from 
the apparatus, generating increasing force until the grip was broken, releasing 
the bar at which point peak or maximum force was produced. The peak force 
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recorded by the force meter at this point was noted and the animal was allowed 
to rest for at least 1 minute before repeating the same procedure. A total of 5 
successful tests were performed with each animal and measurements recorded. 
The highest and lowest measurements were ignored and the middle 3 
measurements were averaged. At the end of the experiment the weights of 
animals were recorded and the individual average forces were then expressed as 
the force exerted per gram of bodyweight. 
3.3.7.2.1 Exclusion of data 
Data from the animals at some points in the study were excluded when they 
were either unable to grasp the bar properly or if they displayed signs of 
spasticity in one or both forepaws (this happened occasionally after the 
contusion injury or transplant operation and it usually resolved within 1-2 
weeks).  
3.3.7.3 Ladder walk test  
In the ladder walk test, animals walked along a horizontal ladder with variable 
rung spacing while being videotaped. The videotapes were then viewed and 
analysed using GOM Player software (version 2.2.64). Animals were allowed to 
cross a 1 meter long grid with the middle part of the grid (40 cm) arranged with 
irregular rung spacing. Figure 3-4 shows the arrangement of irregular spacing 
with a gap of 1 to 3 cm between the rungs. Animals started the test at a loading 
area which allowed them to increase speed before crossing the analysed area of 
the ladder. In addition transparent plastic barriers found both side of the grid to 
restrict the animals to a straight path. The ladder apparatus is shown in Figure 
3-4. A camera was placed on a tripod level with the ladder and focussed on the 
area of the ladder with irregular spacing (analysis part of the ladder) in order to 
record clearly forepaw placements on the grid. Animals were trained during the 
acclimatisation and training period to run across the ladder when placed at one 
end of the platform. The home cage of the animal, containing its cage mate, 
was placed at the other end of the platform, which provided a motivational 
incentive to cross the ladder. The animals were placed at the left end of the 
ladder and video recorded while crossing the ladder. A total of 5 good runs 
where animals showed minimal hesitation in crossing the ladder and did not 
attempt to turn back and/or explored the sides were normally recorded. Animals 
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were allowed to rest for at least 1 minute in between trials. If animals were too 
hesitant to cross they were provided with a longer rest before each trial. All the 
measurements were made on the same day each week in as consistent a way as 
possible.  
3.3.7.3.1 Analysis of videos  
The best 3 out of the 5 runs recorded were chosen for final analysis on the basis 
on minimal hesitation while crossing. The videos were then analysed frame by 
frame using the GOM Media Player software (version 2.2.64). The paw placement 
was carefully observed in each frame and recorded for different errors and 
normal placements. Characteristics of different steps used are summarized in 
Table 3-1. These characteristics are also shown in Figure 3-5.  
The characteristics of paw placements in the ladder walk test are categorised 
as: 
A) Hit: when rat completed the step using the plantar surface of the paw to 
weight-bear while crossing the ladder and there was no disruption of gait. 
B) Sub-optimal: when rat used digits of the paw to bear weight while crossing 
the ladder and there was no disruption of gait.  
C) Slip: when rat placed paw on the rung and the paw then slipped off the rung 
leading to a disruption of gait.  
D) Miss: when the rats paw missed a rung and fell right through between the 
rungs and below their level, but without this leading to a time delay and without 
any disruption of gait. 
E) Clenched paw: when the rat completed the step using the dorsal surface of 
the clenched paw and did not fully bear weight on this limb. 
F) Partial step: when the rat positioned a paw on a rung and did not fully 
weight-bear on this limb before repositioning the paw on another rung.  
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The hit and sub-optimal categories of paw placement were considered normal 
steps while the slip, miss, clenched paw and partial step categories were 
considered errors.   
The number of errors and normal steps were counted for each animal and 
percentage errors for each limb calculated. The percentage errors for forelimbs 
and hindlimbs were averaged separately and expressed as forelimb or hindlimb 
errors.  
In addition, the time taken by the animal to cross the analysed area during each 
trial was calculated from the time difference between first and the last step 
within the analysed area. Stride frequency was calculated by counting the 
number of steps made during the time taken to cross the ladder.   
3.3.8 Electrophysiology   
3.3.8.1 Anaesthesia 
All the animals were anaesthetised with the same protocol as described in 
chapter 2. 
3.3.8.2 Preparatory surgery 
Preparatory surgery for electrophysiological assessment was the same as 
described previously in chapter 2. 
3.3.8.3 Recordings of cord dorsum potentials 
To assess spinal cord function in the vicinity of the lesion after transplantation 
of hESC-MSC or injection of media, CDPs evoked by stimulation of the radial 
nerve and CST within the pyramids were recorded using the same protocol as 
explained in chapter 2. The potentials were stored and analysed in similar 
manner as previously described in chapter 2. 
3.3.9 Perfusion fixation  
All the animals were perfusion-fixed at the end of the electrophysiology 
experiment as described in chapter 2. 
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3.3.10 Histological processing   
Approximately 6 mm of the spinal cord centred on the middle of the injury site 
was dissected out of each animal. The dissected cords were cut in the 
parasagittal plane to preserve information on the extent of the injury site. 
Blocks were cut into 60 µm sections and processed as described in chapter 2. 
Sections were incubated with different combinations of anti-GFP (1:1000), anti-
GFAP (1:1000), anti-NF200 (1:1000), anti-Laminin (1:100), anti-NeuN (1:1000), 
anti-nestin (1:400) and anti-CASPR(1:500) primary antibodies to label 
transplanted cells, astrocytes, axons, basal lamina, neuronal nuclei and 
paranodal junctions respectively. Appropriate species specific antibodies 
conjugated to flourophores (Alexa 488 (1:500), Rhodamine (1:100) and DL649 
(1:500)) were used to label the specific primary antibodies.  
3.3.11 Microscopy   
The sections were examined using epiflourescence and confocal microscopy in a 
similar manner to that described previously in chapter 2. The only difference 
was the use of 3 channels for the confocal scanning at wavelength of 488 nm 
(Alexa 488), 561 nm (Rhodamine) and 633 nm (DL649).   
3.3.12 Measurement of the injury cavity size 
In order to quantify the injury dimensions of the transplanted and control 
animals at 7 weeks post-transplant or medium injection respectively, all sections 
from each animal were examined using a fluorescence microscope. The section 
from the middle (near the midline) with the largest injury cavity in control 
animals and the largest injury site as judged by the glial scar in case of the 
transplanted animals was selected for confocal imaging. The section chosen was 
scanned as a tiled scan at 4X magnification through 2-3 z sections.  The length of 
the injury cavity/site was then calculated using photoshop software with a 
known scale factor. The rostral and caudal margins of the injury site were 
judged by GFAP immunolabelling and lack of normal tissue integrity and the 
measurement was carried out using a ruler tool in photoshop. This length was 
multiplied by the scale factor to determine the extent of the cavity. In addition, 
the width of cavity was calculated by counting the number of sagittal sections 
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where the injury tissue was observed and then multiply this by 60 µm, the 
section thickness.  
3.3.13 Off-line analysis of CDPs   
Off-line analysis of electrophysiological recordings was performed as explained 
in chapter 2. 
3.3.14 Statistical analysis 
Statistical analysis was performed using Graph Pad Prism software version 4.0. 
Results from the grip strength test and horizontal ladder test from each week 
were analysed using two-way ANOVA and Bonferroni post hoc analysis. 
Electrophysiological data from all recording locations for both the radial nerve 
and pyramidal evoked CDPs in control and transplanted groups was also analysed 
using 2-way ANOVA and Bon-ferroni post hoc tests. A paired students t-test was 
applied to compare the cavity length and width between transplanted and 
control animals. 
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Type of Step Characteristics Normal or Error 
Hit 
Completes the step using optimal 
paw position, no disruption of gait 
Normal 
Sub-optimal 
Completes the step using digits for 
weight-bearing, no disruption of gait 
Normal 
Slip 
Places paw on the rung then slips 
off, gait disrupted 
Error 
Miss 
Paw misses a rung and falls right 
through, no time delay 
Error 
Clenched paw 
Completes the step using clenched 
paw, no disruption of gait 
Error 
Partial step 
Positions paw on a rung, does not 
fully weight-bear on this limb and  
repositions paw on another rung  
Error 
Table 3-1. Classification scheme used to define step types made during the ladder rung 
walking test.  
Each step was classified as one of six categories, based on the characteristics observed during 
frame-by-frame analysis. Hit and sub-optimal were categorised as ‘normal’, whereas slip, miss, 
clenched paw and partial step were counted as ‘errors’.  
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Figure 3-1. Schematic diagram summarising the experimental design.  
Schematic diagram to show the overall plan of the experiment. The timing of individual 
experimental procedure is indicated relative to the contusion injury (Week 0). Behavioural testing 
was carried out 2 weeks before the injury to 9 weeks post injury. Cyclosporin injections were 
started 2 days before hESC-MSC tranplants or medium injection (3 weeks post injury). 
Electrophysiology and perfusion were performed 10 weeks post injury.  
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Figure 3-2. The grip strength meter (GSM) (Andilog, Centor v3.22) apparatus.  
The figure shows different parts of the GSM apparatus. The GSM apparatus is fixed firmly to the 
edge of the table with the help of clamps. The animal grips the force sensor bar with both forepaws. 
Force applied to the force sensor bar is recorded and displayed on the screen of the apparatus.  
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Figure 3-3. Images showing animal gripping the force sensor bar of the GSM apparatus.  
The animal is placed so that it grips the bar and then pulled back by the tail in hanging position 
(upper image). The lower image shows the position of both forepaws gripping the sensor bar while 
force generated is displayed on the screen. The animal is retracted away from the apparatus 
generating maximum force until the grip is broken and the bar released.    
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Figure 3-4. Horizontal ladder walk apparatus.  
Image showing the setup of the ladder apparatus (upper image) and the analysis area with 
irregular rung spacing (lower image) for the ladder walk test. The ladder apparatus is placed on a 
stand so that the ladder is suspended above the table. The area analysed lies in the middle part of 
the ladder and is setup with irregular rung spacing (lower image) ranging from 1 to 3 cm. Plastic 
walls are present on both sides of the ladder. The animal is placed between them on the left side to 
cross the ladder. The home cage is placed at the other end of the ladder. A camera is placed on a 
tripod level with the ladder in order to videotape the animals in the analysis area (with irregular rung 
spacing).    
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Figure 3-5. Categorization of paw placement in horizontal ladder walk test.  
Images showing the different types of placement of the forepaws seen while animals cross the 
ladder. Paw positions were categorized as either normal (A, B) or errors (C, D, E, F). A. Hit: The 
animal completes the step using optimal paw position with the digits gripping around the rung. B. 
Sub-optimal: The animal completes the step using digits for weight-bearing. C. Slip: The animal 
places forepaw on the rung then slips off. D. Miss: The animals forepaw misses a rung and falls 
right through. E. Clenched: The animal forepaw completes the step using its clenched paw and the 
dorsal aspect in contact with the ladder. F. Partial: The animal places forepaw on rung but did not 
fully bear weight on this limb before repositioning on another rung. 
  
Chapter 3  199 
 
3.4 Results  
3.4.1 Assignment of animals to hESC-MSC transplanted and 
control groups   
In order to investigate whether hESC-MSC transplants improve functional 
outcome, 48 animals were trained to perform the grip strength and ladder 
walking tests. All of these animals received 175 kdyn contusion injuries at the C6 
level of the spinal cord. One animal did not recover from this operation. One 
week before the transplantation surgery animals were assigned to the transplant 
or control groups on the basis of the grip strength score. The grip strength scores 
at 2 weeks after injury were plotted in descending order and the first 36 animals 
out of the 47 (i.e. those with the highest grip strength score) were divided 
equally into the transplant and control groups. However, after the transplants 1 
animal in the transplant group died post operatively. One more transplanted 
animal and 2 control animals were euthanized in the course of the study due to 
autotomy of a paw. The remaining 16 transplanted animals and 16 control 
animals completed the behavioural assessments up to 9 weeks after the injury. 
One of the transplanted animals and 3 of the control animals died during the 
preparatory surgery for electrophysiological experiments. In addition, injuries 
were found to be erroneously located rostral to the C6 segment in 3 control 
animals and these were therefore excluded from the study. Electrophysiological 
data was therefore obtained from 15 transplanted and 10 control animals. 
Although 16 transplanted and 16 control animals completed behavioural 
assessment, the 3 control animals which were found to have an incorrect injury 
level were not included in the analysis. Therefore behavioural data for the 
ladder walking test was based on 16 transplanted and 13 control animals. For the 
ladder walking test for most time points data was obtained from all animals, 
however, the exceptions were one animal at the pre-operative time point and 
two animals at 1 week after transplantation, where no data could be obtained. 
Although all 16 transplanted and 13 control animals were subjected to the grip 
strength test at each time point, at most time points 3 animals in the transplant 
group were unable to perform the test and these are not included in the final 
analysis. Therefore the data for the grip strength test was based on 13 
transplanted and 13 control animals. It is impossible to be blinded because of 
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the effect of the injury and the surgical site is exposed at the time of 
electrophysiology experiment.  
Retrospectively the injury parameters from the IHI software recorded at the 
time of the contusion injury were graphed for comparison between the two 
groups. These recordings were used to confirm that animals assigned to each 
group (transplant and control) received similar injuries. Graphs showing these 
comparisons for actual force and displacement are shown in Figure 3-6 and 
Figure 3-7 respectively. Figure 3-8 shows comparisons of body weights of animals 
at the time of the contusion injury, transplant/medium injections and 
electrophysiological experiments for both groups. The weights in both animal 
groups were closely similar at the time of the contusion injury, so that they 
would have similar sized cords and therefore be similarly affected by the injury. 
The weights at the time of electrophysiology were also closely similar and 
therefore the electrophysiological data was obtained in similarly sized animals 
for both groups. 
In addition, to improve the survival of the transplanted cells, animals were 
immunosuppressed with daily injections of Cyclosporine at a dose of 20 mg/kg 
body weight. Therefore, for optimisation purposes the same daily dose of 
Cyclosporine was given to the control animals.  
Monitoring and minimising any differences in variables such as weight, injury 
severity or behavioural performance between the transplanted and control 
groups of animals should mean that any changes in functional outcome between 
the groups can more confidently be attributed to the hESC-MSC transplants.  
3.4.2 Behavioural testing   
3.4.2.1 Grip strength test 
All thirteen hESC-MSC transplanted and thirteen control animals included were 
able to perform the grip strength test before the contusion injury. The grip 
strength test was performed on a weekly basis and scores were calculated as the 
ratio of maximum force (g) generated by the animal to its weight (g). 
Comparison of the grip strength scores for the transplanted and control groups of 
animals for each week of testing are shown in Figure 3-9. 
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3.4.2.1.1 Assessment of grip strength score prior to contusion injury 
Normal animals can generate a force of around 3-4 times their body weight with 
the forelimbs. Before the contusion injury, the mean grip strength score was 
approximately 3.6 in animals assigned to both transplant and control groups.   
3.4.2.1.2 Effects of contusion injury on grip strength score  
Contusion injury lead to a significant decline in the grip strength score in all 
animals tested one week after the injury. The mean grip strength score reduced 
to 2.1 in both groups of animals which represents a marked reduction in the 
gripping ability immediately after the injury. There was a modest improvement 
at 2 weeks after the injury with mean scores increasing to about 2.65 in both 
groups. However, this improvement did not persist and there was a decline in 
mean grip strength score at 3 weeks in both transplant and control groups. At 
this point animals were assigned to control or transplant groups on the basis of 
their grip strength score as described above.   
3.4.2.1.3 Effects of the delayed hESC-MSC transplants or medium injections 
on grip strength score  
hESC transplants or medium injections were performed 3 weeks after the 
contusion injury. Grip strength measurements were obtained 1 week after the 
transplants/medium injections i.e. 4 weeks after injury. At week 4 there was a 
modest decline in the grip strength score in the transplanted animals in 
comparison to scores observed before transplantations, the mean score reduced 
to 2.09 from 2.23 observed at week 3 (Figure 3-9). In contrast the mean score in 
the control animals improved to 2.6 after medium injections suggesting that the 
surgery itself might have no detrimental effect on the gripping ability of the 
animals. At week 5 the grip strength score showed improvement in both the 
transplanted and control groups, however, the mean values in the transplanted 
(2.5) animals were still smaller than controls (2.95). Grip strength in 
transplanted animals showed further improvement at week 6 with mean scores 
rising to 2.85, a score comparable to controls (2.86) at this time point. However, 
testing performed at week 7 and 8 showed that the improvement was not 
consistent as the mean grip strength score in both transplanted and control 
groups declined again to between 2.39-2.59. At the last assessment point i.e. 
week 9 the grip strength score again showed enhancements in gripping ability in 
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both groups and was comparable to the mean score at week 6. There was no 
statistically significant difference between the transplanted and control groups 
at any time after the transplantations/medium injections. 
This shows that the grip strength after the contusion injury shows moderate 
spontaneous improvement with time but that a significant functional deficit 
persists. No functional enhancements in the hESC-MSC transplanted group were 
observed in the grip strength test over the 6 weeks examined after the 
transplantations.  
3.4.2.2 Ladder walk test 
The ladder walk test was performed weekly and useful data was obtained from 
16 transplanted and 13 control animals. Forelimb and hindlimb function were 
assessed by counting the number of errors as described previously in the Methods 
and expressed as a percentage of the total steps taken. Stride frequency and 
crossing time for individual animals were also calculated as described previously.  
3.4.2.3 Assessment of the forelimb in ladder walk test 
Figure 3-10 shows a comparison of forelimb errors in the transplant and control 
group of animals for ladder testing performed each week. 
3.4.2.3.1 Assessment of forelimb function in ladder walk test prior to 
contusion injury 
All sixteen animals subsequently transplanted and all but one of the thirteen 
control animals performed the ladder walk test prior to injury, making very few 
errors in forelimb stepping and crossing the ladder with minimal hesitation. The 
forelimb errors in the animals assigned to the transplant and control groups were 
closely similar with mean errors of 16.79 % and 16.44 % respectively.  
3.4.2.3.2 Assessment of forelimb function in ladder walk test after contusion 
injury 
Contusion injury had a substantial effect on forelimb function in the ladder test. 
The mean errors significantly increased 1 week after the injury in all the animals 
assigned to transplant and control groups, however all animals were able to 
cross the ladder. Mean forelimb error rate increased by approximately 20 % in 
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both groups, the mean error rate rising to 36.3 in the transplant and 35.2 in 
control group of animals. The deficit in the forelimbs improved by approximately 
6 % at week 2 in both groups but a modest increase in errors was observed in the 
animals assigned to the transplant group at 3 weeks compared to the control 
group. However, there was no significant difference in scores of transplant and 
control groups of animals at either time point (two-way ANOVA with post hoc 
bonferroni tests).  
3.4.2.3.3 Effects of delayed hESC-MSC transplants or medium injections on 
forelimb function in ladder walk test  
hESC transplants or medium injections were performed 3 weeks after the 
contusion injury and ladder walk test data obtained 1 week after this i.e. week 4 
after injury. Two animals were unable to perform the test at this time point. 
Compared to the errors before the transplant/medium injections, a modest 
increase in errors by a further 3 % and 7 % was observed in the transplanted and 
control groups of animals, respectively (Figure 3-10). This deterioration of 
forelimb function may relate to the transplant/medium injection surgery 
procedure leading to a slight detrimental effect as also observed for 
transplanted animals in the grip strength test. At week 5 and 6 after injury a 
trend towards improved forelimb function was observed in both groups. There 
was a modest reduction in errors by approximately 7 % in the transplanted and 3 
% in control groups of animals at week 6 compared to those at week 4 after 
injury. However, this trend was not consistent. At the last assessment, 9 weeks 
after injury, deficits persisted in the forelimbs for both groups to a similar 
extent. There were no significant differences between the forelimb errors in the 
transplanted and control groups of animals at any time point after 
transplant/medium injection (2-way ANOVA and Bonferroni post-hoc analysis). 
These results show that forelimb function decreases markedly after contusion 
injury with modest spontaneous recovery with time. However, a significant 
functional deficit persists for up to 9 weeks after the injury and hESC-MSC 
transplants did not improve forelimb function. 
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3.4.2.4 Assessment of the hindlimb in ladder walk test 
Figure 3-11 shows a comparison of hindlimb errors in the transplant and control 
groups of animals for ladder testing performed each week. In non-injured 
animals the errors were trivial in the hindlimbs in comparison to those observed 
in the forelimbs. The mean scores in animals assigned to the transplant and 
control groups were very similar before injury and were 2.47 and 3.48 
respectively. The errors remained almost similar throughout the experiment 
suggesting the hindlimbs are not affected by the injury and that the modest and 
variable trend for increased errors after injury may be secondary to errors 
observed in the forelimbs.  
3.4.2.5 Crossing time 
The time taken by animals to cross the analysis area (area with irregular rung 
spacing) was calculated for each trial and averaged to obtain the mean crossing 
time. Figure 3-12 shows a comparison of mean crossing time in the transplant 
and control groups of animals for ladder testing performed each week.  
All animals were able to cross the ladder rapidly without any hesitation and 
delay prior to the contusion injury. The mean time for crossing the 40 cm 
analysis area before the injury was 2.47 seconds for animals assigned to the 
transplant and 2.20 seconds for the control group. One week after the injury 
some of the animals were hesitant or slow to walk, however, all were able to 
cross the ladder. The mean crossing time increased to more than twice that seen 
before the injury in both the transplant (5.23 sec) and the control (5.22 sec) 
groups of animals (Figure 3-12). The crossing time fluctuated but remained 
nearly constant around a mean of 5 seconds throughout the remainder of the 
experiment in both groups. The crossing time was also not affected after the 
hESC-MSC transplants or medium injections performed at 3 weeks.   
3.4.2.6 Stride frequency  
Stride frequency is a measure of the average number of forelimb or hindlimb 
steps taken per unit time. Changes in the stride frequency were calculated 
separately for forelimbs and hindlimbs. Figure 3-13 shows a comparison of 
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forelimb and hindlimb stride frequency in transplant and control groups of 
animals for ladder testing performed each week.   
In normal (non-injured) animals the mean forelimb stride frequency was 
approximately 4 steps/sec in animals assigned to transplant and control groups 
of animals. The forelimb stride frequency declined significantly after the injury 
to a mean of approximately 3 steps/sec in both groups of animals. There was a 
tendency for a further gradual decline over the remainder of the experiment and 
this was approximately similar for transplant and control groups of animals. 
From week 3 till the last assessment time point at week 9 after injury the mean 
stride frequency was between 2.1 and 2.6 steps/sec. There was no difference in 
the hESC-MSC transplanted or control groups of animals (2-way ANOVA and 
Bonferroni post-hoc analysis). 
The hindlimb stride frequency was around 3.0-3.5 steps/sec in normal animals 
(similar to the forelimb) and dropped significantly after injury to a mean of 
approximately 1.5 steps/sec. Thereafter the hindlimb stride frequency remained 
closely similar to this over the rest of the post-injury period and there were no 
significant difference in the transplant and control groups of animals at any time 
point (2-way ANOVA and Bonferroni post-hoc analysis). 
Figure 3-14 shows a comparison of the number of forelimb and hindlimb steps 
taken to cross the ladder in transplant and control groups of animals for tests 
performed each week. In normal animals the forelimb and hindlimb steps were 
approximately 4.7 steps/run and 3.8 steps/run respectively. Immediately after 
the injury the average number of forelimb steps taken significantly increased 
while the number of hindlimb steps did not change. There was modest reduction 
in the number of forelimb steps at 2 weeks after injury which remained similar 
throughout the remainder of the experiment. There was no significant 
difference between transplant and control groups of animals at any time point. 
Stride frequency provides a measure of the degree of co-ordination between 
forelimbs and hindlimbs. Stride frequency is closely similar for forelimbs and 
hindlimbs before the injury. That is to say, the forelimbs and hindlimbs are co-
ordinated. Injury causes lack of co-ordination between the forelimbs and 
hindlimbs. 
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Despite the increase in the number of forelimb steps accompanying the increase 
in crossing time, there is also a decrease in stride frequency or a decrease in the 
number of steps per unit time. The increase in the crossing time was 
approximately 220 % after injury and therefore the expected decrease in stride 
frequency would be to 45 % of that observed before the injury (i.e 1.8 steps/sec 
for the forelimbs and 1.4 steps/sec for the hindlimbs) as the crossing distance is 
fixed. The decrease in stride frequency for the forelimbs is 3 steps/sec (down to 
75 % of that before injury) which is not actually as much as expected (1.8 
steps/sec) given the increase in crossing time. The decrease in stride frequency 
for the hindlimbs is 1.5 steps/sec approximately as expected (i.e. 1.4 steps/sec) 
given the increase in crossing time. This can be observed in the graph showing 
forelimb and hindlimb stride frequency. 
The number of steps taken by the forelimbs and hindlimbs before the injury are 
approximately the same as expected for co-ordinated forelimb and hindlimb 
stepping, so step length should also be similar. The step length in the hindlimb 
does not change because the number of steps in crossing the fixed distance does 
not change before and after the injury, however, it decreases for the forelimbs 
as the number of steps made by forelimbs in crossing the same area increased 
after injury. 
There is a small reduction in the discoordination at 2 weeks after injury but in 
general there is a little change for the remainder of the study. None of the 
parameters differs significantly at any stage between control and transplanted 
animals (2-way ANOVA and Bonferroni post-hoc analysis).  
3.4.3 Electrophysiological assessment of local circuit function of 
the spinal cord in the hESC-MSC transplanted animals  
CDPs evoked by stimulating the radial nerve and pyramidal tract were used to 
assess function in the local grey matter of the spinal cord as described in the 
previous chapter (chapter 2). The electrophysiological data included recordings 
from 15 animals transplanted with hESC-MSCs and 10 medium injected control 
animals. The electrophysiological assessments were carried 10 weeks after the 
contusion injury with transplantation or medium injections performed 3 weeks 
after the injury. 
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3.4.3.1 hESC-MSC transplants and their effects on radial nerve evoked CDPs  
CDPs evoked by radial nerve stimulation were recorded with a sliver ball 
electrode on the dorsal surface of the spinal cord at 1 mm intervals from 8 mm 
rostral to 8 mm caudal to the C5/6 border as described in chapter 2 in both the 
transplanted and control groups of animals. Figure 3-15 shows a comparison of 
the rostro-caudal distribution of CDPs recorded from the transplanted and 
control groups of animals.  
Contusion injury at the C6 level produces a marked reduction in the amplitudes 
of CDPs centred on the contusion site due to loss of neurons in the grey matter 
and their input connections as described previously in chapter 2 and this takes 
the form of a dip in the CDP distribution localised to the injury site as shown in 
Figure 3-15. The CDP mappings show no difference in the amplitudes at most of 
the recording locations in the transplanted and control group of animals except 
at the most caudal end i.e. -6 mm to -8 mm, where amplitudes in the 
transplanted animals were comparatively smaller. However, there were no 
significant differences at any recording location from +8 to -8 which suggest 
hESC-MSC transplantations have no effect on radial evoked CDPs after injury.  
3.4.3.2 hESC-MSC transplants and their effects on pyramidal evoked CDPs  
CDPs evoked by pyramidal stimulation were recorded at 1 mm intervals from 8 
mm rostral to 8 mm caudal to the C5/6 border, in both the transplanted and 
control group of animals (as described in chapter 2). The rostro-caudal 
distribution of pyramidal evoked CDPs in the transplanted and control groups of 
animals is shown in Figure 3-16.  
The general distribution showed the same pattern in transplanted and control 
groups of animals. The CDPs show greater amplitudes at locations above the 
C5/6 border and markedly smaller amplitudes below the C5/6 border which is 
caused by damage to the main CST located in the dorsal column as described in 
chapter 2. However, CDPs at most of the recording locations were larger in 
amplitude in the control group of animals compared to transplanted animals. 
The CDPs rostral to the C5/6 border i.e. from +8 to +1, show significantly higher 
amplitudes, which may be improvements of connections in the grey matter in 
the control group of animals or in contrast, greater deterioration of connections 
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in the transplanted animals. In addition, CDP amplitudes below the injury (-3 
mm to -8 mm) were also greater in the control group of animals compared to the 
transplanted animals, although this difference was non-significant. CDP 
comparisons in the transplanted and control animals suggest transplanted cells 
have some unfavourable effect on the CST fibres which may be responsible for 
the reduction in the CDP amplitudes.     
3.4.4 Histology 
3.4.4.1 Injury site 3 weeks after contusion  
Three animals were perfused 3 weeks after injury and spinal blocks containing 
the injury site were removed in order to assess the injury site at the time of 
transplantation. Examples of histology from the injury site are shown in Figure 
3-17. The injury site showed cavities which encompassed large parts of both 
white and grey matter. Sometimes these consisted of more than one fluid filled 
cavities and sometimes these were partly filled with laminin. A glial scar formed 
around the cavities with dense GFAP immunolabelling observed at the injury 
perimeters compared to areas beyond the injury. 
3.4.4.2 Injury site 7 weeks after hESC-MSC transplants 
Spinal cord blocks containing the injury site were removed from twelve animals 
transplanted with hESC-MSCs and processed for anatomical observations. Figure 
3-18 shows examples of the GFP-labelled hESC-MSCs at the injury site 7 weeks 
after transplantation. Sections from all the transplanted animals showed the 
presence of GFP-labelled cells at the injury site. The distribution of cells was 
variable. In some animals cells were spread throughout the whole of the injury 
area (Figure 3-18B & C) while in other animals surviving cells occupied only part 
of the injury site (Figure 3-18A). However, none of the animals had injury 
cavities. In all animals either transplanted cells or a mixture of cells and 
extracellular matrix (ECM) completely fill the injury site. In a few sections 
transplanted cells were seen beyond the injury site. In areas outside the injury 
site where transplanted cells were observed, GFAP immunolabelling was largely 
absent suggesting neuropil loss at sites where hESC-MSCs migrated.   
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3.4.4.3 Injury site 7 weeks after medium injection  
Spinal cord blocks from nine control animals injected with medium were 
removed and processed for comparison with transplanted animals. Examples of 
histology from medium injected control animals is shown in Figure 3-19. Section 
from all control animals showed extensive cavities and these encompassed large 
parts of both white and grey matter, particularly in the sections close to the 
midline where the cavity is greatest in extent. In some cases cavities partially 
filled with ECM, which was rich in laminin (Figure 3-19A & C). A glial scar was 
formed around the cavities as indicated by denser GFAP immunolabelling. 
3.4.5 Injury cavity size of hESC-MSC transplant and medium 
injection 
To study the effects of hESC-MSCs on the morphology of the contusion injury, 
the injury site/cavity dimensions were calculated in all animals processed for 
histology in the transplanted (n=12) and control (n=9) groups of animals. Cavity 
length and width were determined as described previously in Methods. The data 
is shown in Table 3-2 and Table 3-3 for transplanted and control groups of 
animals, respectively. Figure 3-20 shows a graphical comparison of injury extent 
in both groups of animals. The rostro-caudal length of the injury site was less in 
the transplanted animals than in the non-transplanted control animals and the 
difference was highly significant (p < 0.001). The width of the injury was also 
reduced in the transplanted animals and this also reduced significantly (p < 
0.05). The reduction in extent of the injury site suggests that hESC-MSC 
transplants help preserve surrounding tissue and this may be attributed to the 
neuroprotective nature of MSCs as reported in literature. 
3.4.6 Acute transplants 
As described above, transplants of hESC-derived MSCs performed 3 weeks after 
injury had no observable beneficial effect on functional outcome. Since one 
possible reason for this is that transplants are performed too late after the 
injury to be effective, we performed additional experiments with transplants at 
earlier time point to determine how well the cells survive and to examine the 
histological appearance of the injury site.  
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3.4.6.1 Injury site at 5 and 7 days after injury   
In order to assess the nature of the injury site at the time points when acute 
hESC-MSC transplants were performed, 3 animals were perfused at 5 days after 
injury and 3 animals 7 days after injury and spinal blocks containing the injury 
site were removed and processed. Figure 3-21 shows examples of injury site 
histology from these animals.  
Tissue sections at 5 days after the injury showed extensive damage extending 
several mm from the centre in both rostral and caudal directions. Some loss of 
tissue at the core of the sections may be due to badly disrupted tissue that is 
lost during processing as shown in Figure 3-21(A). Similarly the injury site in 7 
day survival animals showed widespread damage and a modest increase in GFAP 
immunolabelling around the injury perimeter suggesting initiation of cavity 
formation as shown in Figure 3-21(B).   
3.4.6.2 Acute hESC-MSC transplantation at 5 and 7 days 
Three animals transplanted 5 days after injury were perfused three weeks after 
transplantation and spinal cord blocks containing the injury site were removed 
and processed as described in Methods. Examples of injury site in animals 
transplanted at 5 days after injury are shown in Figure 3-22.  
There were no evidence of cavities and all of the sections containing the injury 
site were filled with ECM and transplanted cells, usually a mixture of both but 
predominantly ECM in sections passing through the middle of the injury. 
Although there was evidence of cell survival cells did not extend throughout the 
whole of the injury site. Most of the cells were found at the lateral edges of the 
injury particularly in those sections passing through the very centre of the 
injury. For sections passing through more lateral aspects of the injury where the 
injury site is therefore smaller, a larger proportion of the injury area is occupied 
by transplanted cells. Area of the injury in the transplanted injury site was 
largely devoid of GFAP immunlabelling and in some sections particularly those 
near the midline where transplanted cells have tracked rostrally or caudally, 
GFAP is largely absent. This displacement of the host astrocytes suggest 
transplanted cells causing neuropil disintegration.  
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Three animals transplanted at 7 days after injury were perfused 3 weeks after 
transplantation and spinal cord containing the injury site processed for 
histology. Examples of injury site histology are shown in Figure 3-23. The main 
features of the injury site were generally similar to those observed for 
transplantations performed 5 days after injury. The transplanted injury site was 
noticeably devoid of GFAP immunolabelling. GFP labelled cells were present 
mainly at the rostral and caudal end of the injury but the larger part of the 
injury was filled with matrix. There was no evidence of cavities and in some 
cells had tracked rostrally and caudally leading to the displacement of glia in 
those regions. In more lateral sections a larger proportion of the injury site 
contained transplanted cells, reflecting the tendency for cells to survive better 
at the perimeter of the injury. 
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Animal ID Length (mm) Width (mm) 
R19013 2.728 1.26 
R19113 1.899 1.02 
R18413 2.747 1.2 
R9713 2.718 1.5 
R10713 2.33 1.44 
R10313 2.907 1.8 
R10113 2.921 1.98 
R10913 2.896 1.44 
R26013 2.607 1.92 
R26313 2.671 1.86 
R27013 2.187 1.86 
R27113 3.031 1.56 
Mean  2.637 1.57 
Table 3-2. Table showing injury site/cavity dimensions in transplanted animals. 
Quantification of the maximal length and width of injury area in individual animals in hESC-MSC 
transplants group.   
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Animal ID Length (mm) Width (mm) 
R26213 3.306 2.34 
R26413 3.3 2.04 
R26513 3.982 1.92 
R11113 4.047 1.92 
R11213 3.587 1.92 
R18513 3.252 1.98 
R18713 3.672 1.98 
R26813 3.509 2.04 
R9913 3.192 1.68 
Mean  3.539 1.98 
Table 3-3. Table showing injury site/cavity dimensions in control animals. 
Quantification of the maximal length and width of injury area in individual animals in control group  
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Figure 3-6. Comparison of actual contusion injury force in transplanted and control groups 
of animals.  
Scatter plot showing the actual force applied by the IH impactor set to deliver 175 kdyn force. 
There was no significant difference between the mean force for any of the groups (students t-test). 
Horizontal bars represent the mean force in each group.   
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Figure 3-7. Comparison of actual cord displacement as a result of 175 kdyn contusion injury 
in transplanted and control animals.  
Scatter plot showing the displacement of the impactor tip into the cord tissue from the surface. 
There was no significant difference between the mean displacement for any of the groups 
(students t-test). Horizontal bars represent the mean force in each group. 
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Figure 3-8. Comparison of individual body weights of transplanted and control animals at 
different points in the study. 
Scatter plot showing body weights of individual animals in hESC-MSC transplanted and medium 
control group of animals at the time of contusion injury, cells/medium injection and 
electrophysiology experiments. Horizontal bars represent the mean weight. There was no 
significant difference between the mean weights of transplanted and control animals at any point 
(students t-test, p>0.05 at all points).  
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Figure 3-9. Comparison of grip strength scores for transplanted and control animals. 
Plots of grip strength for hESC-MSCs transplanted (red) and medium injected control (blue) group 
of animals. Grip strength is plotted as a ratio of force to body weight. Each data point is the mean 
score for all animals in the group tested in each week. Error bars represent the standard errors of 
the mean (Fujimoto et al.) within the group. There was no significant difference between the groups 
at any point (2-way ANOVA with Bon-ferroni post hoc analysis, all p values > 0.05). n=13 in 
transplants except week 5 (n=12) and n=13 in controls except week 1 (n=12).  
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Figure 3-10. Comparison of forelimb errors in ladder walk test for transplanted and control 
animals. 
Plots of forelimb errors for hESC-MSCs transplanted (red) and medium injected control (blue) 
group of animals. Forelimb errors are plotted as a percentage of the total number of steps. Each 
data point is the mean of all forelimb errors for all animals in the group tested each week. Error 
bars represent the standard errors of the mean (Fujimoto et al.) within the group. There was no 
significant difference between the groups at any point (2-way ANOVA with Bon-ferroni post hoc 
analysis, all p values > 0.05). n=16 in transplants except week 4 (n=14) and n=13 in controls 
except pre-op (n=12).  
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Figure 3-11. Comparison of hindlimb errors in ladder walk test for transplanted and control 
animals. 
Plots of hindlimb errors for hESC-MSCs transplanted (red) and medium injected control (blue) 
groups of animals. Hindlimb errors are plotted as a percentage of the total number of steps. Each 
data point is the mean of all hindlimb errors for all animals in the group tested in each week. Error 
bars represent the standard errors of the mean (Fujimoto et al.) within the group. There was no 
significant difference between the groups at any point (2-way ANOVA with Bon-ferroni post hoc 
analysis, all p values > 0.05). n=16 in transplants except week 4 (n=14) and n=13 in controls 
except pre-op (n=12).  
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Figure 3-12. Comparison of crossing time in ladder walk test for transplanted and control 
animals. 
Plots of crossing time for hESC-MSCs transplanted (red) and medium injected control (blue) 
groups of animals. Crossing time is plotted as the average time taken by to cross the analysis area 
of the ladder. Each data point is the mean crossing time for all animals in the group tested in each 
week. Error bars represent the standard errors of the mean (Fujimoto et al.) within the group. There 
was no significant difference between the groups at any point (2-way ANOVA with Bon-ferroni post 
hoc analysis, all p values > 0.05). n=16 in transplants except week 4 (n=14) and n=13 in controls 
except pre-op (n=12). 
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Figure 3-13. Comparison of stride frequency in ladder walk test for transplanted and control 
animals. 
Plots of forelimb and hindlimb stride frequency for hESC-MSCs transplanted (red) and medium 
injected control (blue) groups of animals. Stride frequency is plotted as the number of steps per unit 
time (sec). Each data point is the mean stride frequency for all animals in the group tested in each 
week. Error bars represent the standard errors of the mean (Fujimoto et al.) within the group. There 
was no significant difference between the groups at any point (2-way ANOVA with Bon-ferroni post 
hoc analysis, all p values > 0.05). n=16 in transplants except week 4 (n=14) and n=13 in controls 
except pre-op (n=12). 
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Figure 3-14. Comparison of number of steps in ladder walk test for transplanted and control 
animals. 
Plots of average number of forelimb and hindlimb steps for hESC-MSCs transplanted (red) and 
medium injected control (blue) groups of animals. Number of steps is plotted as average number of 
steps per run. Each data point is the mean steps for all animals in the group tested in each week. 
Error bars represent the standard errors of the mean (Fujimoto et al.) within the group. There was 
no significant difference between the groups at any point (2-way ANOVA with Bon-ferroni post hoc 
analysis, all p values > 0.05). n=16 in transplants except week 4 (n=14) and n=13 in controls 
except pre-op (n=12).  
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Figure 3-15. Amplitudes of radial nerve evoked CDPs recorded in transplanted and control 
animals. 
The plot shows a comparison of the amplitudes of CDPs recorded in hESC-MSCs transplanted and 
medium injected control groups of animals. Electrophysiological experiments were carried out 10 
weeks after injury (7 weeks after transplants/medium injections). Each data point is the mean CDP 
amplitude for all animals in the group. The contusion injury was carried out with the rostral edge of 
the impactor tip aligned with C5/6 border (0 mm). The recordings were made over the cervical 
spinal cord. Numbers on the x-axis represent the recording locations on the surface of the cord 
relative to C5/6 border (0 mm). Error bars represent the standard errors of the mean (Fujimoto et 
al.) within the group. There was no significant difference between the groups at any point (2-way 
ANOVA with Bon-ferroni post hoc analysis, all p values > 0.05).  
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Figure 3-16. Amplitudes of pyramidal evoked CDPs recorded in transplanted and control 
animals. 
The plot shows a comparison of the amplitudes of CDPs recorded in hESC-MSCs transplanted and 
medium injected control groups of animals. Electrophysiological experiments were carried out 10 
weeks after injury (7 weeks after transplants/medium injections). Each data point is the mean CDP 
amplitude for all animals in the group. The contusion injury was carried out with the rostral edge of 
the impactor tip aligned with C5/6 border (0 mm). The recordings were made over the cervical 
spinal cord. Numbers on the x-axis represent the recording locations on the surface on the cord 
relative to C5/6 border (0 mm). Error bars represent the standard errors of the mean (Fujimoto et 
al.) within the group. 2-way ANOVA with Bon-ferroni post hoc analysis was applied for statistical 
analysis (* p < 0.05, ** p < 0.01, *** p < 0.001). The error bars show +/- SEM. 
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Figure 3-17. Examples of Injury site at the time of delayed hESC-MSC transplants or medium 
injections into the spinal cord.  
The panels show confocal microscope images of the injury site 3 weeks after injury, the time point 
when transplants were performed. Each panel is an example obtained from a parasagittal section 
passing through the injury area close to the midline. Both panels (A-1 and A-2) show the 
distribution of GFAP (blue) immunolabelling. A-1 also shows NF 200 (red) and A-2 shows Laminin 
(red). The micrographs are projections of 7-9 optical sections and composed from multiple x20 
fields of view. All scale bars are 1 mm. 
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Figure 3-18. Examples of injury site histology from hESC-MSC transplanted animals.  
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The panels show confocal microscope images of the injury site 7 weeks after hESC-MSC 
transplants (10 weeks after injury). Each panel shows sections from a different animal. Transplants 
were performed 3 weeks after contusion injury. All images show the distribution of GFP-labelled 
hESC-MSCs (green). In addition, panel A also shows ED1 (red) and GFAP (blue) immunolabelling, 
panel B shows Nestin (red) and GFAP (blue) immunolabelling, panel C shows CASPR (blue) and 
NF 200 (red) immunolabelling and panel D shows NF-200 (red) and GFAP (blue) immunolabelling. 
The micrographs are projections of 7-9 optical sections and composed from multiple x20 fields of 
view. All scale bars are 1 mm. 
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Figure 3-19. Examples of injury site histology from medium injected control animals.  
The panels show confocal microscope images of the injury site 7 weeks after medium injections 
(10 weeks after injury). Each panel shows sections from a different animal. Medium injections were 
performed 3 weeks after contusion injury. Panel A shows GFAP (blue) and laminin (red) 
immunolabelling, panel B shows NenN (red) and GFAP (blue) immunolabelling and panel C shows 
Laminin (red) and GFAP (blue) immunolabelling. The micrographs are projections of 7-9 optical 
sections and composed from multiple x20 fields of view. All scale bars are 1 mm.  
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Figure 3-20. Comparison of injury dimensions in transplanted and control animals.  
The bar plot shows the total rostro-caudal (length) and lateral (width) extent of the injury site for 
hESC-MSCs transplanted (red) and medium injected control (blue) groups of animals. The injury 
site in transplanted animals was estimated with GFAP (glial scar) and GFP (transplanted cells) 
immunoreactivity. The injury site in medium injection animals was determined from the edge of the 
cavity which formed in these animals. Injury site length was measured directly from histological 
section while the width was estimated from the number of 60 µm thick sagittal sections containing 
injured tissue. The error bars represent the standard errors of the mean (Fujimoto et al.). Statistical 
analysis used was students t-test (* p < 0.05, *** p < 0.001).  
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Figure 3-21. Examples of injury site histology at the time of sub-acute transplantations.  
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The panels show confocal microscope images of the injury site 5 days (A-1 and A-2) and 7 days 
(B-1 and B-2) after injury. Each panel is an example obtained from a parasagittal section passing 
through the injury area close to the midline. The top two panels (A-1 and A-2) show sections from 
animal perfused 5 days after injury and the bottom two panels (B-1 and B-2) show sections from 
animal perfused 7 days after injury. Panels A-1 and A-2 show sections from the same animal (5 
day after injury), however, panels B1 and B-2 are from different animals (7 day after injury). All 
images show the distribution of GFAP immunolabelling (blue). A-1 and B-1 show NF 200 
immunolabelling in addition while A-2 and B-2 show laminin distribution. The micrographs are 
projections of 7-9 optical sections and composed from multiple x20 fields of view. All scale bars are 
1 mm.                                                                                                                                                                                                                                                                                                                  
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Figure 3-22. Examples of injury site histology from animals receiving sub-acute transplants 
(5 days after injury) of hESC-MSCs.  
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The panels show confocal microscope images of the injury site 3 weeks in a sub-acute transplant 
(5 days) of hESC-MSCs. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFP immunolabelling (green), GFAP (blue) and Laminin (red).  A-1 and B-1 are 
examples of injury site with cells from a parasagittal section close to the midline while A-2 and B-2 
are examples of injury site with cells from the lateral part of the injury. The micrographs are 
projections of 7-9 optical sections and composed from multiple x20 fields of view. All scale bars are 
1 mm.  
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Figure 3-23. Examples of injury site histology from animals receiving sub-acute transplants 
(7 days after injury) of hESC-MSCs.  
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The panels show confocal microscope images of the injury site 3 weeks after sub-acute transplants 
(7 days) of hESC-MSCs. The top two panels (A-1 and A-2) show sections from one animal and the 
bottom two panels (B-1 and B-2) show sections from a second animal. All images show the 
distribution of GFP immunolabelling (green), GFAP (blue) and Laminin (red).  A-1 and B-1 are 
examples of injury site with cells from a parasagittal section close to the midline while A-2 and B-2 
are examples of injury site with cells from the lateral part of the injury. The micrographs are 
projections of 7-9 optical sections and composed from multiple x20 fields of view. All scale bars are 
1 mm.  
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3.5 Discussion  
3.5.1 Rationale for using hESC-MSCs in SCI 
Mesenchymal stem cells (MSCs) from different sources have been reported to 
promote functional recovery in SCI. As well as the sources described previously 
MSCs can also be obtained from hESCs and have been successfully derived in our 
lab from a hESC line (Mohamad, 2014). This process of producing MSCs from 
hESCs was repeated several times and the quality of cells obtained were 
comparable within different sets of experiments, confirming these to be of 
consistent reproducibility. In addition, hESC-MSCs resembled adult bone marrow 
derived MSCs according to several criteria including morphology, plastic 
adherence, cell surface markers, gene expression and their ability to 
differentiate into osteoblasts and adipocytes. It has also been demonstrated that 
cryoprotection has minimal effect on the properties of these cells. The ability to 
generate a large amount of cells with a similar reproducible phenotype and 
minimal effect after cryoprotection on phenotypes indicates that these cells 
could be used as an “off the shelf” product for therapeutic interventions. 
These cells offer several advantages over adult sources as they can be prepared 
in larger quantities with more consistency than MSCs obtained from bone marrow 
and adipose tissues. Cells obtained from patients have been shown to vary in 
consistency, quality and therapeutic potential (Minaire et al., 1984, Wright et 
al., 2008). In addition, hESC-MSCs can be produced in large amounts without the 
need for an invasive procedure such as that required to obtain MSCs from the 
bone marrow. Furthermore, hESC-MSCs have been transplanted in animal models 
of SCI in our lab and have been shown to promote anatomical aspects of repair 
as already discussed. These morphological features of repair indicate that these 
cells might be able to improve function after SCI and we therefore transplanted 
them into a clinically relevant model to assess their therapeutic potentials using 
functional outcome measures.  
3.5.2 Injury model and dosing of hESC-MSCs  
The contusion injury model is considered to be a clinically relevant model and 
human SCI resulting from trauma is thought to show many of the same 
pathological mechanisms. Most SCIs now occur at the cervical level of the spinal 
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cord (Anderson, 2004). It is difficult to compare the time course of SCI in rodents 
to that in human clinical scenarios in terms of what should be considered an 
acute and what constitutes a chronic time point. However, in this study we have 
chosen a 3 week time point and consider this to represent a time point in the 
rodent model and comparable to a chronic injury in humans. Part of the 
justification for this is that findings from chapter 2 showed that function at the 
level of the spinal cord stabilizes by 2 weeks and a time point beyond 2 weeks 
might therefore be regarded as chronic. In clinical settings it will be difficult to 
intervene with any cellular therapy early after the injury due to associated co-
morbid injuries and it will be an advantage to delay transplantation in order to 
increase the survival of the transplanted cells by avoiding the period when the 
injury environment is most inhospitable in part due to the host immune 
response. It is therefore more feasible and advantageous to intervene at a 
chronic time point when the injury milieu has stabilised. It has been reported 
that transplantation performed sub-acutely is associated with better cell survival 
and improved functional outcome (Ankeny et al., 2004) and improvements in 
functional outcome have been reported in studies where transplantation was 
performed 3 months after contusion injury in rodents (Vaquero et al., 2006). 
Pal et al. (2010) found in a pre-clinical study of MSCs transplanted into a 
contusion injury that functional outcome is dose dependant, demonstrating 
better results in MSC transplants with larger numbers of injected cells (5 million 
cells/kg) compared to a smaller number of cells (2 million cells/kg) (Pal et al., 
2010). There is a large degree of biological variability in the morphology of 
injury cavities formed after contusion injuries. In part this is due to infilling by 
extracellular matrix which varies from animal to animal. In addition, previous 
studies of hESC-MSCs transplanted in vivo showed that they do not proliferate 
after transplantation. The variability in cavity formation combined with the lack 
of proliferation of the transplanted cells makes it difficult to optimise the dose 
of transplantations for all animals. In order to overcome this problem we used 
the approach of completely filling the injury cavity with cells. hESC-MSCs were 
injected into the injury cavity, until the cells were seen to overflow from the 
injection site. On average we would inject about 40 µl of cell suspension which 
would be around 8 million cells (200,000 cells/µl of suspension), into each 
animal. However, pressure injections of large volumes of cells in SCI models may 
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have a damaging effect because tissue tolerance may be exceeded by raised 
intraparenchymal pressure leading to hydrodynamic dissection and possible cord 
ischemia (Guest et al., 2011). We therefore observed the spinal cord during 
injection to see that there were no obvious signs of swelling or of reduced blood 
flow through pial blood vessels. The amount of cells used in our study represent 
quite a high dose compared to those used by others (e.g. 0.3 million cells; 
(Ankeny et al., 2004), 0.25 million cells; (Chopp et al., 2000), although these 
examples are for thoracic contusion injuries where cavities are probably smaller.  
3.5.3 Interpretation of behavioural assessments   
The first aim of the experiments reported in this chapter was to evaluate the 
functional outcome in terms of the behavioural assessment and correlate it with 
the electrophysiological findings. Previous transplantation studies have most 
commonly been carried out on thoracic injury models and most of the 
behavioural methods in use assess hindlimb function. Methods like the BBB 
scoring and open field locomotion are well recognised and widely used. In the 
case of cervical injuries and forelimb function assessments such as the forelimb 
locomotor scale (FLS) can be used as an alternative to BBB tests. It consists of an 
18 point scale from 0 to 17, 0 representing no movement of the forelimb and 17 
indicating continuous plantar stepping (Cao et al., 2008). However, previous 
findings in the lab using the cervical injury model suggested that rats recovered 
to pre-injury FLS scores within 3 weeks and therefore that this test does not 
show persistent functional deficits and might not be useful in the long term 
assessment of therapeutic effects (Ahmed et al. unpublished data). There are 
other tests to assess forelimb function such as pellet retrieval test (Metz and 
Whishaw, 2000), cylinder test (Liu et al., 1999) and sticker removal task 
(Schrimsher and Reier, 1992). However, the grip strength and ladder walk test 
provide a quantitative and convenient measure of the strength and co-ordination 
of the musculature of the digits and forelimbs. The grip strength and ladder walk 
test requires little expertise to perform and interpret the results. In addition, 
our injury model produces lesion of the main CST in the dorsal column and 
damage to CST has been reported to impair skilled motor movements such as the 
placing response and grasping movements of the distal forelimbs but does not 
affect the overall reaching ability of the proximal forelimb (Schrimsher and 
Reier, 1993, Whishaw et al., 1993). It has also been shown that when there is 
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damage to the main CST in the dorsal column there is no recovery of function in 
the digits (Schrimsher and Reier, 1992).  
Grip strength measurement is one of the methods used in this study to assess the 
neuromuscular function of the forelimbs. It is a simple, reproducible and 
provides quantitative measure for evaluating flexor and extensor function of the 
digits. In addition, it measure muscle functions that are likely to be related to 
the corticospinal tract i.e. digital flexors (Anderson et al., 2005, Anderson et al., 
2009b). Complete lateral hemisection injuries at the C5 segment are reported to 
cause a permanent loss of gripping and partial lesions sparing part of CST 
revealed residual gripping ability (Anderson et al., 2005). The compromised 
function is due to loss of descending input to motor neuron pools supplying the 
digital flexors of the forelimb which are located in C6 to T1 segment of the 
spinal cord (McKenna et al., 2000). In addition, the grip strength is highly 
relevant test as people living with cervical SCI report restoration of arm and 
hand function is of major importance to their daily activities (Anderson, 2004).  
Animals sometimes develop spasticity in their forelimbs after injury with the 
forepaw often becoming stiff and held in flexed position. The animals can still 
passively hook onto the bar but the force generated is due to stiffness of the 
paw and does not show active gripping and therefore animals with these signs of 
spasticity were not included.  
Results obtained from the grip strength test show that there is a significant 
decrease in gripping ability immediately after injury. A modest spontaneous 
recovery was observed afterwards but a significant deficit persists. A similar 
pattern of increase in gripping ability has been observed previously 2 weeks 
after cervical contusion injuries (Anderson et al., 2009b). Transplantation of 
hESC-MSCs did not show any further improvement in the gripping ability 
compared to controls suggesting no advantage of hESC-MSC transplants. 
The horizontal ladder walking test is a sensitive test for evaluating sensory-
motor co-ordination and the descending motor control of the limbs and can 
reveal deficits that are not obvious during normal locomotion or gait. The 
correct placement of the paw on the rungs, the weight bearing on each limb and 
forelimb-hindlimb co-ordination is required to successfully cross the ladder (Metz 
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and Whishaw, 2002, Webb and Muir, 2005, Metz and Whishaw, 2009). This task 
requires integrity of multiple systems including propiospinal, corticospinal, 
rubrospinal and dorsal column sensory fibres (Metz et al., 2000, Metz and 
Whishaw, 2002, Pearse et al., 2005). Our injury model shows complete axotomy 
of the main CST component in the dorsal column and the deficits or errors 
observed after injury might be mainly due to loss of CST control. 
In this study an irregular rung pattern was used in order to make the task more 
demanding (Metz and Whishaw, 2009). It has been reported that gait velocity 
and stress can influence the outcome of the task and more errors can result 
when animals cross the ladder faster or without care and attention (Metz et al., 
2000). Similar observations were made in our study where some animals crossed 
the ladder slowly and cautiously making few errors compared to those crossing 
faster. One strategy to overcome this problem in future studies would be to take 
into consideration the crossing approach while scoring the animals. Animals 
frequently used partial steps after injury and occasionally used the dorsal 
surface when the paw show signs of spasticity suggesting compensatory 
mechanisms in order to complete the task. Similar compensatory strategies have 
been reported with the use of wrist and forearm in the ladder walk test in 
severe cervical contusion injuries (Soblosky et al., 2001). 
There was a significant increase in the forelimb errors after injury with modest 
improvement over time and the hindlimbs were not affected by injury. There 
was also loss of forelimb/hindlimb co-ordination with an increase in forelimb 
stepping frequency and crossing time. Transplantation of hESC-MSCs did not 
promote any improvement in comparison to controls throughout the assessment 
period. Similar observations are reported for the ladder walk test for hindlimb 
analysis after a thoracic contusion injury where MSC transplantation showed no 
improvement in comparison to controls (Himes et al., 2006). In contrast, there 
was improvement in hindlimb function revealed by the ladder test after 
transplantation of human bone marrow derived MSCs in a thoracic injury model 
but this was not accompanied by improvement in BBB scores (Park et al., 
2010b).  
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3.5.4 Interpretation of electrophysiology assessment 
The other aim of the experiments reported in this chapter was to test whether 
delayed hESC-MSC transplants lead to enhancement of corticospinal and radial 
nerve evoked CDPs after SCI. That is, to see if the presence of hESC-MSCs within 
the injury cavity can improve function at the injury epicentre and vicinity of the 
injured spinal cord by inducing plasticity of the spared fibre tracts and therefore 
lead to the improvements of CDP amplitudes in the transplanted animals 
compared to controls. However, the results obtained suggest that the presence 
of hESC-MSCs had no detectable effect on the amplitudes of CDPs in comparison 
to the control animals. These observations suggest that hESC-MSCs were not able 
to promote plasticity and/or improvement of function in sensorimotor pathways. 
In contrast, a reduction in the amplitudes of the CST evoked CDPs was observed 
in the transplanted animals suggesting a worsening of function compared to 
control animals. 
There is a possibility that the electrophysiological assessment method is not 
sensitive enough to detect improvements in function. This seems unlikely 
because findings in the previous chapter showed that this technique is able to 
detect minor changes in amplitude of radial nerve evoked CDPs late in the 
course of the injury (i.e. reduction in CDP amplitudes below the level in the 6 
month survival animals) and also evidence of plasticity in the minor component 
of the CST. This suggests that this method is sensitive enough to detect minor 
changes in the circuitry at the level of the spinal cord. Furthermore, 
enhancements in CDP amplitudes after OEC transplants have previously been 
reported after bilateral dorsal column lesions at the lumbar level (Toft et al., 
2007). It is therefore reasonable to assume that if there was hESC-MSCs induced 
plasticity it would have been detected with the electrophysiological approach 
used. 
3.5.5 Potential reasons for absence of functionally detectable 
improvements after hESC-MSC transplants 
One possibility that might explain the current findings is that cells might not 
survive in sufficient numbers to promote robust plasticity in order to 
compensate for the functional deficit due to tissue loss in the grey and white 
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matter. However, this seems unlikely since we found that considerable numbers 
of the transplanted cells survived 7 weeks after transplantation. Although the 
number of transplanted cells remaining were not quantified, GFP-labelled cells 
were present in all the transplanted animals in the injury site. Furthermore, 
functional improvements have been reported with only 15 % of the transplanted 
MSCs surviving in a thoracic contusion injury 3 weeks after acute transplantation 
(Wu et al., 2003) and 1 % survival with improved function is reported in a 
compression injury model in mice (Boido et al., 2014).   
To improve cell survival and make the host tissue more receptive to cells 
immunosuppression was given by administering cyclosporine daily by injection 
throughout the course of the study, starting 2 days prior to the transplantation 
of cells. Previous observations in the lab showed that without 
immunosuppression transplanted cells die within days of transplantation. 
However, a daily injection of 20 mg/kg body weight of cyclosporine significantly 
improved survival and was well tolerated by the animals (Mohamad, 2014). This 
is in agreement with reports that high doses of cyclosporine improve survival of 
transplanted neural stem progenitor cells after SCI (Parr et al., 2008a). 
However, immunosuppression might not be very efficient in longer studies as the 
number of transplanted cells surviving reduces with time (Mohamad, 2014); 
equally, long-term immunosuppression might not be desirable in clinical 
settings.  
Transplantation of human cells into animal model (xenografting) may well 
exacerbate problems relating to graft survival. One possible strategy to avoid 
this could be the use of nude rats i.e. rats that are genetically altered so they do 
not express full complement of immune cells. This approach has been used in 
other xenotransplantation studies for example human MSCs (Hodgetts et al., 
2013), glial restricted-progenitors (Jin et al., 2011) and OECs (Gorrie et al., 
2010) transplantations in immunocompromised rats models of SCI. Because of 
the reduced immune response survival of the cells is generally good. However, 
the disadvantage of this approach is that it is less translationally relevant 
because clinical use of these cells will invariably require immunosuppressive 
treatment. In addition, to carry out behavioural testing in animals that are 
immunocompromised and should be maintained in a sterile environment.  
Chapter 3  243 
 
As large cavities are already present at the time of transplantations there is also 
a possibility that transplanted cells present in the centre of the cavity are not 
able to get enough nutrients and metabolic support to survive, and die off in the 
course of time. 
Because Cyclosporine administration has been shown to offer neuroprotective 
effects (Ibarra and Diaz-Ruiz, 2006) together with the enhancement of function 
in SCI models (McMahon et al., 2009), to be sure that any improvement of 
function could be attributed to the transplanted cells the same dose of 
cyclosporine was also administered to the control animals.    
The timing of transplantation after injury also appears to have a crucial role in 
determining functional outcome as the neuroprotective and immune modulatory 
actions of MSC transplants may be of greatest benefit in the early stages after 
injury. There have been several studies reporting to improved function when 
MSC transplantations were performed either immediately or with shorter delay 
after injury (Chopp et al., 2000, Hofstetter et al., 2002, Cizkova et al., 2006b, 
Dasari et al., 2007). Therefore, it is a possibility that in chronic injuries the 
neuroprotective actions are less effective and that this is one of the reasons for 
lack of functional improvement in this study with transplants performed 3 weeks 
after injury. However, no direct association between locomotor recovery and 
the timing of MSC transplants has been observed in a meta-analysis of animal 
studies reported by (Oliveri et al., 2014). Osaka and colleagues (2010) studied 
the effects of i.v. administration of MSCs at different time points on functional 
outcome and reported significant improvements with injections of cells 
performed in the first 3 days after contusion injury (Osaka et al., 2010). Despite 
promising results in the use of MSCs to treat acute SCI, there are fewer studies 
in chronic injury models. Zurita et al. (2006) have reported some degree of 
functional improvement in paraplegic rats after administration of MSCs 3 months 
after thoracic contusion injury. They also claimed differentiation of transplanted 
MSCs into neural tissue one year after transplantation (Zurita and Vaquero, 
2006).   
It has been reported that MSCs promote functional improvement by mechanisms 
other than axonal regeneration and proliferation, such as improved blood supply, 
secretion of trophic factors that promote plasticity, remyelination and 
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immunomodulation of the injury (reviewed by (Forostyak et al., 2013). 
Observations in our lab have shown that hESC-MSCs, like other sources of MSCs, 
promote laminin production, myelination and angiogenesis at the injury site. 
However they are not able to promote bridging axonal regeneration and there is 
no evidence of proliferation or differentiation (Mohamad, 2014). In this study we 
have also not observed that these cells promote plasticity. In addition, 
neuroprotective mechanisms offered by transplanted cells are likely to decrease 
with time after injury and the therapeutic window for ameliorating the 
consequences of injury may be very narrow. In this study transplants were 
performed 3 weeks after injury and findings from previous chapter show there is 
no secondary damage and injury has stabilized, therefore neuroprotection is 
unlikely to be beneficial in this model of SCI. ECM rich in laminin at the injury 
site provides a good substrate for axonal regeneration and improved blood 
supply through angiogenesis may be important in survival of the transplanted 
cells but may not be enough to promote in functional improvement. Similarly, 
the immune response after trauma develops in first few days and anti-immune 
effects of MSCs would less likely benefit at this stage.   
3.5.6 Are MSCs derived from hESC different from other sources 
of MSCs? 
The International Society for Cellular Therapy (ISCT) has proposed three minimal 
criteria to define MSCs. These include plastic adherence, in vitro differentiation 
potential, the presence of CD73, CD90 and CD105 surface markers and absence 
of haematopoietic antigens such as CD14, CD34, CD45 or CD11b, CD79α or CD19 
and HLA class II (Dominici et al., 2006). The hESC derived MSCs used in this study 
shown to meet the criteria of plastic adherence and in vitro differentiation into 
osteoblasts and adipocytes. They were also shown to express most of the 
markers described for other sources of MSCs. The hESC-MSCs were 70-90 % 
positive for the majority of the proposed markers i.e. CD44, CD73, CD105, CD166 
and HLA-ABC but relatively low for CD90 (Mohamad, 2014). The in vitro analysis 
of these cells also showed decreased transcription of genes for pluripotency 
specifically expressed in hESCs (OCT4 and NANOG) as differentiation of the cells 
into mesenchymal cells progressed. In addition, COL1A1, Twist1 and CD105 gene 
expression was upregulated which supports the commitment towards a 
mesenchymal lineage (Mohamad, 2014). The surface markers, gene expression 
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and in vitro differentiation all indicate that hESC-MSCs are very similar to MSCs 
derived from other sources and therefore it is reasonable to assume that they 
would behave similarly in vivo. However, secretome of the hESC-MSCs used in 
this study has not been fully investigated. It is possible that the cells fail to 
secrete molecules that are critical for the beneficial effects which some reports 
have claimed for MSCs or that they secrete factors which have a negative effect. 
The transplanted cells have been shown to displace the resident glial cells in 
areas where cells have tracked outside the injury site. Similar observations have 
been made with bone marrow MSCs, OECs and Schwann cell transplantations (Lu 
et al., 2006, Toft et al., 2013). This intense reactivity to the host tissue is also 
observed when hESC-MSCs are transplanted into normal cords (Mohamad, 2014). 
This undesirable property of transplanted cells may be another possibility for the 
poor functional outcome in this study.    
3.5.7 Transplanted cells fill the injury site and reduce the extent of 
injury  
Animals transplanted with the hESC-MSCs showed solid filling of the lesion area 
in contrast to the medium injected control animals which showed extensive 
cavitation and tissue disruption. Solid infilling of the injury site was a consistent 
feature in all the transplanted animals and the injury area was occupied by a 
mixture of GFP labelled cells and endogenous matrix. hESC-MSC transplantation 
has been shown to encourage production of ECM rich in laminin throughout the 
injury site and profuse blood vessel formation in the area surrounding the injury 
site (Mohamad, 2014).  
In addition, assessment of the extent of the injury by calculating injury size from 
the margins of the glial scar around the area filled with cells in transplanted 
animals and comparing this to the size of the cavity in controls indicated a 
reduction in injury size in transplanted animals at 10 weeks. Reduction in the 
cavity formation is in accordance with other studies using adult sources of MSCs 
(Wu et al., 2003, Ankeny et al., 2004) although in these studies transplants were 
done after a shorter delay after injury as compared to 3 weeks in this study. 
However, reduction of the injury size and prevention of cavity formation with 
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secretion of ECM rich in laminin, appears not to be sufficient alone to improve 
functional outcome.  
We considered the possibility that a chronic injury may not be amenable to the 
therapeutic effects of hESC-MSC transplantations. We therefore investigated the 
feasibility of transplantations after a shorter delay. Results revealed cell 
survival, migration of transplanted cells, lack of cavities and filling of the injury 
predominantly with laminin. Survival of cells was found mostly at the margins of 
the injury site which suggest that cells at the core may die off due to lack of 
adequate metabolic support. Furthermore, absence of host astrocytes in areas 
where transplanted cells have tracked suggest an undesirable effect on the host 
tissue. This effect has also been observed after injection of hESC-MSCs in normal 
cords (Mohamad, 2014). These findings suggest hESC-MSC transplants performed 
earlier after SCI are feasible but may not have any added advantage in terms of 
cell survival and tissue preservation compared to 3 week delayed transplants. 
ED1 immunolabelling was not used systematically but in the example (Figure 3-
18) it provided clear evidence of luminous macrophages in the vicinity of the 
injury. These may be involved in phagocytosis of cellular debris from ongoing 
death of transplanted cells. 
3.5.8 Comparison with previous studies 
It is difficult to make direct comparisons with our behavioural observations as 
there are no previous studies assessing the effects of MSCs in cervical contusion 
injuries. However, several studies have reported investigation of MSCs in 
thoracic contusion and compression injury models. Recently a systematic review 
with meta-analysis suggested that MSC transplantations have a substantial 
beneficial effect on locomotor recovery in rat SCI models (Oliveri et al., 2014). 
In addition, there has not been any study reporting any detrimental effects with 
administration of MSCs and no correlation has been reported between locomotor 
recovery and the timing of administration of MSCs (Oliveri et al., 2014). 
Furthermore, there are studies which correspond with the results reported in 
this chapter indicating that MSC transplants can reduce cavity formation but 
without any corresponding improvement in the functional outcome (Ankeny et 
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al., 2004, Sheth et al., 2008) or only transient improvements with no consistent 
long term benefits compared to controls (Himes et al., 2006).  
Pre-clinical investigations have used a variety of MSCs from different sources 
using different purification protocols and routes of administration and this may 
therefore explain some of the vastly different functional outcomes reported. In 
addition, the injury level and severity along with behavioural assessments are 
not standardized for and this heterogeneity between studies makes direct 
comparison difficult. All studies have demonstrated that MSC transplantation is 
safe without any detrimental effect regardless of recovery of function. However, 
there is a lack of studies using cervical level injury and this complicates the 
translation of these results into human SCI where traumatic injuries at the 
cervical level are most common. There is therefore need as for further 
evaluation of MSCs as a therapeutic intervention using cervical contusion injury 
models.  
This study had been designed to investigate the therapeutic potential of hESC-
MSCs in a clinically relevant model with the aim of having an off the shelf 
cellular transplant strategy for the treatment of SCI. This is the first time these 
cells have been used in vivo to assess functional outcome measures although, no 
functional improvements are observed with transplantation of hESC-MSCs. 
Further investigation with the aim of exploring the in vitro and in vivo trophic 
factor secreting properties of these cells would be desirable to better 
understand the potential therapeutic value of these cells.
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4 General discussion and future directions 
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4.1 General discussion 
4.1.1 Electrophysiological approaches for investigating function 
after spinal cord injury 
In this project we have demonstrated that CDP recording can provide a sensitive 
method to detect changes within the grey matter of the spinal cord. We have 
used this approach to provide for the first time complete and detailed 
information on the time course of functional changes in circuits of the grey 
matter of the spinal cord after a contusion injury.  
The work in the first part of the thesis provides an accurate picture of the 
temporal progression of functional changes in the spinal cord starting 
immediately after contusion injury and at different time points up to 6 months. 
Other electrophysiological techniques such as field potential recordings could be 
used to further explore functional changes in the spinal cord. However, 
recording of field potential may be difficult when there is cavity formation as 
observed after contusion injury. 
In vivo electrophysiology is the only way to provide direct information on what is 
happening in the local circuits and pathways in the spinal cord after injury and 
treatments in experimental models of SCI. It has been demonstrated in this 
project that with this approach it is possible to observe changes in the sensory 
pathways after stimulation of peripheral nerves and the descending corticospinal 
system in the vicinity of a SCI. Other methods like behavioural testing can 
provide evidence of improved functional performance in the ability of the 
animal to fulfil certain sensorimotor tasks. However, the improvement of 
behavioural function cannot provide information on whether improvement 
occurs due to compensatory changes at supraspinal or spinal levels. 
Furthermore, most studies combine behavioural testing with anatomical 
assessments and draw conclusions based on correlation between these two 
approaches whether function improves or worsens after SCI and/or therapeutic 
strategy. However, an electrophysiological approach has the advantage that it 
can evaluate the function of specific pathways and changes in the functional 
connections within the target pathway. Hence in vivo electrophysiology is the 
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only method that can provide information on changes in function at the spinal 
cord level.  
4.1.2 Limitation of electrophysiological approach 
A limitation of the electrophysiological approach is that it can only be used to 
evaluate the function of certain pathways. This is because the pathways to be 
investigated need to be in a relatively accessible anatomical location. In 
addition, only certain pathways can be maximally activated which is essential in 
order to make quantitative comparisons among different groups of animals. In 
rats the corticospinal and the dorsal column pathways, which have been used in 
this thesis, are the most convenient for study as it is possible to stimulate them 
selectively and record the synaptic activity generated by these pathways in the 
form of CDPs.  
Another disadvantage of the electrophysiological assessment approach is that it 
is not able to differentiate between strengthened connections that could be 
functionally and those that could have a detrimental effect. Plasticity in certain 
pathways might be beneficial and lead to improvement of function or 
maladaptive leading to problems such as pain or autonomic dysfunction. 
Therefore behavioural assessments are desirable along with electrophysiology to 
correlate the electrophysiological changes with behavioural outcomes. However, 
it is difficult to make specific correlations between changes in a single pathway 
like the corticospinal tract and behavioural outcomes as behaviour depends on 
the interaction of many different systems in the brain and spinal cord. These 
problems are not likely to impact on assessing contributions of primary and 
secondary damage and neuroprotective action (i.e. preservation of existing 
connection) but interpretation of the functional significance of plasticity is 
difficult with electrophysiology alone. 
Another limitation of in vivo electrophysiological technique is that it requires 
immense expertise and extensive personnel training in order to conduct these 
experiments consistently. Similarly, expertise is needed for the interpretation of 
the recordings and dealing with any technical issues that arise during the 
experiments. The cost, time and sacrifice of large number of animals required to 
reach an adequate level of competency are issues in this kind of work. 
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4.1.3 Future directions  
This thesis has provided useful information on using an in vivo 
electrophysiological approach to assess function in the grey matter after a 
contusion injury due to a high velocity impact to the cervical spinal cord. A 
similar approach has been used in animals with a dorsal column lesion to assess 
the effects of OEC transplants after SCI (Toft et al., 2007). However, so far 
there have been no investigations of the effects on the local circuit function of a 
compression or crush injury. The same electrophysiological method could 
provide valuable information on functional changes over time in grey matter in 
the vicinity of these injury models. It has previously been reported that there is 
gradual neuronal loss after compression injury rostral and caudal to the injury 
centre (Huang et al., 2007). Neuronal loss assessed by NeuN immunostaining at 
the core of the injury increased to 73 % at 3 days compared to 44 % 1 day after 
the compression injury (Huang et al., 2007). In contrast, neuronal loss is not 
evident after 24 hours in contusion injury models (Crowe et al., 1997, Liu et al., 
1997). This suggests that secondary processes may be more pronounced in 
compression injury compared to the contusion injury model where the higher 
velocity impact may lead to greater neuronal loss at the time of injury. It could 
be valuable to know this for testing neuroprotective strategies and has 
implications for understanding how secondary damage caused in compression 
injury could be diminished.   
As discussed previously in Chapter 2 deterioration of function in the local 
sensory system was observed at 3 days in fibres above the injury which is 
possibly due to demyelination of the parent axons past the injury. Furthermore, 
restoration of function has been observed over the same locations in 2 week 
survival animals attributed to spontaneous remyelination of the demyelinated 
axons. The process of demyelination and remyelination of the sensory axons 
have not been confirmed using anatomical techniques. Confirmatory evidence 
for these findings can be obtained with electron microscopy in future studies. In 
addition, electron microscopic investigation will provide information on the 
proportion of demyelinated, normally myelinated and remyelinated axons after 
injury confirming and evaluate the extent of damage and spontaneous repair to 
the sensory axons. Also information on peripheral versus central type myelin 
that lead to recovery of function in the affected axons can be obtained.   
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4.1.4 hESC derived MSCs as a potential therapy for SCI 
There are numerous reports that transplants of mesenchymal stem cells derived 
from various sources have produced a positive outcome in pre-clinical models of 
SCI. MSCs derived from a hESC line resemble MSCs derived from other sources 
and offer several advantages. Firstly, hESC-MSCs can be expanded efficiently to 
produce large volumes of cells with a consistent phenotype. Secondly, 
cryopreservation has been shown minimal effect on the properties of these cells. 
Also cryopreserved cells would be easier to transport compared to cells in 
culture. Thirdly, with the use of these cells invasive procedures to obtain cells 
from the donors or patients themselves can be avoided. In addition, it provides 
an opportunity for an “off the shelf” product for early therapeutic interventions 
in SCI and other neurological conditions. However, as observed in this thesis 
delayed transplantation of hESC-MSCs in a contusion injury model did not lead to 
functional improvements and as discussed previously in Chapter 3, there are 
several potential reasons for these findings. However, the most likely of these is 
that the majority of previous studies were of the effects of transplants 
performed acutely or within a relatively short time (a few days) after SCI. The 
aim of a cellular transplant therapy for chronic stage injuries would be different 
from acute SCI and may necessitate reconstruction of the injured spinal cord via 
cellular replacement, glial scar modification, functional axonal regeneration and 
filling of the cavities that may form. Furthermore, SCI is a multifaceted problem 
and it is anticipated that a combination therapy will be a more effective way to 
promote recovery than a single therapy alone.  
In fact, cellular transplants or even a mixture of cell therapies alone are not 
capable of reversing the consequences of SCI to any significant degree (Silva et 
al., 2014). Although, engineered cells might help, to achieve axonal 
regeneration a number of different strategies will need to be applied in 
combination. Lu et al. (2012) reported that combinatorial treatment can support 
axonal regeneration of the reticulospinal tract into and beyond either a partial 
cervical hemisection or complete thoracic spinal transection. They performed 
injections of cAMP into the reticular formation to stimulate endogenous growth 
of reticulospinal fibres. Secondly, they grafted bone marrow stromal cells into 
the lesion sites to provide a permissive bridge for axonal growth and thirdly, 
brain derived neurotrophic factor was applied to the spinal cord caudal to the 
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injury site in order to stimulate distal growth of motor axons. The severed 
reticulospinal fibres regenerated through the injury and also formed synapses on 
motor neuron below the lesion. Despite functional synapses below the lesion the 
behavioural outcome worsened in the treated animals (Lu et al., 2012). This 
highlights the complexity of reconstructing the injured spinal cord. Although 
with combinatorial therapy it is possible to achieve functional axonal 
regeneration a desirable functional outcome can only be achieved with 
formation of appropriate connections between regenerating axons and target 
neurons. Therefore looking at the complex nature of the SCI pathophysiology a 
mixture of therapies needs to be applied in a timely sequence with optimum 
dosing and route of administration to achieve functional improvement. In 
addition, intensive rehabilitation therapy may enhance functional recovery. 
Further pre-clinical studies using combination therapies are needed in other 
models of SCI before translating these strategies into clinics. 
Gene therapies hold great promise for the treatment of many neurodegenerative 
disorders and traumatic injuries in the CNS. Advancement in the field of genetic 
research in SCI might lead to the identification of genes and their biomolecular 
targets that have potential to induce robust improvements through axonal 
regeneration and formation of functional connection. Furthermore gene 
therapies may provide transgene expression for longer duration and sustained 
production of desired factors, for example, sustained release of BDNF, NT-3/4 
etc. This will be advantageous over cellular therapy where cells die off with the 
passage of time and steady levels of desired factors (e.g. neurotrophins/growth 
factors) cannot be maintained.  Another advantage of gene delivery is that 
multiple therapeutic genes can be delivered in tandem from the same delivery 
systems including vectors and biomaterials. In order to promote repair in SCI 
researchers are exploring gene delivery as a mechanism to reduce inflammation, 
decrease the glial scar, improve cell survival, promote axonal regeneration and 
plasticity and promote differentiation/engraftment of transplanted 
stem/progenitor cells (Walthers CM 2015). Gene therapy therefore provides 
another therapeutic approach along with the combinatorial therapies which can 
be translated into clinics and can be beneficial for SCI patients. 
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4.1.5 Conclusion 
This thesis provides a valuable insight into the changes in function that occur in 
spinal cord circuits in the vicinity of a contusion injury. It also provides a useful 
cervical model of SCI together with electrophysiological assessment to test 
therapies. Based on our results we conclude that injury due to a high velocity 
impact as made by IHI device shows that maximal damage or functional loss 
occurs at the time of primary trauma and secondary mechanisms have a minimal 
role in this injury model. This has implication that therapeutic window for a 
therapy aiming at neuroprotection that does not provide functional axonal 
regeneration may be very small to ameliorate the damage caused by contusion 
injury. The finding in this thesis has not been previously taken into consideration 
and it would have implication in terms of translation of a particular therapy into 
clinics and assigning patients that would benefit from a specific treatment. For 
example the mechanics of the injury may play a role in determining the 
appropriateness of specific treatment. SCI patients with a high velocity impact 
injury may need a different therapy compared to those with a more pronounced 
compression injury. This consideration has not been taken into account in 
clinical trials and may be one of the reasons for failure of improvement of 
function in SCI patients. Furthermore, delayed hESC-MSC transplants were not 
shown to provide any advantage in improvement of functional outcome. In 
addition, single therapy might not be sufficient to overcome the multifaceted 
pathology of SCI. 
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Appendix-A. Statistical analysis of differences between radial nerve evoked CDPs in different animals groups at each recording location.  
Results of ANOVA and Tukey’s post-hoc multiple comparison tests performed on mean CDP amplitudes at each recording location for each experimental group 
included in the study. 
 
-8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8 
One way ANOVA 0.1659 0.4729 0.3355 0.0205 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 0.0005 P<0.0001 P<0.0001 0.0053 
Tukey's Multiple Comparison Test 
                 
Normal vs Acute 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P < 0.05 P > 0.05 P < 0.01 P < 0.01 P > 0.05 
Normal vs 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 1hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 1hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P > 0.05 
Normal vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P < 0.05 P < 0.01 P > 0.05 
Normal vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 
Normal vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P < 0.05 P < 0.01 P > 0.05 
Normal vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P < 0.05 P < 0.05 P > 0.05 
Acute 20mins vs 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 1hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 1hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.01 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.001 P > 0.05 P > 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 1hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 1hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
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50 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.01 P < 0.01 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P > 0.05 P > 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 1hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.01 P < 0.01 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.05 P < 0.05 P > 0.05 P < 0.05 P > 0.05 P < 0.05 
1hr 50 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
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2hr 50 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.05 P > 0.05 P > 0.05 
3 dys vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2wks vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2wks vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2wks vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2wks vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
4wks vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
4wks vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
4wks vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
7wks vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
7wks vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3mths vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
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Appendix-B. Statistical analysis of differences between pyramidal evoked CDPs in different animals groups at each recording location.  
Results of ANOVA and Tukey’s post-hoc multiple comparison tests performed on mean CDP amplitudes at each recording location for each experimental group 
included in the study. 
 
-8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8 
One way ANOVA P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 P<0.0001 0.0322 0.0647 0.1562 0.0009 0.0002 P<0.0001 
Tukey's Multiple Comparison Test 
                 
Normal vs Acute 20mins P < 0.001 P < 0.001 P < 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 50 mins P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 1hr 20 mins P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 1hr 50 mins P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 2hr 20mins P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 2hr 50 mins P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 3hr 20 mins P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs Acute 4hrs P < 0.001 P < 0.001 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 3 dys P < 0.001 P < 0.001 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 2wks P < 0.001 P < 0.001 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 4wks P < 0.001 P < 0.001 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 7wks P < 0.001 P < 0.001 P < 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 3mths P < 0.001 P < 0.001 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Normal vs 6mths P < 0.001 P < 0.001 P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 1hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 1hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 20mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.001 P < 0.01 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 
Acute 20mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 
Acute 20mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 
Acute 20mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 
Acute 20mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 
Acute 20mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 
50 mins vs 1hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 1hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
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50 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.01 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
50 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 1hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.01 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 20 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 2hr 20mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.01 P < 0.01 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
1hr 50 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 2hr 50 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.01 P < 0.01 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 20mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 3hr 20 mins P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
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2hr 50 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2hr 50 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs Acute 4hrs P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.01 P < 0.001 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3hr 20 mins vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 3 dys P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
Acute 4hrs vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 2wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 3mths P > 0.05 P > 0.05 P > 0.05 P < 0.01 P < 0.01 P < 0.01 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3 dys vs 6mths P > 0.05 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2wks vs 4wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2wks vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2wks vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
2wks vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
4wks vs 7wks P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
4wks vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
4wks vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
7wks vs 3mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
7wks vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
3mths vs 6mths P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
 
